date generated: 2024-11-01

Background

Mitch performs unidimensional and multidimensional gene set enrichment analysis. The concept behind this dates to work by Cox and Mann (https://doi.org/10.1186/1471-2105-13-S16-S12). This implementation is suited to R based workflows of multi-omics datasets. This software was developed by Antony Kaspi and Mark Ziemann. Learn more about Mitch at the website: https://github.com/markziemann/Mitch

Input profiles

Here is the first few lines of the input profile.

The profiling data being passed to mitch
x
5_8S_rRNA -1.9378570
A1BG -1.0557397
A1BG-AS1 -0.1955978
A1CF 0.6818832
A2M 0.4955888
A2M-AS1 0.8142046

Here are some metrics about the input data profile:

Profiling data metrics
Profile metrics
num_genesets 2725
num_genes_in_profile 21999
duplicated_genes_present 0
num_profile_genes_in_sets 8829
num_profile_genes_not_in_sets 13170

Here is a plot of the input profiles. Note the dynamic ranges.

Here is the contour plot of the profile including all detected genes.

Input genesets

Here are some metrics about the gene sets used:

GMT file of genesets:
Gene set metrics
Gene sets metrics
num_genesets 2725
num_genesets_excluded 1188
num_genesets_included 1537

Differential pathway expression


Interactive enrichment scatterplot

Significance is calculated by -log10(p-value). All points shown are FDR<0.05.

Significance is calculated by -log10(p-value). Top N sets shown irrespective of FDR.

Results table

Top N= 50 gene sets
set setSize pANOVA s.dist p.adjustANOVA
Arachidonate production from DAG 5 1.55e-03 -0.817 1.08e-02
Formation of ATP by chemiosmotic coupling 20 2.93e-10 -0.814 8.83e-09
MET activates PI3K/AKT signaling 5 2.63e-03 0.777 1.69e-02
PI3K events in ERBB4 signaling 6 1.53e-03 0.747 1.07e-02
Malate-aspartate shuttle 8 4.35e-04 -0.718 3.68e-03
Negative regulation of activity of TFAP2 (AP-2) family transcription factors 6 2.36e-03 -0.717 1.54e-02
Synthesis of Ketone Bodies 6 2.77e-03 -0.705 1.76e-02
Purine ribonucleoside monophosphate biosynthesis 9 3.05e-04 -0.695 2.67e-03
Maturation of spike protein 9683686 5 7.16e-03 -0.694 3.85e-02
Ketone body metabolism 8 7.27e-04 -0.690 5.78e-03
Mitochondrial translation elongation 90 1.03e-29 -0.689 1.53e-27
Peptide chain elongation 88 1.76e-28 -0.682 1.70e-26
Mitochondrial translation initiation 90 9.60e-29 -0.677 1.03e-26
Viral mRNA Translation 88 1.72e-27 -0.669 1.45e-25
Cristae formation 33 3.62e-11 -0.665 1.13e-09
Eukaryotic Translation Elongation 93 1.40e-28 -0.664 1.42e-26
Complex III assembly 23 3.92e-08 -0.662 9.46e-07
Mitochondrial translation termination 90 2.15e-27 -0.660 1.73e-25
Eukaryotic Translation Termination 92 1.09e-27 -0.657 1.00e-25
SRP-dependent cotranslational protein targeting to membrane 111 7.62e-33 -0.655 1.64e-30
Formation of a pool of free 40S subunits 100 1.88e-29 -0.651 2.14e-27
Selenocysteine synthesis 92 4.54e-27 -0.649 3.37e-25
SARS-CoV-1 modulates host translation machinery 36 1.70e-11 -0.648 5.46e-10
Synthesis of GDP-mannose 6 6.02e-03 -0.648 3.30e-02
Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) 94 3.18e-27 -0.644 2.45e-25
Mitochondrial translation 96 1.63e-27 -0.641 1.44e-25
Mitochondrial protein import 63 1.71e-18 -0.639 8.24e-17
Nucleotide biosynthesis 12 1.58e-04 -0.630 1.49e-03
L13a-mediated translational silencing of Ceruloplasmin expression 110 1.15e-29 -0.623 1.59e-27
Release of apoptotic factors from the mitochondria 6 8.48e-03 -0.621 4.42e-02
GTP hydrolysis and joining of the 60S ribosomal subunit 111 1.25e-29 -0.620 1.59e-27
Response of EIF2AK4 (GCN2) to amino acid deficiency 100 7.88e-27 -0.620 5.64e-25
Cohesin Loading onto Chromatin 10 7.31e-04 0.617 5.79e-03
Cap-dependent Translation Initiation 118 8.08e-31 -0.614 1.42e-28
Eukaryotic Translation Initiation 118 8.08e-31 -0.614 1.42e-28
Translation 293 1.36e-70 -0.601 2.63e-67
SARS-CoV-2 modulates host translation machinery 49 5.28e-13 -0.596 1.93e-11
rRNA processing in the nucleus and cytosol 189 6.04e-45 -0.592 3.89e-42
Mitochondrial tRNA aminoacylation 21 2.66e-06 -0.592 3.99e-05
Major pathway of rRNA processing in the nucleolus and cytosol 179 1.69e-42 -0.591 8.17e-40
rRNA processing 213 1.07e-49 -0.588 1.03e-46
Formation of xylulose-5-phosphate 5 2.54e-02 -0.577 1.02e-01
Classical antibody-mediated complement activation 69 1.19e-16 -0.576 5.47e-15
Formation of the ternary complex, and subsequently, the 43S complex 51 1.11e-12 -0.576 3.89e-11
SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs 11 1.03e-03 -0.571 7.87e-03
Folding of actin by CCT/TriC 10 2.03e-03 -0.564 1.37e-02
Ribosomal scanning and start codon recognition 58 1.50e-13 -0.560 5.92e-12
Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus 5 3.01e-02 -0.560 1.16e-01
Cytosolic iron-sulfur cluster assembly 13 4.72e-04 -0.560 3.99e-03
Selenoamino acid metabolism 115 3.38e-25 -0.559 2.25e-23


Results (complete table)


Click HERE to show results for all gene sets

Complete results
set setSize pANOVA s.dist p.adjustANOVA
Arachidonate production from DAG 5 1.55e-03 -0.817000 1.08e-02
Formation of ATP by chemiosmotic coupling 20 2.93e-10 -0.814000 8.83e-09
MET activates PI3K/AKT signaling 5 2.63e-03 0.777000 1.69e-02
PI3K events in ERBB4 signaling 6 1.53e-03 0.747000 1.07e-02
Malate-aspartate shuttle 8 4.35e-04 -0.718000 3.68e-03
Negative regulation of activity of TFAP2 (AP-2) family transcription factors 6 2.36e-03 -0.717000 1.54e-02
Synthesis of Ketone Bodies 6 2.77e-03 -0.705000 1.76e-02
Purine ribonucleoside monophosphate biosynthesis 9 3.05e-04 -0.695000 2.67e-03
Maturation of spike protein 9683686 5 7.16e-03 -0.694000 3.85e-02
Ketone body metabolism 8 7.27e-04 -0.690000 5.78e-03
Mitochondrial translation elongation 90 1.03e-29 -0.689000 1.53e-27
Peptide chain elongation 88 1.76e-28 -0.682000 1.70e-26
Mitochondrial translation initiation 90 9.60e-29 -0.677000 1.03e-26
Viral mRNA Translation 88 1.72e-27 -0.669000 1.45e-25
Cristae formation 33 3.62e-11 -0.665000 1.13e-09
Eukaryotic Translation Elongation 93 1.40e-28 -0.664000 1.42e-26
Complex III assembly 23 3.92e-08 -0.662000 9.46e-07
Mitochondrial translation termination 90 2.15e-27 -0.660000 1.73e-25
Eukaryotic Translation Termination 92 1.09e-27 -0.657000 1.00e-25
SRP-dependent cotranslational protein targeting to membrane 111 7.62e-33 -0.655000 1.64e-30
Formation of a pool of free 40S subunits 100 1.88e-29 -0.651000 2.14e-27
Selenocysteine synthesis 92 4.54e-27 -0.649000 3.37e-25
SARS-CoV-1 modulates host translation machinery 36 1.70e-11 -0.648000 5.46e-10
Synthesis of GDP-mannose 6 6.02e-03 -0.648000 3.30e-02
Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) 94 3.18e-27 -0.644000 2.45e-25
Mitochondrial translation 96 1.63e-27 -0.641000 1.44e-25
Mitochondrial protein import 63 1.71e-18 -0.639000 8.24e-17
Nucleotide biosynthesis 12 1.58e-04 -0.630000 1.49e-03
L13a-mediated translational silencing of Ceruloplasmin expression 110 1.15e-29 -0.623000 1.59e-27
Release of apoptotic factors from the mitochondria 6 8.48e-03 -0.621000 4.42e-02
GTP hydrolysis and joining of the 60S ribosomal subunit 111 1.25e-29 -0.620000 1.59e-27
Response of EIF2AK4 (GCN2) to amino acid deficiency 100 7.88e-27 -0.620000 5.64e-25
Cohesin Loading onto Chromatin 10 7.31e-04 0.617000 5.79e-03
Cap-dependent Translation Initiation 118 8.08e-31 -0.614000 1.42e-28
Eukaryotic Translation Initiation 118 8.08e-31 -0.614000 1.42e-28
Translation 293 1.36e-70 -0.601000 2.63e-67
SARS-CoV-2 modulates host translation machinery 49 5.28e-13 -0.596000 1.93e-11
rRNA processing in the nucleus and cytosol 189 6.04e-45 -0.592000 3.89e-42
Mitochondrial tRNA aminoacylation 21 2.66e-06 -0.592000 3.99e-05
Major pathway of rRNA processing in the nucleolus and cytosol 179 1.69e-42 -0.591000 8.17e-40
rRNA processing 213 1.07e-49 -0.588000 1.03e-46
Formation of xylulose-5-phosphate 5 2.54e-02 -0.577000 1.02e-01
Classical antibody-mediated complement activation 69 1.19e-16 -0.576000 5.47e-15
Formation of the ternary complex, and subsequently, the 43S complex 51 1.11e-12 -0.576000 3.89e-11
SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs 11 1.03e-03 -0.571000 7.87e-03
Folding of actin by CCT/TriC 10 2.03e-03 -0.564000 1.37e-02
Ribosomal scanning and start codon recognition 58 1.50e-13 -0.560000 5.92e-12
Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus 5 3.01e-02 -0.560000 1.16e-01
Cytosolic iron-sulfur cluster assembly 13 4.72e-04 -0.560000 3.99e-03
Selenoamino acid metabolism 115 3.38e-25 -0.559000 2.25e-23
rRNA modification in the nucleus and cytosol 59 1.13e-13 -0.559000 4.53e-12
RUNX1 regulates transcription of genes involved in BCR signaling 6 1.83e-02 0.556000 8.03e-02
Abacavir ADME 5 3.15e-02 0.555000 1.21e-01
Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S 59 1.70e-13 -0.554000 6.58e-12
Translation initiation complex formation 58 3.72e-13 -0.551000 1.38e-11
tRNA processing in the mitochondrion 24 3.03e-06 -0.550000 4.46e-05
Erythropoietin activates Phosphoinositide-3-kinase (PI3K) 11 1.57e-03 0.550000 1.09e-02
Creation of C4 and C2 activators 71 1.54e-15 -0.547000 6.90e-14
rRNA processing in the mitochondrion 24 3.92e-06 -0.544000 5.41e-05
SLBP independent Processing of Histone Pre-mRNAs 10 3.05e-03 -0.541000 1.93e-02
Scavenging of heme from plasma 70 4.89e-15 -0.541000 2.05e-13
Defective GALNT12 causes CRCS1 9 5.12e-03 -0.539000 2.90e-02
Respiratory electron transport 149 6.48e-30 -0.538000 1.04e-27
Phosphate bond hydrolysis by NUDT proteins 7 1.36e-02 -0.538000 6.47e-02
rRNA modification in the mitochondrion 8 8.55e-03 -0.537000 4.44e-02
Regulation of expression of SLITs and ROBOs 149 1.32e-29 -0.536000 1.59e-27
Competing endogenous RNAs (ceRNAs) regulate PTEN translation 11 2.12e-03 0.535000 1.42e-02
CD22 mediated BCR regulation 58 1.79e-12 -0.535000 6.19e-11
Specification of primordial germ cells 6 2.34e-02 0.534000 9.64e-02
Sulfide oxidation to sulfate 5 3.91e-02 -0.533000 1.41e-01
PI-3K cascade:FGFR3 10 3.71e-03 0.530000 2.22e-02
Metabolism of folate and pterines 16 2.46e-04 -0.529000 2.23e-03
Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) 114 1.72e-22 -0.528000 9.49e-21
Nonsense-Mediated Decay (NMD) 114 1.72e-22 -0.528000 9.49e-21
Maturation of TCA enzymes and regulation of TCA cycle 20 4.33e-05 -0.528000 4.84e-04
PTK6 Regulates Cell Cycle 6 2.57e-02 -0.526000 1.03e-01
GDP-fucose biosynthesis 6 2.61e-02 -0.524000 1.03e-01
tRNA Aminoacylation 42 4.28e-09 -0.524000 1.25e-07
FGFR3 ligand binding and activation 5 4.31e-02 0.522000 1.49e-01
FGFR3c ligand binding and activation 5 4.31e-02 0.522000 1.49e-01
Organic anion transporters 7 1.72e-02 -0.520000 7.78e-02
Initial triggering of complement 79 1.58e-15 -0.518000 6.94e-14
ARMS-mediated activation 6 2.82e-02 0.517000 1.09e-01
Mitochondrial iron-sulfur cluster biogenesis 13 1.25e-03 -0.517000 9.10e-03
FASTK family proteins regulate processing and stability of mitochondrial RNAs 19 9.67e-05 -0.517000 9.94e-04
Ubiquitin Mediated Degradation of Phosphorylated Cdc25A 39 2.58e-08 -0.515000 6.40e-07
p53-Independent DNA Damage Response 39 2.58e-08 -0.515000 6.40e-07
p53-Independent G1/S DNA damage checkpoint 39 2.58e-08 -0.515000 6.40e-07
Negative regulation of TCF-dependent signaling by DVL-interacting proteins 5 4.63e-02 -0.515000 1.56e-01
Influenza Viral RNA Transcription and Replication 135 7.99e-25 -0.512000 5.14e-23
FBXL7 down-regulates AURKA during mitotic entry and in early mitosis 41 1.83e-08 -0.508000 4.78e-07
Vif-mediated degradation of APOBEC3G 41 1.99e-08 -0.506000 5.12e-07
Post-transcriptional silencing by small RNAs 7 2.04e-02 0.506000 8.76e-02
MECP2 regulates transcription factors 5 5.09e-02 0.504000 1.67e-01
Regulation of ornithine decarboxylase (ODC) 38 1.10e-07 -0.498000 2.47e-06
Mitochondrial calcium ion transport 22 5.44e-05 -0.497000 6.00e-04
Complex I biogenesis 66 3.59e-12 -0.495000 1.22e-10
Metabolism of polyamines 46 6.90e-09 -0.494000 1.93e-07
Citric acid cycle (TCA cycle) 34 6.88e-07 -0.492000 1.24e-05
Complex IV assembly 45 1.13e-08 -0.492000 3.11e-07
Synthesis of 12-eicosatetraenoic acid derivatives 6 4.01e-02 -0.484000 1.42e-01
Autodegradation of the E3 ubiquitin ligase COP1 38 2.68e-07 -0.482000 5.59e-06
PI3K events in ERBB2 signaling 11 5.73e-03 0.481000 3.19e-02
Ubiquitin-dependent degradation of Cyclin D 39 2.46e-07 -0.477000 5.22e-06
Synthesis of 15-eicosatetraenoic acid derivatives 6 4.36e-02 -0.476000 1.50e-01
mRNA decay by 3’ to 5’ exoribonuclease 13 3.11e-03 -0.474000 1.95e-02
Influenza Infection 154 3.44e-24 -0.473000 2.14e-22
Cytosolic tRNA aminoacylation 24 6.12e-05 -0.473000 6.64e-04
Regulation of activated PAK-2p34 by proteasome mediated degradation 37 6.74e-07 -0.472000 1.23e-05
mitochondrial fatty acid beta-oxidation of unsaturated fatty acids 6 4.53e-02 -0.472000 1.54e-01
Cleavage of the damaged purine 22 1.49e-04 -0.467000 1.43e-03
Depurination 22 1.49e-04 -0.467000 1.43e-03
Recognition and association of DNA glycosylase with site containing an affected purine 22 1.49e-04 -0.467000 1.43e-03
Vpu mediated degradation of CD4 39 4.51e-07 -0.467000 8.63e-06
Beta oxidation of hexanoyl-CoA to butanoyl-CoA 5 7.11e-02 -0.466000 2.09e-01
Aerobic respiration and respiratory electron transport 245 2.90e-36 -0.466000 6.99e-34
Activated NTRK3 signals through PI3K 5 7.22e-02 0.464000 2.12e-01
Cellular response to starvation 148 2.32e-22 -0.463000 1.25e-20
Defective HLCS causes multiple carboxylase deficiency 7 3.43e-02 -0.462000 1.29e-01
SCF-beta-TrCP mediated degradation of Emi1 42 2.23e-07 -0.462000 4.83e-06
Formation of tubulin folding intermediates by CCT/TriC 21 2.50e-04 -0.462000 2.26e-03
DNA Damage Reversal 8 2.47e-02 -0.458000 1.00e-01
Modulation by Mtb of host immune system 7 3.58e-02 -0.458000 1.32e-01
Hh mutants are degraded by ERAD 42 2.86e-07 -0.458000 5.82e-06
Phenylalanine and tyrosine metabolism 9 1.76e-02 -0.457000 7.88e-02
Cross-presentation of soluble exogenous antigens (endosomes) 35 3.18e-06 -0.455000 4.63e-05
KSRP (KHSRP) binds and destabilizes mRNA 17 1.17e-03 -0.455000 8.65e-03
APOBEC3G mediated resistance to HIV-1 infection 5 7.86e-02 -0.454000 2.23e-01
ATF6 (ATF6-alpha) activates chaperone genes 10 1.30e-02 -0.454000 6.27e-02
Hh mutants abrogate ligand secretion 43 2.72e-07 -0.453000 5.59e-06
Mitochondrial RNA degradation 25 8.86e-05 -0.453000 9.20e-04
Recycling of eIF2:GDP 8 2.71e-02 -0.451000 1.06e-01
Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA 5 8.13e-02 -0.450000 2.28e-01
FGFR2c ligand binding and activation 5 8.18e-02 0.449000 2.29e-01
Proteasome assembly 50 4.19e-08 -0.448000 9.99e-07
Negative regulation of NOTCH4 signaling 44 2.71e-07 -0.448000 5.59e-06
Defective CFTR causes cystic fibrosis 47 1.12e-07 -0.447000 2.49e-06
Alternative complement activation 5 8.33e-02 -0.447000 2.33e-01
Killing mechanisms 9 2.06e-02 -0.446000 8.78e-02
WNT5:FZD7-mediated leishmania damping 9 2.06e-02 -0.446000 8.78e-02
FCGR activation 76 2.00e-11 -0.445000 6.35e-10
Molybdenum cofactor biosynthesis 6 5.93e-02 -0.445000 1.84e-01
tRNA modification in the mitochondrion 9 2.13e-02 -0.443000 8.95e-02
Prefoldin mediated transfer of substrate to CCT/TriC 25 1.29e-04 -0.442000 1.29e-03
Mitochondrial protein degradation 96 7.34e-14 -0.442000 3.02e-12
DNA methylation 18 1.20e-03 -0.441000 8.80e-03
LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production 5 8.82e-02 0.440000 2.42e-01
AUF1 (hnRNP D0) binds and destabilizes mRNA 42 8.13e-07 -0.440000 1.45e-05
The role of GTSE1 in G2/M progression after G2 checkpoint 59 5.13e-09 -0.440000 1.48e-07
Synthesis of Dolichyl-phosphate 6 6.24e-02 -0.439000 1.91e-01
Glycosphingolipid transport 7 4.48e-02 -0.438000 1.53e-01
RUNX2 regulates genes involved in cell migration 6 6.37e-02 -0.437000 1.92e-01
Fatty acids 6 6.39e-02 0.437000 1.92e-01
Synthesis of diphthamide-EEF2 8 3.27e-02 -0.436000 1.24e-01
Activation of RAS in B cells 5 9.17e-02 0.435000 2.48e-01
Hedgehog ligand biogenesis 47 2.43e-07 -0.435000 5.22e-06
Abortive elongation of HIV-1 transcript in the absence of Tat 23 3.06e-04 -0.435000 2.67e-03
Phenylalanine metabolism 5 9.31e-02 -0.434000 2.50e-01
Diseases of Base Excision Repair 5 9.42e-02 -0.432000 2.53e-01
Degradation of DVL 43 9.63e-07 -0.432000 1.66e-05
Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding 28 7.69e-05 -0.432000 8.12e-04
Interleukin-6 signaling 11 1.35e-02 0.430000 6.46e-02
Packaging Of Telomere Ends 18 1.64e-03 -0.429000 1.13e-02
Binding and Uptake of Ligands by Scavenger Receptors 94 7.46e-13 -0.428000 2.67e-11
IFNG signaling activates MAPKs 8 3.63e-02 0.427000 1.34e-01
Gain-of-function MRAS complexes activate RAF signaling 8 3.65e-02 0.427000 1.34e-01
SHOC2 M1731 mutant abolishes MRAS complex function 8 3.65e-02 0.427000 1.34e-01
Signaling by MRAS-complex mutants 8 3.65e-02 0.427000 1.34e-01
Gamma-carboxylation of protein precursors 6 7.06e-02 -0.426000 2.08e-01
RNA Polymerase III Chain Elongation 18 1.76e-03 -0.426000 1.20e-02
Reversal of alkylation damage by DNA dioxygenases 7 5.13e-02 -0.425000 1.68e-01
Defective GALNT3 causes HFTC 9 2.73e-02 -0.425000 1.07e-01
PI-3K cascade:FGFR4 11 1.47e-02 0.425000 6.83e-02
Signaling by FGFR3 in disease 14 5.94e-03 0.425000 3.28e-02
Regulation of PTEN mRNA translation 13 8.13e-03 0.424000 4.29e-02
Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET) 5 1.01e-01 0.423000 2.64e-01
Regulation of Apoptosis 40 3.64e-06 -0.423000 5.17e-05
Regulation of CDH11 mRNA translation by microRNAs 8 3.85e-02 0.423000 1.40e-01
Regulation of NPAS4 mRNA translation 8 3.85e-02 0.423000 1.40e-01
TNFR1-mediated ceramide production 6 7.34e-02 -0.422000 2.14e-01
GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 42 2.25e-06 -0.422000 3.48e-05
Signaling by LTK in cancer 7 5.51e-02 0.419000 1.75e-01
NADE modulates death signalling 5 1.06e-01 -0.418000 2.72e-01
Acyl chain remodelling of PI 10 2.24e-02 0.417000 9.31e-02
Asymmetric localization of PCP proteins 49 4.45e-07 -0.417000 8.59e-06
Post-chaperonin tubulin folding pathway 18 2.26e-03 -0.416000 1.48e-02
NFE2L2 regulates pentose phosphate pathway genes 8 4.30e-02 0.413000 1.49e-01
Interleukin-18 signaling 6 8.13e-02 0.411000 2.28e-01
Calcitonin-like ligand receptors 5 1.12e-01 0.410000 2.85e-01
Protein localization 157 6.47e-19 -0.410000 3.20e-17
SCF(Skp2)-mediated degradation of p27/p21 50 5.13e-07 -0.410000 9.46e-06
Formation of axial mesoderm 6 8.18e-02 0.410000 2.29e-01
Gluconeogenesis 19 2.02e-03 -0.409000 1.37e-02
ATF6 (ATF6-alpha) activates chaperones 12 1.43e-02 -0.408000 6.69e-02
Regulation of RUNX3 expression and activity 45 2.15e-06 -0.408000 3.36e-05
Role of LAT2/NTAL/LAB on calcium mobilization 77 6.08e-10 -0.408000 1.81e-08
SUMO is transferred from E1 to E2 (UBE2I, UBC9) 7 6.20e-02 -0.407000 1.90e-01
Stabilization of p53 43 3.81e-06 -0.407000 5.34e-05
Regulation of Complement cascade 96 5.25e-12 -0.407000 1.75e-10
RNA Polymerase I Promoter Opening 17 3.65e-03 -0.407000 2.21e-02
Germ layer formation at gastrulation 9 3.47e-02 0.407000 1.29e-01
MET activates RAP1 and RAC1 10 2.69e-02 0.404000 1.06e-01
Defective C1GALT1C1 causes TNPS 10 2.75e-02 -0.403000 1.07e-01
HDMs demethylate histones 22 1.09e-03 0.402000 8.09e-03
Signaling by ROBO receptors 189 1.50e-21 -0.402000 7.84e-20
Somitogenesis 41 9.34e-06 -0.400000 1.21e-04
Diseases associated with glycosylation precursor biosynthesis 15 7.44e-03 -0.399000 3.97e-02
Prostanoid ligand receptors 8 5.15e-02 -0.398000 1.68e-01
Pausing and recovery of Tat-mediated HIV elongation 30 1.65e-04 -0.397000 1.54e-03
Tat-mediated HIV elongation arrest and recovery 30 1.65e-04 -0.397000 1.54e-03
Degradation of GLI2 by the proteasome 45 4.47e-06 -0.395000 6.04e-05
Signaling by FLT3 fusion proteins 18 3.70e-03 0.395000 2.22e-02
Diseases associated with N-glycosylation of proteins 20 2.24e-03 -0.395000 1.48e-02
Reversible hydration of carbon dioxide 8 5.32e-02 0.395000 1.71e-01
Complement cascade 100 9.73e-12 -0.394000 3.19e-10
Phase 3 - rapid repolarisation 6 9.57e-02 0.393000 2.56e-01
APC/C:Cdc20 mediated degradation of Securin 55 4.78e-07 -0.392000 9.06e-06
Phosphorylation of Emi1 6 9.73e-02 -0.391000 2.58e-01
POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation 5 1.30e-01 0.391000 3.13e-01
Ubiquinol biosynthesis 13 1.51e-02 -0.389000 6.98e-02
Termination of O-glycan biosynthesis 16 7.28e-03 -0.387000 3.91e-02
Sema4D mediated inhibition of cell attachment and migration 7 7.60e-02 -0.387000 2.19e-01
RUNX3 regulates BCL2L11 (BIM) transcription 5 1.36e-01 0.385000 3.20e-01
RNA Polymerase III Transcription Initiation From Type 1 Promoter 28 4.17e-04 -0.385000 3.58e-03
RNA Polymerase III Transcription Initiation From Type 2 Promoter 27 5.30e-04 -0.385000 4.34e-03
Signaling by cytosolic FGFR1 fusion mutants 18 5.02e-03 0.382000 2.86e-02
Digestion 5 1.40e-01 0.382000 3.24e-01
Na+/Cl- dependent neurotransmitter transporters 8 6.26e-02 0.380000 1.91e-01
APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 61 2.93e-07 -0.380000 5.89e-06
Mitotic Telophase/Cytokinesis 13 1.79e-02 0.379000 7.99e-02
GLI3 is processed to GLI3R by the proteasome 46 8.99e-06 -0.378000 1.18e-04
Purine catabolism 16 8.85e-03 -0.378000 4.56e-02
Defects in biotin (Btn) metabolism 8 6.43e-02 -0.378000 1.93e-01
Autodegradation of Cdh1 by Cdh1:APC/C 54 1.84e-06 -0.375000 2.97e-05
SUMO is conjugated to E1 (UBA2:SAE1) 5 1.46e-01 -0.375000 3.35e-01
PTK6 promotes HIF1A stabilization 6 1.12e-01 0.374000 2.85e-01
Regulation of RUNX2 expression and activity 54 2.05e-06 -0.373000 3.22e-05
Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane 11 3.20e-02 -0.373000 1.22e-01
Erythropoietin activates Phospholipase C gamma (PLCG) 6 1.14e-01 0.372000 2.88e-01
Degradation of cysteine and homocysteine 13 2.02e-02 -0.372000 8.69e-02
Base-Excision Repair, AP Site Formation 29 5.32e-04 -0.372000 4.34e-03
Protein hydroxylation 17 8.19e-03 -0.370000 4.31e-02
FCERI mediated NF-kB activation 129 3.68e-13 -0.370000 1.38e-11
Processing of SMDT1 15 1.31e-02 -0.370000 6.33e-02
Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha 52 3.95e-06 -0.370000 5.41e-05
DNA Damage Recognition in GG-NER 38 8.23e-05 -0.369000 8.64e-04
Orc1 removal from chromatin 58 1.17e-06 -0.369000 1.95e-05
Degradation of AXIN 42 3.76e-05 -0.367000 4.25e-04
G1/S DNA Damage Checkpoints 54 3.02e-06 -0.367000 4.46e-05
Inhibition of DNA recombination at telomere 33 2.85e-04 -0.365000 2.52e-03
Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE) 6 1.23e-01 0.364000 3.05e-01
CD209 (DC-SIGN) signaling 20 4.91e-03 0.363000 2.80e-02
Degradation of GLI1 by the proteasome 46 2.03e-05 -0.363000 2.37e-04
Defective pyroptosis 27 1.09e-03 -0.363000 8.11e-03
SARS-CoV-2 targets host intracellular signalling and regulatory pathways 12 2.94e-02 -0.363000 1.14e-01
Activation of the phototransduction cascade 8 7.60e-02 0.362000 2.19e-01
NOTCH2 intracellular domain regulates transcription 11 3.75e-02 0.362000 1.37e-01
Removal of aminoterminal propeptides from gamma-carboxylated proteins 6 1.25e-01 -0.362000 3.07e-01
HIV elongation arrest and recovery 32 4.33e-04 -0.359000 3.68e-03
Pausing and recovery of HIV elongation 32 4.33e-04 -0.359000 3.68e-03
Synthesis of glycosylphosphatidylinositol (GPI) 18 8.67e-03 -0.357000 4.49e-02
TGFBR3 expression 20 5.74e-03 0.357000 3.19e-02
SIRT1 negatively regulates rRNA expression 22 3.87e-03 -0.356000 2.30e-02
Biotin transport and metabolism 11 4.13e-02 -0.355000 1.44e-01
Miscellaneous substrates 7 1.06e-01 0.353000 2.73e-01
Metabolism of amino acids and derivatives 308 1.98e-26 -0.352000 1.37e-24
Apoptotic factor-mediated response 19 7.95e-03 -0.352000 4.22e-02
Methionine salvage pathway 6 1.36e-01 -0.351000 3.20e-01
Cellular hexose transport 14 2.29e-02 -0.351000 9.49e-02
p53-Dependent G1 DNA Damage Response 52 1.24e-05 -0.350000 1.53e-04
p53-Dependent G1/S DNA damage checkpoint 52 1.24e-05 -0.350000 1.53e-04
Regulation of IFNG signaling 14 2.36e-02 0.349000 9.72e-02
Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation 52 1.35e-05 -0.349000 1.62e-04
Ribavirin ADME 11 4.57e-02 -0.348000 1.55e-01
Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins 64 1.52e-06 -0.347000 2.49e-05
Sulfur amino acid metabolism 23 4.11e-03 -0.346000 2.41e-02
CDK-mediated phosphorylation and removal of Cdc6 60 3.76e-06 -0.345000 5.31e-05
Cdc20:Phospho-APC/C mediated degradation of Cyclin A 60 3.85e-06 -0.345000 5.35e-05
PDH complex synthesizes acetyl-CoA from PYR 5 1.83e-01 -0.344000 3.77e-01
Displacement of DNA glycosylase by APEX1 9 7.42e-02 -0.344000 2.16e-01
Insertion of tail-anchored proteins into the endoplasmic reticulum membrane 22 5.29e-03 -0.343000 2.97e-02
RUNX1 regulates estrogen receptor mediated transcription 6 1.45e-01 0.343000 3.35e-01
SHC1 events in ERBB4 signaling 10 6.02e-02 0.343000 1.86e-01
Glutamate and glutamine metabolism 12 3.96e-02 -0.343000 1.41e-01
Regulation of APC/C activators between G1/S and early anaphase 68 1.04e-06 -0.342000 1.79e-05
FGFR2 alternative splicing 25 3.11e-03 -0.342000 1.95e-02
Cleavage of the damaged pyrimidine 27 2.20e-03 -0.340000 1.46e-02
Depyrimidination 27 2.20e-03 -0.340000 1.46e-02
Recognition and association of DNA glycosylase with site containing an affected pyrimidine 27 2.20e-03 -0.340000 1.46e-02
Xenobiotics 12 4.12e-02 0.340000 1.44e-01
NIK–>noncanonical NF-kB signaling 46 7.06e-05 -0.339000 7.55e-04
RNA Polymerase I Promoter Escape 45 8.61e-05 -0.338000 8.99e-04
Reactions specific to the complex N-glycan synthesis pathway 7 1.21e-01 -0.338000 3.02e-01
PCP/CE pathway 75 4.12e-07 -0.338000 8.03e-06
APC/C:Cdc20 mediated degradation of mitotic proteins 63 3.46e-06 -0.338000 4.98e-05
tRNA processing 128 4.14e-11 -0.338000 1.27e-09
Activation of RAC1 downstream of NMDARs 7 1.22e-01 -0.337000 3.04e-01
GAB1 signalosome 15 2.38e-02 0.337000 9.75e-02
Signaling by FGFR1 in disease 32 9.67e-04 0.337000 7.39e-03
Signaling by MST1 5 1.92e-01 -0.337000 3.88e-01
Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA 6 1.54e-01 -0.336000 3.47e-01
FGFR1 mutant receptor activation 25 3.66e-03 0.336000 2.21e-02
APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint 61 5.90e-06 -0.335000 7.87e-05
PERK regulates gene expression 30 1.48e-03 -0.335000 1.04e-02
Role of phospholipids in phagocytosis 88 5.40e-08 -0.335000 1.27e-06
Signaling by Erythropoietin 24 4.58e-03 0.334000 2.65e-02
Signaling by FGFR4 in disease 11 5.55e-02 0.333000 1.76e-01
XBP1(S) activates chaperone genes 44 1.31e-04 -0.333000 1.30e-03
Establishment of Sister Chromatid Cohesion 11 5.62e-02 0.332000 1.78e-01
RUNX1 regulates transcription of genes involved in differentiation of HSCs 69 1.87e-06 -0.332000 2.98e-05
VLDLR internalisation and degradation 16 2.16e-02 -0.332000 9.08e-02
Synthesis of wybutosine at G37 of tRNA(Phe) 6 1.60e-01 -0.331000 3.55e-01
Aflatoxin activation and detoxification 14 3.19e-02 -0.331000 1.21e-01
PI-3K cascade:FGFR2 13 3.91e-02 0.331000 1.41e-01
Cholesterol biosynthesis 26 3.54e-03 -0.330000 2.18e-02
Prolonged ERK activation events 13 3.93e-02 0.330000 1.41e-01
Regulation of NPAS4 gene expression 11 5.84e-02 0.330000 1.82e-01
ABC transporter disorders 60 1.09e-05 -0.328000 1.40e-04
Assembly of the pre-replicative complex 87 1.23e-07 -0.328000 2.70e-06
Regulation of RAS by GAPs 55 2.66e-05 -0.327000 3.04e-04
Erythrocytes take up oxygen and release carbon dioxide 7 1.34e-01 0.327000 3.19e-01
Glutathione conjugation 28 2.77e-03 -0.327000 1.76e-02
Synthesis of Prostaglandins (PG) and Thromboxanes (TX) 13 4.16e-02 -0.326000 1.45e-01
Zinc influx into cells by the SLC39 gene family 9 9.01e-02 -0.326000 2.45e-01
RHOBTB3 ATPase cycle 10 7.47e-02 -0.325000 2.16e-01
DNA Replication Pre-Initiation 103 1.23e-08 -0.325000 3.34e-07
Hydrolysis of LPC 8 1.12e-01 0.325000 2.85e-01
NFE2L2 regulating ER-stress associated genes 5 2.11e-01 0.323000 4.13e-01
Ras activation upon Ca2+ influx through NMDA receptor 18 1.76e-02 0.323000 7.88e-02
Formation of definitive endoderm 9 9.32e-02 0.323000 2.50e-01
Metabolism of cofactors 25 5.15e-03 -0.323000 2.91e-02
RORA activates gene expression 18 1.76e-02 0.323000 7.88e-02
Activation of BAD and translocation to mitochondria 15 3.03e-02 -0.323000 1.17e-01
Base Excision Repair 57 2.46e-05 -0.323000 2.83e-04
Biosynthesis of maresins 7 1.39e-01 0.323000 3.24e-01
IRE1alpha activates chaperones 46 1.55e-04 -0.322000 1.48e-03
UCH proteinases 73 1.92e-06 -0.322000 3.05e-05
Bicarbonate transporters 9 9.62e-02 0.320000 2.56e-01
ATF4 activates genes in response to endoplasmic reticulum stress 25 5.61e-03 -0.320000 3.13e-02
Inhibition of Signaling by Overexpressed EGFR 6 1.76e-01 0.319000 3.71e-01
Signaling by Overexpressed Wild-Type EGFR in Cancer 6 1.76e-01 0.319000 3.71e-01
Butyrophilin (BTN) family interactions 9 9.75e-02 0.319000 2.58e-01
tRNA modification in the nucleus and cytosol 43 3.00e-04 -0.319000 2.65e-03
FCERI mediated MAPK activation 93 1.10e-07 -0.318000 2.47e-06
Maturation of spike protein 9694548 36 9.50e-04 -0.318000 7.28e-03
Fibronectin matrix formation 6 1.77e-01 -0.318000 3.72e-01
Downstream signaling of activated FGFR3 17 2.32e-02 0.318000 9.56e-02
Dectin-1 mediated noncanonical NF-kB signaling 48 1.41e-04 -0.317000 1.39e-03
Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex 13 4.76e-02 -0.317000 1.60e-01
Formation of Senescence-Associated Heterochromatin Foci (SAHF) 13 4.77e-02 -0.317000 1.60e-01
PRC2 methylates histones and DNA 27 4.41e-03 -0.317000 2.56e-02
Synthesis of PIPs at the late endosome membrane 11 6.93e-02 0.316000 2.06e-01
Josephin domain DUBs 10 8.36e-02 -0.316000 2.33e-01
CREB phosphorylation 7 1.49e-01 0.315000 3.40e-01
FGFR2b ligand binding and activation 6 1.83e-01 -0.314000 3.77e-01
MASTL Facilitates Mitotic Progression 10 8.59e-02 -0.314000 2.38e-01
APC/C-mediated degradation of cell cycle proteins 75 2.65e-06 -0.314000 3.99e-05
Regulation of mitotic cell cycle 75 2.65e-06 -0.314000 3.99e-05
IkBA variant leads to EDA-ID 7 1.52e-01 0.313000 3.44e-01
PINK1-PRKN Mediated Mitophagy 31 2.63e-03 -0.312000 1.69e-02
Diseases associated with surfactant metabolism 6 1.86e-01 0.312000 3.80e-01
Interleukin-21 signaling 9 1.06e-01 0.312000 2.72e-01
MAPK3 (ERK1) activation 10 8.95e-02 0.310000 2.44e-01
Mitochondrial Fatty Acid Beta-Oxidation 36 1.36e-03 -0.308000 9.65e-03
Cellular response to hypoxia 59 4.29e-05 -0.308000 4.82e-04
Formation of paraxial mesoderm 52 1.24e-04 -0.308000 1.25e-03
FCERI mediated Ca+2 mobilization 92 3.57e-07 -0.307000 7.11e-06
Biosynthesis of maresin-like SPMs 5 2.35e-01 0.307000 4.41e-01
Unfolded Protein Response (UPR) 84 1.17e-06 -0.307000 1.95e-05
mRNA Splicing - Minor Pathway 50 1.90e-04 -0.305000 1.75e-03
Interleukin-6 family signaling 20 1.82e-02 0.305000 8.02e-02
ChREBP activates metabolic gene expression 7 1.63e-01 -0.304000 3.58e-01
Regulation of PTEN stability and activity 55 9.43e-05 -0.304000 9.74e-04
Removal of the Flap Intermediate 14 4.87e-02 -0.304000 1.62e-01
Glyoxylate metabolism and glycine degradation 13 5.75e-02 -0.304000 1.80e-01
Regulation of mRNA stability by proteins that bind AU-rich elements 76 4.58e-06 -0.304000 6.15e-05
Sensing of DNA Double Strand Breaks 6 1.98e-01 0.304000 3.95e-01
Signaling by ERBB2 KD Mutants 20 1.88e-02 0.303000 8.21e-02
TRAIL signaling 8 1.38e-01 0.303000 3.21e-01
PI-3K cascade:FGFR1 13 5.90e-02 0.302000 1.83e-01
Interleukin receptor SHC signaling 23 1.21e-02 0.302000 5.92e-02
Epithelial-Mesenchymal Transition (EMT) during gastrulation 6 2.02e-01 -0.301000 4.02e-01
Switching of origins to a post-replicative state 79 4.13e-06 -0.300000 5.61e-05
GRB2 events in EGFR signaling 11 8.61e-02 0.299000 2.38e-01
Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane 12 7.33e-02 -0.299000 2.14e-01
Transport of connexons to the plasma membrane 12 7.33e-02 -0.299000 2.14e-01
DEx/H-box helicases activate type I IFN and inflammatory cytokines production 7 1.72e-01 0.298000 3.69e-01
TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway 17 3.33e-02 0.298000 1.26e-01
Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 20 2.11e-02 -0.298000 8.95e-02
Transcriptional regulation of pluripotent stem cells 21 1.82e-02 0.298000 8.01e-02
Cyclin A:Cdk2-associated events at S phase entry 75 8.99e-06 -0.296000 1.18e-04
Interleukin-20 family signaling 17 3.43e-02 0.296000 1.29e-01
Cyclin E associated events during G1/S transition 73 1.19e-05 -0.296000 1.48e-04
Receptor-type tyrosine-protein phosphatases 12 7.68e-02 0.295000 2.20e-01
HSF1 activation 26 9.37e-03 -0.294000 4.80e-02
Unwinding of DNA 12 7.84e-02 -0.293000 2.23e-01
Cellular response to mitochondrial stress 9 1.28e-01 -0.293000 3.10e-01
Interconversion of nucleotide di- and triphosphates 27 8.71e-03 -0.292000 4.50e-02
IRAK4 deficiency (TLR2/4) 15 5.06e-02 0.292000 1.67e-01
Metabolism of RNA 718 2.19e-40 -0.291000 7.06e-38
Formation of the Early Elongation Complex 33 3.87e-03 -0.291000 2.30e-02
Formation of the HIV-1 Early Elongation Complex 33 3.87e-03 -0.291000 2.30e-02
Axonal growth inhibition (RHOA activation) 7 1.83e-01 -0.290000 3.77e-01
p75NTR regulates axonogenesis 7 1.83e-01 -0.290000 3.77e-01
MAPK1 (ERK2) activation 9 1.32e-01 0.290000 3.16e-01
Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA 17 3.90e-02 -0.289000 1.41e-01
Diseases of programmed cell death 58 1.43e-04 -0.289000 1.40e-03
FRS-mediated FGFR3 signaling 12 8.37e-02 0.288000 2.33e-01
Lysosphingolipid and LPA receptors 11 9.79e-02 -0.288000 2.58e-01
Regulation of gene expression by Hypoxia-inducible Factor 8 1.58e-01 0.288000 3.53e-01
NR1H2 & NR1H3 regulate gene expression linked to lipogenesis 8 1.59e-01 -0.288000 3.54e-01
MyD88 deficiency (TLR2/4) 14 6.23e-02 0.288000 1.91e-01
Cross-presentation of particulate exogenous antigens (phagosomes) 8 1.59e-01 0.288000 3.54e-01
Formation of HIV-1 elongation complex containing HIV-1 Tat 42 1.28e-03 -0.287000 9.15e-03
HIV Transcription Elongation 42 1.28e-03 -0.287000 9.15e-03
Tat-mediated elongation of the HIV-1 transcript 42 1.28e-03 -0.287000 9.15e-03
DNA replication initiation 8 1.60e-01 -0.287000 3.55e-01
Class I peroxisomal membrane protein import 20 2.63e-02 -0.287000 1.04e-01
Response of EIF2AK1 (HRI) to heme deficiency 14 6.31e-02 -0.287000 1.91e-01
p75NTR negatively regulates cell cycle via SC1 5 2.67e-01 -0.287000 4.77e-01
Signaling by FGFR2 IIIa TM 18 3.53e-02 -0.287000 1.31e-01
POLB-Dependent Long Patch Base Excision Repair 8 1.60e-01 -0.287000 3.55e-01
Basigin interactions 23 1.76e-02 -0.286000 7.88e-02
Apoptosis induced DNA fragmentation 10 1.18e-01 -0.286000 2.96e-01
p75NTR recruits signalling complexes 12 8.72e-02 -0.285000 2.40e-01
RNA Polymerase III Transcription Termination 23 1.82e-02 -0.285000 8.01e-02
RUNX1 regulates transcription of genes involved in WNT signaling 5 2.71e-01 0.284000 4.77e-01
Replacement of protamines by nucleosomes in the male pronucleus 13 7.68e-02 -0.283000 2.20e-01
Transcriptional regulation by RUNX2 92 2.62e-06 -0.283000 3.99e-05
RNA Polymerase III Transcription Initiation 36 3.29e-03 -0.283000 2.05e-02
Synthesis of PIPs at the early endosome membrane 16 5.02e-02 0.283000 1.66e-01
Synthesis of DNA 108 3.91e-07 -0.282000 7.71e-06
FCGR3A-mediated IL10 synthesis 99 1.20e-06 -0.282000 1.98e-05
Nuclear events mediated by NFE2L2 82 9.89e-06 -0.282000 1.27e-04
POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation 7 1.96e-01 0.282000 3.93e-01
Unblocking of NMDA receptors, glutamate binding and activation 16 5.08e-02 0.282000 1.67e-01
DNA Replication 128 3.77e-08 -0.281000 9.21e-07
Frs2-mediated activation 11 1.07e-01 0.281000 2.74e-01
Sealing of the nuclear envelope (NE) by ESCRT-III 24 1.73e-02 -0.281000 7.80e-02
Small interfering RNA (siRNA) biogenesis 9 1.46e-01 0.280000 3.35e-01
LTC4-CYSLTR mediated IL4 production 5 2.79e-01 0.280000 4.87e-01
Triglyceride biosynthesis 10 1.26e-01 0.279000 3.08e-01
Antigen activates B Cell Receptor (BCR) leading to generation of second messengers 83 1.15e-05 -0.278000 1.46e-04
Defective Intrinsic Pathway for Apoptosis 24 1.85e-02 -0.278000 8.10e-02
Nef Mediated CD4 Down-regulation 9 1.49e-01 -0.278000 3.40e-01
NF-kB is activated and signals survival 12 9.59e-02 -0.278000 2.56e-01
FLT3 signaling by CBL mutants 7 2.03e-01 -0.278000 4.04e-01
Physiological factors 9 1.49e-01 0.278000 3.40e-01
CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling 26 1.46e-02 0.277000 6.80e-02
Phospholipase C-mediated cascade; FGFR3 5 2.84e-01 0.277000 4.94e-01
Transport of RCbl within the body 8 1.76e-01 -0.277000 3.71e-01
Processing of Capped Intronless Pre-mRNA 29 9.97e-03 -0.276000 5.03e-02
Mitophagy 38 3.28e-03 -0.276000 2.04e-02
Gamma-carboxylation, transport, and amino-terminal cleavage of proteins 7 2.08e-01 -0.275000 4.09e-01
Plasma lipoprotein clearance 33 6.24e-03 -0.275000 3.41e-02
Metabolism of nucleotides 85 1.17e-05 -0.275000 1.47e-04
tRNA processing in the nucleus 59 2.71e-04 -0.274000 2.41e-03
Interleukin-10 signaling 38 3.57e-03 0.273000 2.19e-02
GABA receptor activation 38 3.59e-03 0.273000 2.19e-02
Z-decay: degradation of maternal mRNAs by zygotically expressed factors 10 1.36e-01 -0.272000 3.20e-01
Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation 10 1.37e-01 -0.272000 3.21e-01
Synthesis of substrates in N-glycan biosythesis 59 3.17e-04 -0.271000 2.76e-03
Azathioprine ADME 21 3.16e-02 -0.271000 1.21e-01
IL-6-type cytokine receptor ligand interactions 13 9.21e-02 0.270000 2.48e-01
ERBB2 Regulates Cell Motility 10 1.40e-01 0.269000 3.25e-01
Defective binding of VWF variant to GPIb:IX:V 7 2.18e-01 -0.269000 4.20e-01
Enhanced binding of GP1BA variant to VWF multimer:collagen 7 2.18e-01 -0.269000 4.20e-01
Organic cation transport 8 1.88e-01 0.269000 3.81e-01
Organic cation/anion/zwitterion transport 8 1.88e-01 0.269000 3.81e-01
ERBB2 Activates PTK6 Signaling 8 1.89e-01 0.268000 3.82e-01
Resolution of Abasic Sites (AP sites) 38 4.27e-03 -0.268000 2.49e-02
Host Interactions of HIV factors 118 5.14e-07 -0.268000 9.46e-06
Signaling by PDGFR in disease 19 4.39e-02 0.267000 1.51e-01
Recycling of bile acids and salts 10 1.44e-01 0.267000 3.33e-01
Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein 74 7.30e-05 -0.267000 7.75e-04
CYP2E1 reactions 6 2.59e-01 0.266000 4.68e-01
RNA Polymerase I Transcription Termination 30 1.17e-02 -0.266000 5.75e-02
Heme signaling 45 2.03e-03 0.266000 1.37e-02
TRIF-mediated programmed cell death 9 1.68e-01 0.266000 3.64e-01
Downstream signaling of activated FGFR4 18 5.11e-02 0.266000 1.67e-01
Assembly of active LPL and LIPC lipase complexes 10 1.46e-01 -0.266000 3.35e-01
Intrinsic Pathway for Apoptosis 54 7.58e-04 -0.265000 5.97e-03
Phase 0 - rapid depolarisation 24 2.47e-02 0.265000 1.00e-01
p130Cas linkage to MAPK signaling for integrins 11 1.28e-01 -0.265000 3.11e-01
Formation of HIV elongation complex in the absence of HIV Tat 44 2.39e-03 -0.265000 1.55e-02
Androgen biosynthesis 5 3.06e-01 0.265000 5.18e-01
BMAL1:CLOCK,NPAS2 activates circadian gene expression 25 2.23e-02 0.264000 9.31e-02
GRB2 events in ERBB2 signaling 11 1.29e-01 0.264000 3.13e-01
APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway 7 2.27e-01 -0.264000 4.31e-01
Processive synthesis on the lagging strand 15 7.90e-02 -0.262000 2.24e-01
Acyl chain remodelling of PC 19 4.81e-02 0.262000 1.61e-01
Telomere Extension By Telomerase 23 3.01e-02 -0.261000 1.16e-01
Fructose metabolism 7 2.32e-01 -0.261000 4.37e-01
DAP12 interactions 39 4.86e-03 0.261000 2.79e-02
Metabolism of non-coding RNA 53 1.07e-03 -0.260000 8.05e-03
snRNP Assembly 53 1.07e-03 -0.260000 8.05e-03
Glucagon-like Peptide-1 (GLP1) regulates insulin secretion 33 9.83e-03 0.260000 4.97e-02
Negative regulation of NMDA receptor-mediated neuronal transmission 18 5.68e-02 0.259000 1.78e-01
N-glycan trimming in the ER and Calnexin/Calreticulin cycle 35 8.22e-03 -0.258000 4.32e-02
G1/S Transition 120 1.07e-06 -0.258000 1.82e-05
Glutathione synthesis and recycling 10 1.59e-01 -0.257000 3.54e-01
Cation-coupled Chloride cotransporters 6 2.76e-01 0.257000 4.83e-01
P2Y receptors 10 1.60e-01 0.257000 3.55e-01
Formation of annular gap junctions 10 1.61e-01 -0.256000 3.55e-01
Rap1 signalling 14 9.75e-02 0.256000 2.58e-01
FGFR2 mutant receptor activation 23 3.38e-02 -0.256000 1.27e-01
SARS-CoV-1-host interactions 95 1.67e-05 -0.256000 1.98e-04
VEGF binds to VEGFR leading to receptor dimerization 5 3.23e-01 -0.255000 5.40e-01
VEGF ligand-receptor interactions 5 3.23e-01 -0.255000 5.40e-01
Insulin processing 19 5.46e-02 0.255000 1.75e-01
ER-Phagosome pathway 75 1.37e-04 -0.255000 1.36e-03
Assembly of the ORC complex at the origin of replication 23 3.47e-02 -0.254000 1.29e-01
Activation of NF-kappaB in B cells 54 1.25e-03 -0.254000 9.10e-03
Defects of platelet adhesion to exposed collagen 8 2.14e-01 -0.254000 4.16e-01
Signaling by ERBB2 in Cancer 21 4.46e-02 0.253000 1.53e-01
Defects in vitamin and cofactor metabolism 21 4.51e-02 -0.253000 1.54e-01
Voltage gated Potassium channels 26 2.61e-02 0.252000 1.03e-01
Mitochondrial Uncoupling 6 2.89e-01 -0.250000 4.99e-01
YAP1- and WWTR1 (TAZ)-stimulated gene expression 7 2.52e-01 0.250000 4.60e-01
SMAC (DIABLO) binds to IAPs 7 2.52e-01 -0.250000 4.60e-01
SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes 7 2.52e-01 -0.250000 4.60e-01
SMAC, XIAP-regulated apoptotic response 7 2.52e-01 -0.250000 4.60e-01
Transcriptional Regulation by NPAS4 27 2.49e-02 0.249000 1.00e-01
Diseases of branched-chain amino acid catabolism 13 1.20e-01 -0.249000 3.01e-01
TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest 14 1.07e-01 -0.249000 2.74e-01
B-WICH complex positively regulates rRNA expression 45 3.90e-03 -0.249000 2.30e-02
Hedgehog ‘on’ state 65 5.26e-04 -0.249000 4.34e-03
CaMK IV-mediated phosphorylation of CREB 9 1.97e-01 0.249000 3.94e-01
Free fatty acids regulate insulin secretion 10 1.74e-01 0.248000 3.71e-01
Impaired BRCA2 binding to PALB2 24 3.55e-02 0.248000 1.31e-01
Processing and activation of SUMO 10 1.75e-01 -0.248000 3.71e-01
Regulation of CDH11 Expression and Function 23 3.99e-02 0.247000 1.41e-01
Association of TriC/CCT with target proteins during biosynthesis 35 1.15e-02 -0.247000 5.72e-02
ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression 30 1.93e-02 -0.247000 8.39e-02
RHO GTPases Activate Rhotekin and Rhophilins 8 2.28e-01 -0.246000 4.31e-01
Heme degradation 11 1.57e-01 -0.246000 3.52e-01
Metabolism of porphyrins 23 4.10e-02 -0.246000 1.44e-01
CRMPs in Sema3A signaling 13 1.25e-01 0.246000 3.07e-01
N-glycan antennae elongation in the medial/trans-Golgi 21 5.13e-02 -0.246000 1.68e-01
RNA Polymerase I Promoter Clearance 64 6.77e-04 -0.246000 5.43e-03
RNA Polymerase I Transcription 64 6.77e-04 -0.246000 5.43e-03
Fructose catabolism 5 3.43e-01 -0.245000 5.61e-01
Negative epigenetic regulation of rRNA expression 63 8.03e-04 -0.244000 6.23e-03
mitochondrial fatty acid beta-oxidation of saturated fatty acids 11 1.61e-01 -0.244000 3.55e-01
Erythropoietin activates RAS 13 1.28e-01 0.244000 3.11e-01
SOS-mediated signalling 7 2.64e-01 0.244000 4.74e-01
Pregnenolone biosynthesis 10 1.83e-01 -0.243000 3.77e-01
ABC-family proteins mediated transport 81 1.56e-04 -0.243000 1.48e-03
WNT5A-dependent internalization of FZD2, FZD5 and ROR2 11 1.63e-01 -0.243000 3.58e-01
Telomere Maintenance 78 2.13e-04 -0.242000 1.94e-03
Myogenesis 21 5.48e-02 0.242000 1.75e-01
SHC-mediated cascade:FGFR3 10 1.85e-01 0.242000 3.80e-01
Regulation of MITF-M-dependent genes involved in apoptosis 16 9.55e-02 0.241000 2.55e-01
G beta:gamma signalling through CDC42 17 8.61e-02 0.240000 2.38e-01
Activation of G protein gated Potassium channels 20 6.29e-02 0.240000 1.91e-01
G protein gated Potassium channels 20 6.29e-02 0.240000 1.91e-01
Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits 20 6.29e-02 0.240000 1.91e-01
Polo-like kinase mediated events 16 9.63e-02 -0.240000 2.56e-01
Uptake and function of anthrax toxins 11 1.69e-01 0.240000 3.66e-01
EGFR Transactivation by Gastrin 7 2.73e-01 0.239000 4.79e-01
MicroRNA (miRNA) biogenesis 24 4.24e-02 -0.239000 1.47e-01
Lewis blood group biosynthesis 14 1.22e-01 -0.239000 3.04e-01
Activation of BH3-only proteins 30 2.39e-02 -0.238000 9.77e-02
Transcriptional regulation by small RNAs 61 1.29e-03 -0.238000 9.15e-03
NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake 5 3.57e-01 -0.238000 5.73e-01
Regulation of MECP2 expression and activity 29 2.71e-02 0.237000 1.06e-01
Formation of TC-NER Pre-Incision Complex 51 3.49e-03 -0.236000 2.15e-02
Mitotic G1 phase and G1/S transition 138 1.67e-06 -0.236000 2.72e-05
Removal of the Flap Intermediate from the C-strand 17 9.21e-02 -0.236000 2.48e-01
Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA 17 9.21e-02 -0.236000 2.48e-01
EGFR interacts with phospholipase C-gamma 7 2.80e-01 0.236000 4.88e-01
RNA Polymerase III Transcription Initiation From Type 3 Promoter 28 3.16e-02 -0.235000 1.21e-01
Paracetamol ADME 19 7.68e-02 -0.235000 2.20e-01
Cell surface interactions at the vascular wall 176 7.98e-08 -0.234000 1.84e-06
KEAP1-NFE2L2 pathway 107 2.95e-05 -0.234000 3.36e-04
Long-term potentiation 18 8.67e-02 0.233000 2.39e-01
eNOS activation 12 1.62e-01 -0.233000 3.57e-01
Defects of contact activation system (CAS) and kallikrein/kinin system (KKS) 12 1.63e-01 -0.233000 3.58e-01
Branched-chain amino acid catabolism 21 6.50e-02 -0.233000 1.95e-01
Signaling by the B Cell Receptor (BCR) 150 9.26e-07 -0.232000 1.61e-05
Metabolism of amine-derived hormones 10 2.04e-01 0.232000 4.05e-01
Signaling by NOTCH4 70 7.90e-04 -0.232000 6.18e-03
Acyl chain remodelling of PS 14 1.34e-01 0.231000 3.19e-01
Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex 23 5.48e-02 -0.231000 1.75e-01
Regulation of actin dynamics for phagocytic cup formation 123 9.36e-06 -0.231000 1.21e-04
Activation of GABAB receptors 31 2.58e-02 0.231000 1.03e-01
GABA B receptor activation 31 2.58e-02 0.231000 1.03e-01
Relaxin receptors 5 3.71e-01 0.231000 5.86e-01
Zinc transporters 12 1.66e-01 -0.231000 3.62e-01
G2/M DNA replication checkpoint 5 3.71e-01 -0.231000 5.86e-01
Drug-mediated inhibition of CDK4/CDK6 activity 5 3.71e-01 -0.231000 5.86e-01
NoRC negatively regulates rRNA expression 60 1.98e-03 -0.231000 1.34e-02
Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 14 1.35e-01 0.231000 3.19e-01
Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) 14 1.35e-01 -0.231000 3.19e-01
HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand 48 5.77e-03 -0.230000 3.19e-02
CLEC7A (Dectin-1) induces NFAT activation 11 1.86e-01 0.230000 3.80e-01
Downstream signaling of activated FGFR1 22 6.21e-02 0.230000 1.90e-01
FCGR3A-mediated phagocytosis 121 1.30e-05 -0.229000 1.56e-04
Leishmania phagocytosis 121 1.30e-05 -0.229000 1.56e-04
Parasite infection 121 1.30e-05 -0.229000 1.56e-04
Regulation of TP53 Activity through Methylation 19 8.33e-02 -0.229000 2.33e-01
Regulation of NFE2L2 gene expression 8 2.61e-01 0.229000 4.70e-01
Nef Mediated CD8 Down-regulation 7 2.93e-01 -0.229000 5.04e-01
FGFR1b ligand binding and activation 5 3.75e-01 -0.229000 5.89e-01
Resolution of AP sites via the multiple-nucleotide patch replacement pathway 25 4.78e-02 -0.229000 1.61e-01
Inwardly rectifying K+ channels 24 5.26e-02 0.229000 1.71e-01
ROBO receptors bind AKAP5 7 2.98e-01 0.227000 5.11e-01
Activation of the pre-replicative complex 32 2.62e-02 -0.227000 1.04e-01
Deposition of new CENPA-containing nucleosomes at the centromere 38 1.56e-02 -0.227000 7.16e-02
Nucleosome assembly 38 1.56e-02 -0.227000 7.16e-02
Activated NTRK2 signals through FRS2 and FRS3 8 2.67e-01 0.226000 4.77e-01
Regulation of Expression and Function of Type II Classical Cadherins 25 5.02e-02 0.226000 1.66e-01
Regulation of Homotypic Cell-Cell Adhesion 25 5.02e-02 0.226000 1.66e-01
Diseases of hemostasis 15 1.30e-01 -0.226000 3.13e-01
Caspase activation via Death Receptors in the presence of ligand 16 1.19e-01 0.225000 2.97e-01
GRB2:SOS provides linkage to MAPK signaling for Integrins 12 1.77e-01 -0.225000 3.72e-01
Dermatan sulfate biosynthesis 6 3.39e-01 -0.225000 5.57e-01
Biosynthesis of E-series 18(S)-resolvins 5 3.85e-01 -0.224000 5.98e-01
Beta-oxidation of pristanoyl-CoA 9 2.44e-01 -0.224000 4.53e-01
SHC1 events in EGFR signaling 12 1.79e-01 0.224000 3.75e-01
Cellular responses to stress 698 6.16e-24 -0.224000 3.72e-22
Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function 25 5.31e-02 0.223000 1.71e-01
Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function 25 5.31e-02 0.223000 1.71e-01
Defective homologous recombination repair (HRR) due to BRCA1 loss of function 25 5.31e-02 0.223000 1.71e-01
Defective homologous recombination repair (HRR) due to PALB2 loss of function 25 5.31e-02 0.223000 1.71e-01
PIWI-interacting RNA (piRNA) biogenesis 23 6.37e-02 -0.223000 1.92e-01
Gap-filling DNA repair synthesis and ligation in GG-NER 25 5.36e-02 -0.223000 1.72e-01
Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) 14 1.49e-01 -0.223000 3.40e-01
Regulation of MITF-M-dependent genes involved in cell cycle and proliferation 15 1.35e-01 -0.223000 3.19e-01
Aggrephagy 34 2.49e-02 -0.222000 1.00e-01
Gastrin-CREB signalling pathway via PKC and MAPK 14 1.50e-01 0.222000 3.41e-01
Cytochrome c-mediated apoptotic response 13 1.67e-01 -0.221000 3.64e-01
Activated NTRK3 signals through RAS 7 3.11e-01 0.221000 5.24e-01
RNA Polymerase III Abortive And Retractive Initiation 41 1.42e-02 -0.221000 6.68e-02
RNA Polymerase III Transcription 41 1.42e-02 -0.221000 6.68e-02
TFAP2 (AP-2) family regulates transcription of growth factors and their receptors 7 3.12e-01 0.221000 5.25e-01
Growth hormone receptor signaling 21 8.00e-02 0.221000 2.26e-01
Tryptophan catabolism 12 1.86e-01 0.220000 3.80e-01
Downstream signaling of activated FGFR2 20 8.81e-02 0.220000 2.42e-01
Impaired BRCA2 binding to RAD51 35 2.45e-02 0.220000 9.95e-02
DNA Damage/Telomere Stress Induced Senescence 42 1.38e-02 -0.220000 6.50e-02
Condensation of Prophase Chromosomes 27 4.85e-02 -0.219000 1.62e-01
Negative feedback regulation of MAPK pathway 6 3.52e-01 0.219000 5.70e-01
HCMV Early Events 84 5.21e-04 -0.219000 4.32e-03
HCMV Infection 106 9.86e-05 -0.219000 1.01e-03
FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes 24 6.35e-02 0.219000 1.92e-01
WNT5A-dependent internalization of FZD4 13 1.72e-01 -0.219000 3.69e-01
Erythrocytes take up carbon dioxide and release oxygen 11 2.10e-01 0.218000 4.11e-01
O2/CO2 exchange in erythrocytes 11 2.10e-01 0.218000 4.11e-01
FRS-mediated FGFR4 signaling 13 1.74e-01 0.218000 3.70e-01
Degradation of beta-catenin by the destruction complex 72 1.38e-03 -0.218000 9.74e-03
Diseases associated with the TLR signaling cascade 29 4.22e-02 0.218000 1.47e-01
Diseases of Immune System 29 4.22e-02 0.218000 1.47e-01
Role of second messengers in netrin-1 signaling 6 3.57e-01 -0.217000 5.73e-01
G beta:gamma signalling through BTK 15 1.46e-01 0.217000 3.35e-01
Serine biosynthesis 8 2.89e-01 0.217000 4.99e-01
Regulation of FOXO transcriptional activity by acetylation 10 2.36e-01 0.216000 4.42e-01
HCMV Late Events 67 2.23e-03 -0.216000 1.47e-02
Other semaphorin interactions 16 1.35e-01 0.216000 3.19e-01
Interleukin-2 family signaling 38 2.13e-02 0.216000 8.95e-02
Gap junction assembly 17 1.24e-01 -0.215000 3.06e-01
RAS processing 23 7.40e-02 -0.215000 2.16e-01
Disorders of transmembrane transporters 137 1.38e-05 -0.215000 1.65e-04
Adenylate cyclase inhibitory pathway 11 2.18e-01 0.215000 4.20e-01
Pentose phosphate pathway 13 1.82e-01 -0.214000 3.77e-01
Eicosanoids 6 3.65e-01 0.214000 5.81e-01
HIV Infection 213 7.92e-08 -0.213000 1.84e-06
Mismatch Repair 15 1.53e-01 -0.213000 3.45e-01
Viral Messenger RNA Synthesis 44 1.45e-02 -0.213000 6.76e-02
Synthesis of PIPs at the plasma membrane 52 8.09e-03 0.212000 4.28e-02
Positive epigenetic regulation of rRNA expression 60 4.45e-03 -0.212000 2.58e-02
Ca2+ pathway 58 5.22e-03 0.212000 2.94e-02
Global Genome Nucleotide Excision Repair (GG-NER) 84 7.84e-04 -0.212000 6.16e-03
Interleukin-3, Interleukin-5 and GM-CSF signaling 44 1.51e-02 0.212000 6.98e-02
Nucleotide Excision Repair 108 1.45e-04 -0.212000 1.41e-03
TRAF3-dependent IRF activation pathway 13 1.88e-01 0.211000 3.81e-01
SHC-related events triggered by IGF1R 8 3.02e-01 0.211000 5.14e-01
G2/M Checkpoints 126 4.40e-05 -0.211000 4.88e-04
Viral Infection Pathways 776 1.60e-23 -0.211000 9.38e-22
Formyl peptide receptors bind formyl peptides and many other ligands 7 3.34e-01 -0.211000 5.52e-01
Peroxisomal protein import 58 5.54e-03 -0.211000 3.10e-02
Constitutive Signaling by EGFRvIII 14 1.73e-01 0.210000 3.69e-01
Signaling by EGFRvIII in Cancer 14 1.73e-01 0.210000 3.69e-01
Activation of the TFAP2 (AP-2) family of transcription factors 7 3.35e-01 -0.210000 5.52e-01
InlA-mediated entry of Listeria monocytogenes into host cells 9 2.76e-01 -0.210000 4.83e-01
Platelet degranulation 106 1.93e-04 -0.210000 1.77e-03
Dual Incision in GG-NER 41 2.04e-02 -0.209000 8.76e-02
Metabolism of nitric oxide: NOS3 activation and regulation 15 1.61e-01 -0.209000 3.55e-01
APC/C:Cdc20 mediated degradation of Cyclin B 24 7.73e-02 -0.208000 2.21e-01
Glycogen breakdown (glycogenolysis) 12 2.12e-01 0.208000 4.13e-01
Protein folding 83 1.04e-03 -0.208000 7.91e-03
Transcription-Coupled Nucleotide Excision Repair (TC-NER) 76 1.72e-03 -0.208000 1.18e-02
Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer’s disease models 21 9.95e-02 -0.208000 2.61e-01
Neurodegenerative Diseases 21 9.95e-02 -0.208000 2.61e-01
Signaling by PDGFRA extracellular domain mutants 12 2.13e-01 0.207000 4.15e-01
Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants 12 2.13e-01 0.207000 4.15e-01
Signaling by FLT3 ITD and TKD mutants 15 1.67e-01 0.206000 3.64e-01
Cytochrome P450 - arranged by substrate type 38 2.81e-02 0.206000 1.09e-01
Regulation of innate immune responses to cytosolic DNA 14 1.84e-01 -0.205000 3.77e-01
FOXO-mediated transcription of cell cycle genes 15 1.70e-01 0.205000 3.67e-01
FGFR4 ligand binding and activation 5 4.29e-01 0.204000 6.37e-01
NFE2L2 regulating MDR associated enzymes 8 3.17e-01 0.204000 5.33e-01
Beta oxidation of octanoyl-CoA to hexanoyl-CoA 5 4.30e-01 -0.204000 6.38e-01
Diseases of carbohydrate metabolism 29 5.75e-02 -0.204000 1.80e-01
ADP signalling through P2Y purinoceptor 12 18 1.35e-01 0.203000 3.19e-01
Retrograde neurotrophin signalling 12 2.23e-01 -0.203000 4.25e-01
S Phase 150 1.84e-05 -0.203000 2.16e-04
NrCAM interactions 6 3.90e-01 0.203000 6.03e-01
Suppression of apoptosis 7 3.54e-01 -0.202000 5.72e-01
Fc epsilon receptor (FCERI) signaling 179 3.14e-06 -0.202000 4.60e-05
RNA Polymerase I Transcription Initiation 47 1.68e-02 -0.202000 7.63e-02
Acyl chain remodelling of PG 11 2.47e-01 0.201000 4.56e-01
RMTs methylate histone arginines 35 3.95e-02 -0.201000 1.41e-01
Transport of vitamins, nucleosides, and related molecules 32 4.92e-02 -0.201000 1.64e-01
Asparagine N-linked glycosylation 286 5.26e-09 -0.201000 1.49e-07
Histidine catabolism 7 3.58e-01 0.200000 5.75e-01
TRAF6 mediated IRF7 activation 15 1.81e-01 0.200000 3.76e-01
Glycosphingolipid catabolism 31 5.48e-02 -0.199000 1.75e-01
Glutamate binding, activation of AMPA receptors and synaptic plasticity 20 1.23e-01 0.199000 3.05e-01
Trafficking of AMPA receptors 20 1.23e-01 0.199000 3.05e-01
Transcription of the HIV genome 67 4.83e-03 -0.199000 2.78e-02
Cellular responses to stimuli 779 3.15e-21 -0.199000 1.60e-19
SARS-CoV-2-host interactions 183 3.54e-06 -0.199000 5.07e-05
NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose 5 4.43e-01 -0.198000 6.50e-01
Nef and signal transduction 8 3.32e-01 0.198000 5.49e-01
Striated Muscle Contraction 27 7.48e-02 0.198000 2.16e-01
Signaling by TGFBR3 39 3.23e-02 0.198000 1.22e-01
SARS-CoV-1 Infection 138 5.89e-05 -0.198000 6.46e-04
Metabolism of Angiotensinogen to Angiotensins 12 2.36e-01 0.198000 4.42e-01
PI3K/AKT activation 8 3.33e-01 0.198000 5.51e-01
NFE2L2 regulating tumorigenic genes 11 2.57e-01 0.197000 4.65e-01
Erythropoietin activates STAT5 6 4.03e-01 0.197000 6.14e-01
Transport of Mature mRNAs Derived from Intronless Transcripts 43 2.54e-02 -0.197000 1.02e-01
Regulation of insulin secretion 63 6.86e-03 0.197000 3.73e-02
Selective autophagy 77 2.91e-03 -0.196000 1.85e-02
LDL clearance 18 1.50e-01 -0.196000 3.41e-01
Expression and translocation of olfactory receptors 56 1.14e-02 0.196000 5.67e-02
TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling 13 2.22e-01 -0.195000 4.24e-01
APC-Cdc20 mediated degradation of Nek2A 26 8.47e-02 -0.195000 2.35e-01
mRNA Capping 29 6.91e-02 -0.195000 2.05e-01
Meiotic recombination 37 4.04e-02 -0.195000 1.42e-01
Metabolism of proteins 1777 2.85e-42 -0.194000 1.10e-39
Interleukin-15 signaling 14 2.08e-01 0.194000 4.11e-01
mTORC1-mediated signalling 24 9.97e-02 -0.194000 2.61e-01
NPAS4 regulates expression of target genes 16 1.79e-01 0.194000 3.75e-01
TP53 Regulates Metabolic Genes 78 3.17e-03 -0.193000 1.98e-02
Proton-coupled monocarboxylate transport 6 4.13e-01 -0.193000 6.22e-01
PCNA-Dependent Long Patch Base Excision Repair 21 1.26e-01 -0.193000 3.08e-01
Response to elevated platelet cytosolic Ca2+ 110 4.97e-04 -0.192000 4.14e-03
Regulation of NF-kappa B signaling 18 1.58e-01 -0.192000 3.54e-01
RNA Polymerase II Transcription Termination 66 7.00e-03 -0.192000 3.78e-02
FLT3 signaling in disease 27 8.43e-02 0.192000 2.34e-01
Signaling by ERBB2 TMD/JMD mutants 17 1.72e-01 0.192000 3.69e-01
Lysosome Vesicle Biogenesis 32 6.11e-02 -0.191000 1.88e-01
Nucleotide catabolism 28 7.98e-02 -0.191000 2.26e-01
Plasma lipoprotein assembly, remodeling, and clearance 56 1.36e-02 -0.191000 6.46e-02
Mitochondrial biogenesis 91 1.67e-03 -0.191000 1.15e-02
SUMOylation of DNA methylation proteins 16 1.87e-01 -0.190000 3.81e-01
Synthesis of Leukotrienes (LT) and Eoxins (EX) 15 2.02e-01 0.190000 4.02e-01
Chromosome Maintenance 103 8.69e-04 -0.190000 6.69e-03
CREB1 phosphorylation through the activation of Adenylate Cyclase 9 3.25e-01 0.190000 5.42e-01
Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects 17 1.76e-01 -0.189000 3.72e-01
Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) 17 1.76e-01 -0.189000 3.72e-01
Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) 50 2.05e-02 -0.189000 8.77e-02
Anti-inflammatory response favouring Leishmania parasite infection 132 1.71e-04 -0.189000 1.58e-03
Leishmania parasite growth and survival 132 1.71e-04 -0.189000 1.58e-03
DNA Double Strand Break Response 47 2.49e-02 -0.189000 1.00e-01
RNA Pol II CTD phosphorylation and interaction with CE 27 8.92e-02 -0.189000 2.43e-01
RNA Pol II CTD phosphorylation and interaction with CE during HIV infection 27 8.92e-02 -0.189000 2.43e-01
Gap junction trafficking 28 8.37e-02 -0.189000 2.33e-01
RUNX1 regulates transcription of genes involved in differentiation of keratinocytes 7 3.87e-01 0.189000 6.00e-01
SUMOylation of DNA replication proteins 46 2.68e-02 -0.189000 1.06e-01
Gap-filling DNA repair synthesis and ligation in TC-NER 62 1.03e-02 -0.188000 5.18e-02
Vitamin B1 (thiamin) metabolism 5 4.66e-01 -0.188000 6.71e-01
Pyroptosis 25 1.04e-01 -0.188000 2.70e-01
Aspartate and asparagine metabolism 9 3.31e-01 -0.187000 5.49e-01
RUNX3 regulates NOTCH signaling 14 2.26e-01 0.187000 4.29e-01
Senescence-Associated Secretory Phenotype (SASP) 65 9.15e-03 -0.187000 4.70e-02
Antigen processing-Cross presentation 89 2.33e-03 -0.187000 1.52e-02
Fanconi Anemia Pathway 36 5.34e-02 -0.186000 1.71e-01
Heme biosynthesis 13 2.46e-01 -0.186000 4.55e-01
ZBP1(DAI) mediated induction of type I IFNs 20 1.51e-01 0.185000 3.43e-01
Late Phase of HIV Life Cycle 131 2.52e-04 -0.185000 2.27e-03
Formation of apoptosome 11 2.88e-01 -0.185000 4.98e-01
Regulation of the apoptosome activity 11 2.88e-01 -0.185000 4.98e-01
Negative regulation of MET activity 18 1.74e-01 0.185000 3.71e-01
DNA strand elongation 32 7.03e-02 -0.185000 2.08e-01
H139Hfs13* PPM1K causes a mild variant of MSUD 5 4.74e-01 0.185000 6.73e-01
Maple Syrup Urine Disease 5 4.74e-01 0.185000 6.73e-01
Regulation of RUNX1 Expression and Activity 18 1.76e-01 0.184000 3.71e-01
ALK mutants bind TKIs 11 2.90e-01 0.184000 5.00e-01
Cellular response to chemical stress 179 2.18e-05 -0.184000 2.52e-04
Signaling by KIT in disease 20 1.55e-01 0.184000 3.49e-01
Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants 20 1.55e-01 0.184000 3.49e-01
Signaling by Hippo 18 1.78e-01 0.183000 3.72e-01
CTNNB1 S33 mutants aren’t phosphorylated 15 2.19e-01 0.183000 4.20e-01
CTNNB1 S37 mutants aren’t phosphorylated 15 2.19e-01 0.183000 4.20e-01
CTNNB1 S45 mutants aren’t phosphorylated 15 2.19e-01 0.183000 4.20e-01
CTNNB1 T41 mutants aren’t phosphorylated 15 2.19e-01 0.183000 4.20e-01
Signaling by CTNNB1 phospho-site mutants 15 2.19e-01 0.183000 4.20e-01
Signaling by GSK3beta mutants 15 2.19e-01 0.183000 4.20e-01
PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 9 3.42e-01 -0.183000 5.61e-01
Translation of Structural Proteins 9694635 56 1.80e-02 -0.183000 8.00e-02
Prevention of phagosomal-lysosomal fusion 9 3.43e-01 -0.183000 5.61e-01
Rev-mediated nuclear export of HIV RNA 35 6.17e-02 -0.182000 1.90e-01
COPI-mediated anterograde transport 92 2.52e-03 -0.182000 1.63e-02
Apoptotic cleavage of cell adhesion proteins 8 3.74e-01 0.182000 5.88e-01
Synthesis of pyrophosphates in the cytosol 8 3.74e-01 -0.181000 5.88e-01
Respiratory syncytial virus (RSV) genome replication, transcription and translation 16 2.09e-01 -0.181000 4.11e-01
Transport of Mature mRNA Derived from an Intronless Transcript 42 4.25e-02 -0.181000 1.47e-01
Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors 27 1.04e-01 -0.181000 2.70e-01
Antigen Presentation: Folding, assembly and peptide loading of class I MHC 30 8.74e-02 -0.180000 2.40e-01
Metabolism 1835 1.58e-37 -0.180000 4.37e-35
Budding and maturation of HIV virion 26 1.13e-01 -0.180000 2.85e-01
Reelin signalling pathway 5 4.88e-01 0.179000 6.83e-01
G-protein mediated events 44 4.01e-02 0.179000 1.42e-01
Adrenaline,noradrenaline inhibits insulin secretion 24 1.30e-01 0.179000 3.13e-01
Interactions of Rev with host cellular proteins 37 6.03e-02 -0.178000 1.86e-01
Diseases of glycosylation 109 1.29e-03 -0.178000 9.15e-03
Membrane binding and targetting of GAG proteins 13 2.66e-01 -0.178000 4.76e-01
Synthesis And Processing Of GAG, GAGPOL Polyproteins 13 2.66e-01 -0.178000 4.76e-01
N-glycan trimming and elongation in the cis-Golgi 5 4.92e-01 -0.178000 6.87e-01
Gap junction trafficking and regulation 30 9.24e-02 -0.178000 2.49e-01
Endogenous sterols 18 1.93e-01 0.177000 3.88e-01
Phosphorylation of the APC/C 20 1.70e-01 -0.177000 3.67e-01
HIV Transcription Initiation 45 3.98e-02 -0.177000 1.41e-01
RNA Polymerase II HIV Promoter Escape 45 3.98e-02 -0.177000 1.41e-01
RNA Polymerase II Promoter Escape 45 3.98e-02 -0.177000 1.41e-01
RNA Polymerase II Transcription Initiation 45 3.98e-02 -0.177000 1.41e-01
RNA Polymerase II Transcription Initiation And Promoter Clearance 45 3.98e-02 -0.177000 1.41e-01
RNA Polymerase II Transcription Pre-Initiation And Promoter Opening 45 3.98e-02 -0.177000 1.41e-01
RAF-independent MAPK1/3 activation 22 1.51e-01 0.177000 3.42e-01
Formation of Incision Complex in GG-NER 43 4.54e-02 -0.176000 1.54e-01
Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks 46 3.85e-02 -0.176000 1.40e-01
Synthesis of PA 31 9.04e-02 0.176000 2.46e-01
Late endosomal microautophagy 30 9.60e-02 -0.176000 2.56e-01
Defects in cobalamin (B12) metabolism 13 2.74e-01 -0.175000 4.80e-01
SARS-CoV-2 Infection 267 8.18e-07 -0.175000 1.45e-05
G-protein beta:gamma signalling 29 1.02e-01 0.175000 2.67e-01
G-protein activation 19 1.87e-01 0.175000 3.81e-01
HDR through Single Strand Annealing (SSA) 37 6.58e-02 0.175000 1.97e-01
Downstream signaling events of B Cell Receptor (BCR) 68 1.29e-02 -0.174000 6.27e-02
CHL1 interactions 8 3.94e-01 0.174000 6.06e-01
Neddylation 215 1.10e-05 -0.174000 1.40e-04
Chaperonin-mediated protein folding 77 8.48e-03 -0.173000 4.42e-02
Translation of Structural Proteins 9683701 29 1.06e-01 -0.173000 2.72e-01
Transport of Mature Transcript to Cytoplasm 81 6.98e-03 -0.173000 3.78e-02
Signaling by Leptin 10 3.43e-01 0.173000 5.61e-01
Transport of nucleotide sugars 9 3.68e-01 -0.173000 5.85e-01
Interaction between L1 and Ankyrins 26 1.27e-01 0.173000 3.08e-01
Calnexin/calreticulin cycle 26 1.27e-01 -0.173000 3.08e-01
Olfactory Signaling Pathway 61 1.95e-02 0.173000 8.46e-02
COPI-dependent Golgi-to-ER retrograde traffic 90 4.72e-03 -0.172000 2.72e-02
Nuclear Envelope (NE) Reassembly 68 1.41e-02 -0.172000 6.65e-02
MAPK6/MAPK4 signaling 69 1.35e-02 -0.172000 6.46e-02
PI5P Regulates TP53 Acetylation 8 4.00e-01 -0.172000 6.12e-01
Signaling by CSF1 (M-CSF) in myeloid cells 30 1.03e-01 0.172000 2.68e-01
Activation of HOX genes during differentiation 70 1.30e-02 -0.172000 6.27e-02
Activation of anterior HOX genes in hindbrain development during early embryogenesis 70 1.30e-02 -0.172000 6.27e-02
Regulation of CDH11 function 10 3.48e-01 0.171000 5.67e-01
RAC1 GTPase cycle 173 1.00e-04 0.171000 1.02e-03
NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux 33 8.85e-02 0.171000 2.42e-01
BBSome-mediated cargo-targeting to cilium 22 1.64e-01 -0.171000 3.60e-01
HIV Life Cycle 144 3.89e-04 -0.171000 3.36e-03
RHO GTPases activate PKNs 46 4.47e-02 -0.171000 1.53e-01
Collagen biosynthesis and modifying enzymes 48 4.05e-02 -0.171000 1.42e-01
Maturation of nucleoprotein 9694631 15 2.52e-01 0.171000 4.60e-01
Adherens junctions interactions 41 5.84e-02 0.171000 1.82e-01
G alpha (12/13) signalling events 68 1.49e-02 0.171000 6.92e-02
Regulation of gene expression in beta cells 8 4.03e-01 0.171000 6.14e-01
Assembly Of The HIV Virion 15 2.53e-01 -0.171000 4.60e-01
RUNX3 Regulates Immune Response and Cell Migration 6 4.70e-01 -0.171000 6.72e-01
Translesion Synthesis by POLH 18 2.11e-01 -0.170000 4.13e-01
APC truncation mutants have impaired AXIN binding 14 2.70e-01 0.170000 4.77e-01
AXIN missense mutants destabilize the destruction complex 14 2.70e-01 0.170000 4.77e-01
Signaling by AMER1 mutants 14 2.70e-01 0.170000 4.77e-01
Signaling by APC mutants 14 2.70e-01 0.170000 4.77e-01
Signaling by AXIN mutants 14 2.70e-01 0.170000 4.77e-01
Truncations of AMER1 destabilize the destruction complex 14 2.70e-01 0.170000 4.77e-01
Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell 187 5.98e-05 -0.170000 6.53e-04
Loss of Function of SMAD2/3 in Cancer 7 4.36e-01 0.170000 6.43e-01
Transcriptional Regulation by MECP2 49 3.94e-02 0.170000 1.41e-01
Interleukin-7 signaling 21 1.77e-01 0.170000 3.72e-01
Peroxisomal lipid metabolism 27 1.27e-01 -0.170000 3.08e-01
Metabolism of vitamins and cofactors 166 1.59e-04 -0.170000 1.50e-03
Signaling by ERBB2 ECD mutants 15 2.55e-01 0.170000 4.62e-01
Potassium Channels 64 1.89e-02 0.170000 8.25e-02
PD-1 signaling 28 1.21e-01 -0.169000 3.02e-01
Activation of caspases through apoptosome-mediated cleavage 6 4.74e-01 -0.169000 6.73e-01
Respiratory syncytial virus (RSV) attachment and entry 18 2.15e-01 0.169000 4.17e-01
Myoclonic epilepsy of Lafora 8 4.09e-01 -0.169000 6.19e-01
Regulation of signaling by CBL 22 1.72e-01 0.168000 3.69e-01
Inactivation of APC/C via direct inhibition of the APC/C complex 21 1.83e-01 -0.168000 3.77e-01
Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components 21 1.83e-01 -0.168000 3.77e-01
Dual incision in TC-NER 63 2.13e-02 -0.168000 8.95e-02
DAP12 signaling 28 1.25e-01 0.167000 3.07e-01
Signaling by NTRK2 (TRKB) 20 1.95e-01 0.167000 3.92e-01
p75NTR signals via NF-kB 15 2.62e-01 -0.167000 4.70e-01
RHO GTPases Activate ROCKs 18 2.19e-01 0.167000 4.20e-01
TP53 Regulates Transcription of DNA Repair Genes 61 2.40e-02 -0.167000 9.79e-02
Sodium-coupled phosphate cotransporters 5 5.18e-01 -0.167000 7.08e-01
Regulation of beta-cell development 22 1.75e-01 0.167000 3.71e-01
G1/S-Specific Transcription 29 1.20e-01 -0.167000 3.00e-01
Cytosolic sulfonation of small molecules 18 2.20e-01 -0.167000 4.20e-01
Phase II - Conjugation of compounds 71 1.54e-02 -0.166000 7.07e-02
Peptide hormone metabolism 54 3.47e-02 0.166000 1.29e-01
MET receptor recycling 9 3.89e-01 0.166000 6.01e-01
Attenuation phase 23 1.69e-01 -0.166000 3.66e-01
Downstream TCR signaling 89 6.94e-03 -0.166000 3.77e-02
Late SARS-CoV-2 Infection Events 64 2.23e-02 -0.165000 9.31e-02
Regulation of TP53 Activity through Acetylation 29 1.24e-01 -0.165000 3.06e-01
Uptake and function of diphtheria toxin 6 4.84e-01 -0.165000 6.80e-01
Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells 14 2.86e-01 0.165000 4.96e-01
Metabolism of fat-soluble vitamins 28 1.32e-01 -0.165000 3.15e-01
Downregulation of ERBB4 signaling 8 4.21e-01 -0.164000 6.30e-01
PI Metabolism 79 1.17e-02 0.164000 5.75e-02
Activation of C3 and C5 7 4.52e-01 -0.164000 6.59e-01
FRS-mediated FGFR2 signaling 15 2.72e-01 0.164000 4.78e-01
Regulation of BACH1 activity 11 3.47e-01 -0.164000 5.66e-01
RAF activation 33 1.05e-01 0.163000 2.70e-01
Ion transport by P-type ATPases 43 6.40e-02 0.163000 1.92e-01
SHC-mediated cascade:FGFR4 11 3.50e-01 0.163000 5.68e-01
SUMOylation of transcription factors 16 2.60e-01 -0.163000 4.69e-01
Infectious disease 959 1.49e-17 -0.162000 7.02e-16
Hedgehog ‘off’ state 91 7.42e-03 -0.162000 3.97e-02
Glycogen storage diseases 13 3.12e-01 -0.162000 5.25e-01
Transcriptional regulation by RUNX3 81 1.19e-02 -0.162000 5.81e-02
Scavenging by Class F Receptors 5 5.32e-01 -0.161000 7.16e-01
ABC transporters in lipid homeostasis 14 2.96e-01 0.161000 5.07e-01
Synthesis of bile acids and bile salts 27 1.49e-01 0.161000 3.40e-01
Downregulation of SMAD2/3:SMAD4 transcriptional activity 30 1.29e-01 0.160000 3.11e-01
Formation of the active cofactor, UDP-glucuronate 5 5.36e-01 -0.160000 7.19e-01
Formation of the nephric duct 8 4.34e-01 -0.160000 6.42e-01
Diseases of metabolism 208 7.08e-05 -0.160000 7.55e-04
Apoptosis 158 5.30e-04 -0.160000 4.34e-03
Protein methylation 15 2.84e-01 -0.160000 4.94e-01
Defective homologous recombination repair (HRR) due to BRCA2 loss of function 41 7.71e-02 0.160000 2.20e-01
Diseases of DNA Double-Strand Break Repair 41 7.71e-02 0.160000 2.20e-01
Cardiac conduction 89 9.41e-03 0.159000 4.81e-02
Signaling by EGFR in Cancer 23 1.86e-01 0.159000 3.80e-01
Gene Silencing by RNA 87 1.07e-02 -0.158000 5.33e-02
Interactions of Vpr with host cellular proteins 37 9.58e-02 -0.158000 2.56e-01
Metabolism of ingested SeMet, Sec, MeSec into H2Se 7 4.69e-01 0.158000 6.72e-01
SARS-CoV Infections 433 1.81e-08 -0.158000 4.78e-07
Nuclear import of Rev protein 34 1.12e-01 -0.157000 2.85e-01
Interleukin-1 processing 8 4.42e-01 0.157000 6.49e-01
Uptake of dietary cobalamins into enterocytes 6 5.08e-01 0.156000 7.00e-01
Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) 18 2.52e-01 0.156000 4.60e-01
CLEC7A/inflammasome pathway 6 5.09e-01 0.156000 7.00e-01
Translocation of ZAP-70 to Immunological synapse 24 1.86e-01 -0.156000 3.80e-01
Acyl chain remodeling of CL 5 5.46e-01 0.156000 7.25e-01
Transport of the SLBP Dependant Mature mRNA 36 1.06e-01 -0.156000 2.72e-01
Regulation of HSF1-mediated heat shock response 79 1.68e-02 -0.156000 7.63e-02
N-Glycan antennae elongation 13 3.32e-01 -0.156000 5.49e-01
Activation of PUMA and translocation to mitochondria 9 4.19e-01 -0.155000 6.28e-01
Fcgamma receptor (FCGR) dependent phagocytosis 147 1.17e-03 -0.155000 8.65e-03
Nicotinate metabolism 26 1.72e-01 0.155000 3.69e-01
RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known 36 1.10e-01 0.154000 2.81e-01
Glycosphingolipid biosynthesis 15 3.02e-01 0.154000 5.14e-01
PTEN Regulation 127 2.74e-03 -0.154000 1.76e-02
Regulation of IFNA/IFNB signaling 12 3.56e-01 0.154000 5.73e-01
Processive synthesis on the C-strand of the telomere 19 2.47e-01 -0.154000 4.55e-01
Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) 27 1.68e-01 0.153000 3.64e-01
Glucose metabolism 76 2.08e-02 -0.153000 8.87e-02
Signaling by ERBB4 45 7.53e-02 0.153000 2.17e-01
NRIF signals cell death from the nucleus 15 3.04e-01 -0.153000 5.17e-01
MET activates RAS signaling 10 4.02e-01 0.153000 6.14e-01
Signaling by TGF-beta Receptor Complex in Cancer 8 4.54e-01 0.153000 6.61e-01
CASP8 activity is inhibited 11 3.80e-01 0.153000 5.93e-01
Dimerization of procaspase-8 11 3.80e-01 0.153000 5.93e-01
Regulation by c-FLIP 11 3.80e-01 0.153000 5.93e-01
Linoleic acid (LA) metabolism 7 4.84e-01 -0.153000 6.80e-01
GPVI-mediated activation cascade 33 1.31e-01 0.152000 3.14e-01
Diseases of Mismatch Repair (MMR) 5 5.58e-01 -0.151000 7.34e-01
Collagen formation 66 3.37e-02 -0.151000 1.27e-01
Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding 32 1.39e-01 -0.151000 3.24e-01
Chaperone Mediated Autophagy 20 2.45e-01 -0.150000 4.53e-01
PLC beta mediated events 40 1.00e-01 0.150000 2.62e-01
Cobalamin (Cbl, vitamin B12) transport and metabolism 18 2.70e-01 -0.150000 4.77e-01
Plasma lipoprotein remodeling 18 2.70e-01 -0.150000 4.77e-01
Dopamine Neurotransmitter Release Cycle 20 2.45e-01 0.150000 4.53e-01
Transport to the Golgi and subsequent modification 171 7.11e-04 -0.150000 5.68e-03
Signal amplification 28 1.69e-01 0.150000 3.67e-01
Signaling by Activin 14 3.31e-01 0.150000 5.49e-01
Cobalamin (Cbl) metabolism 7 4.93e-01 -0.150000 6.88e-01
Ca-dependent events 30 1.56e-01 0.150000 3.51e-01
Tie2 Signaling 16 3.00e-01 0.150000 5.13e-01
Recognition of DNA damage by PCNA-containing replication complex 30 1.57e-01 -0.149000 3.52e-01
Purine salvage 12 3.72e-01 -0.149000 5.86e-01
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 6 5.28e-01 0.149000 7.15e-01
Constitutive Signaling by Aberrant PI3K in Cancer 59 4.90e-02 0.148000 1.63e-01
M-decay: degradation of maternal mRNAs by maternally stored factors 41 1.01e-01 0.148000 2.63e-01
ADP signalling through P2Y purinoceptor 1 21 2.41e-01 0.148000 4.49e-01
Formation of RNA Pol II elongation complex 56 5.56e-02 -0.148000 1.76e-01
RNA Polymerase II Transcription Elongation 56 5.56e-02 -0.148000 1.76e-01
Gap junction degradation 11 3.97e-01 -0.148000 6.09e-01
Translesion synthesis by REV1 16 3.09e-01 -0.147000 5.22e-01
Activation of ATR in response to replication stress 37 1.23e-01 -0.147000 3.05e-01
Regulation of localization of FOXO transcription factors 11 4.00e-01 -0.146000 6.12e-01
Opioid Signalling 75 2.85e-02 0.146000 1.10e-01
Pexophagy 10 4.24e-01 -0.146000 6.32e-01
Postmitotic nuclear pore complex (NPC) reformation 27 1.90e-01 -0.146000 3.84e-01
DNA Repair 289 2.06e-05 -0.146000 2.40e-04
Binding of TCF/LEF:CTNNB1 to target gene promoters 8 4.76e-01 0.146000 6.74e-01
Mitotic G2-G2/M phases 179 8.01e-04 -0.145000 6.23e-03
Presynaptic phase of homologous DNA pairing and strand exchange 40 1.12e-01 0.145000 2.85e-01
Acyl chain remodelling of PE 20 2.61e-01 0.145000 4.70e-01
Acetylcholine binding and downstream events 5 5.75e-01 -0.145000 7.45e-01
Postsynaptic nicotinic acetylcholine receptors 5 5.75e-01 -0.145000 7.45e-01
ERKs are inactivated 13 3.67e-01 -0.145000 5.84e-01
Extension of Telomeres 51 7.46e-02 -0.144000 2.16e-01
Defective B3GALTL causes PpS 27 1.95e-01 0.144000 3.91e-01
Norepinephrine Neurotransmitter Release Cycle 14 3.51e-01 0.144000 5.69e-01
Alpha-oxidation of phytanate 6 5.41e-01 -0.144000 7.21e-01
NOTCH3 Activation and Transmission of Signal to the Nucleus 23 2.32e-01 -0.144000 4.37e-01
NFE2L2 regulating anti-oxidant/detoxification enzymes 17 3.05e-01 -0.144000 5.18e-01
Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) 9 4.55e-01 -0.144000 6.61e-01
Apoptotic cleavage of cellular proteins 35 1.41e-01 0.144000 3.27e-01
TNFR2 non-canonical NF-kB pathway 84 2.29e-02 -0.144000 9.49e-02
Amyloid fiber formation 52 7.33e-02 -0.144000 2.14e-01
Aberrant regulation of mitotic cell cycle due to RB1 defects 36 1.36e-01 -0.144000 3.20e-01
Cellular response to heat stress 94 1.65e-02 -0.143000 7.50e-02
RIP-mediated NFkB activation via ZBP1 17 3.07e-01 0.143000 5.20e-01
Infection with Mycobacterium tuberculosis 26 2.08e-01 -0.143000 4.09e-01
Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer 50 8.08e-02 0.143000 2.28e-01
G2/M Transition 177 1.08e-03 -0.142000 8.05e-03
mRNA Splicing - Major Pathway 203 4.84e-04 -0.142000 4.05e-03
RAC2 GTPase cycle 86 2.31e-02 0.142000 9.56e-02
RHO GTPases activate KTN1 11 4.16e-01 0.142000 6.25e-01
Mitotic Metaphase and Anaphase 212 3.80e-04 -0.142000 3.29e-03
Signaling by WNT in cancer 30 1.80e-01 0.141000 3.75e-01
Signaling by activated point mutants of FGFR1 5 5.85e-01 0.141000 7.49e-01
Transport of Mature mRNA derived from an Intron-Containing Transcript 72 3.87e-02 -0.141000 1.41e-01
Chromatin modifications during the maternal to zygotic transition (MZT) 23 2.42e-01 -0.141000 4.51e-01
Signaling by NTRK3 (TRKC) 16 3.31e-01 0.140000 5.49e-01
Caspase activation via extrinsic apoptotic signalling pathway 25 2.25e-01 0.140000 4.27e-01
Metabolism of water-soluble vitamins and cofactors 115 9.72e-03 -0.140000 4.93e-02
Signaling by Hedgehog 120 8.27e-03 -0.140000 4.33e-02
FRS-mediated FGFR1 signaling 15 3.49e-01 0.140000 5.68e-01
Mitotic Anaphase 211 4.76e-04 -0.140000 4.00e-03
Phase 2 - plateau phase 11 4.25e-01 0.139000 6.32e-01
RNA Polymerase II Pre-transcription Events 77 3.50e-02 -0.139000 1.30e-01
TP53 Regulates Transcription of Death Receptors and Ligands 12 4.05e-01 0.139000 6.15e-01
Processing of Capped Intron-Containing Pre-mRNA 279 6.94e-05 -0.138000 7.49e-04
Activation of Ca-permeable Kainate Receptor 9 4.72e-01 0.138000 6.73e-01
Ionotropic activity of kainate receptors 9 4.72e-01 0.138000 6.73e-01
Signalling to ERKs 32 1.77e-01 0.138000 3.72e-01
TNFR1-induced proapoptotic signaling 24 2.44e-01 0.137000 4.53e-01
Drug ADME 59 6.81e-02 -0.137000 2.03e-01
Interferon gamma signaling 90 2.43e-02 0.137000 9.92e-02
BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members 9 4.76e-01 -0.137000 6.74e-01
Circadian Clock 67 5.26e-02 0.137000 1.71e-01
mRNA Splicing 211 6.16e-04 -0.137000 4.98e-03
Potential therapeutics for SARS 149 4.00e-03 -0.137000 2.36e-02
TCF dependent signaling in response to WNT 153 3.63e-03 -0.136000 2.20e-02
Signaling by FGFR2 61 6.64e-02 -0.136000 1.98e-01
Synthesis of active ubiquitin: roles of E1 and E2 enzymes 30 1.98e-01 -0.136000 3.95e-01
Nucleotide salvage 21 2.82e-01 -0.136000 4.91e-01
FGFR1c ligand binding and activation 8 5.07e-01 0.136000 7.00e-01
Fatty acid metabolism 155 3.59e-03 -0.136000 2.19e-02
Transport of the SLBP independent Mature mRNA 35 1.66e-01 -0.135000 3.63e-01
ER to Golgi Anterograde Transport 145 5.08e-03 -0.135000 2.89e-02
Separation of Sister Chromatids 168 2.63e-03 -0.135000 1.69e-02
GABA synthesis, release, reuptake and degradation 12 4.20e-01 -0.134000 6.29e-01
Nervous system development 478 4.92e-07 -0.134000 9.24e-06
Constitutive Signaling by NOTCH1 HD Domain Mutants 14 3.85e-01 -0.134000 5.98e-01
Signaling by NOTCH1 HD Domain Mutants in Cancer 14 3.85e-01 -0.134000 5.98e-01
Axon guidance 459 8.74e-07 -0.134000 1.54e-05
Incretin synthesis, secretion, and inactivation 14 3.86e-01 -0.134000 5.98e-01
Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) 14 3.86e-01 -0.134000 5.98e-01
Bile acid and bile salt metabolism 31 1.97e-01 0.134000 3.95e-01
HSF1-dependent transactivation 30 2.09e-01 -0.133000 4.11e-01
Activation of the AP-1 family of transcription factors 10 4.68e-01 0.133000 6.72e-01
VxPx cargo-targeting to cilium 19 3.17e-01 0.133000 5.33e-01
Glycolysis 68 5.89e-02 -0.132000 1.83e-01
IRS-related events triggered by IGF1R 37 1.64e-01 0.132000 3.60e-01
Transport and synthesis of PAPS 6 5.75e-01 -0.132000 7.45e-01
Amino acids regulate mTORC1 48 1.14e-01 -0.132000 2.87e-01
TP53 Regulates Transcription of Genes Involved in Cytochrome C Release 19 3.19e-01 -0.132000 5.36e-01
DAG and IP3 signaling 34 1.83e-01 0.132000 3.77e-01
Transcription of E2F targets under negative control by DREAM complex 19 3.20e-01 -0.132000 5.36e-01
Regulation of PTEN gene transcription 59 8.04e-02 -0.132000 2.27e-01
Propionyl-CoA catabolism 5 6.13e-01 -0.131000 7.71e-01
Thrombin signalling through proteinase activated receptors (PARs) 27 2.41e-01 0.130000 4.49e-01
Golgi Cisternae Pericentriolar Stack Reorganization 14 3.99e-01 -0.130000 6.11e-01
Estrogen biosynthesis 5 6.15e-01 -0.130000 7.71e-01
Protein ubiquitination 71 5.85e-02 -0.130000 1.82e-01
Activation of kainate receptors upon glutamate binding 26 2.52e-01 0.130000 4.60e-01
O-glycosylation of TSR domain-containing proteins 28 2.37e-01 0.129000 4.45e-01
Golgi-to-ER retrograde transport 123 1.35e-02 -0.129000 6.46e-02
Blood group systems biosynthesis 18 3.45e-01 -0.128000 5.64e-01
Activated NTRK2 signals through RAS 6 5.86e-01 0.128000 7.49e-01
Translesion synthesis by POLI 17 3.60e-01 -0.128000 5.76e-01
DNA Double-Strand Break Repair 137 9.58e-03 -0.128000 4.88e-02
Meiotic synapsis 43 1.46e-01 -0.128000 3.35e-01
Synthesis of PG 8 5.32e-01 -0.128000 7.16e-01
AKT phosphorylates targets in the cytosol 14 4.09e-01 -0.127000 6.19e-01
Lysine catabolism 11 4.65e-01 -0.127000 6.71e-01
RIPK1-mediated regulated necrosis 31 2.20e-01 0.127000 4.20e-01
Regulation of necroptotic cell death 31 2.20e-01 0.127000 4.20e-01
G beta:gamma signalling through PI3Kgamma 22 3.02e-01 0.127000 5.14e-01
Spry regulation of FGF signaling 16 3.79e-01 -0.127000 5.93e-01
TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest 18 3.52e-01 -0.127000 5.70e-01
Homology Directed Repair 110 2.23e-02 -0.126000 9.31e-02
Phospholipase C-mediated cascade; FGFR4 6 5.93e-01 0.126000 7.54e-01
SUMOylation of RNA binding proteins 47 1.35e-01 -0.126000 3.19e-01
Zygotic genome activation (ZGA) 5 6.25e-01 0.126000 7.80e-01
IKK complex recruitment mediated by RIP1 23 2.96e-01 0.126000 5.07e-01
Urea cycle 7 5.64e-01 -0.126000 7.39e-01
SUMOylation of ubiquitinylation proteins 39 1.74e-01 -0.126000 3.71e-01
SLC transporter disorders 77 5.66e-02 -0.126000 1.78e-01
STAT3 nuclear events downstream of ALK signaling 11 4.71e-01 0.125000 6.73e-01
G beta:gamma signalling through PLC beta 17 3.71e-01 0.125000 5.86e-01
Presynaptic function of Kainate receptors 17 3.71e-01 0.125000 5.86e-01
Diseases of mitotic cell cycle 38 1.83e-01 -0.125000 3.77e-01
Laminin interactions 26 2.71e-01 0.125000 4.77e-01
Neurotoxicity of clostridium toxins 9 5.17e-01 -0.125000 7.07e-01
Regulation of HMOX1 expression and activity 5 6.29e-01 0.125000 7.81e-01
Interleukin-35 Signalling 12 4.55e-01 0.125000 6.61e-01
FLT3 signaling through SRC family kinases 6 5.98e-01 -0.124000 7.59e-01
TGFBR3 regulates TGF-beta signaling 8 5.44e-01 0.124000 7.22e-01
MECP2 regulates neuronal receptors and channels 14 4.23e-01 0.124000 6.31e-01
Intrinsic Pathway of Fibrin Clot Formation 15 4.08e-01 -0.123000 6.18e-01
Muscle contraction 145 1.05e-02 0.123000 5.25e-02
Surfactant metabolism 21 3.29e-01 0.123000 5.48e-01
Signaling by Retinoic Acid 29 2.52e-01 -0.123000 4.60e-01
Hyaluronan uptake and degradation 12 4.61e-01 -0.123000 6.67e-01
PKA-mediated phosphorylation of CREB 17 3.81e-01 0.123000 5.94e-01
Regulation of PTEN localization 9 5.24e-01 -0.123000 7.13e-01
Ovarian tumor domain proteases 37 1.98e-01 0.122000 3.96e-01
Inflammasomes 21 3.35e-01 0.121000 5.52e-01
mRNA 3’-end processing 57 1.13e-01 -0.121000 2.86e-01
Signaling by FGFR3 32 2.35e-01 0.121000 4.42e-01
Macroautophagy 128 1.80e-02 -0.121000 7.99e-02
Synthesis of 5-eicosatetraenoic acids 7 5.79e-01 -0.121000 7.47e-01
Deadenylation-dependent mRNA decay 50 1.39e-01 -0.121000 3.24e-01
PP2A-mediated dephosphorylation of key metabolic factors 7 5.80e-01 -0.121000 7.47e-01
Regulation of TLR by endogenous ligand 15 4.18e-01 0.121000 6.27e-01
Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters 21 3.38e-01 -0.121000 5.56e-01
Intra-Golgi traffic 43 1.71e-01 0.121000 3.69e-01
Gastrulation 76 6.95e-02 -0.120000 2.06e-01
EPHB-mediated forward signaling 40 1.88e-01 0.120000 3.81e-01
Neurotransmitter receptors and postsynaptic signal transmission 141 1.38e-02 0.120000 6.50e-02
RHO GTPases Activate WASPs and WAVEs 35 2.19e-01 0.120000 4.20e-01
RAC3 GTPase cycle 88 5.15e-02 0.120000 1.68e-01
Nicotinamide salvaging 15 4.21e-01 0.120000 6.30e-01
ADORA2B mediated anti-inflammatory cytokines production 36 2.13e-01 0.120000 4.15e-01
NEP/NS2 Interacts with the Cellular Export Machinery 32 2.40e-01 -0.120000 4.49e-01
Cell Cycle Checkpoints 246 1.22e-03 -0.120000 8.90e-03
Lagging Strand Synthesis 20 3.55e-01 -0.120000 5.72e-01
NRAGE signals death through JNK 52 1.36e-01 0.120000 3.20e-01
E3 ubiquitin ligases ubiquitinate target proteins 51 1.40e-01 -0.120000 3.24e-01
Protein repair 6 6.13e-01 -0.119000 7.71e-01
SHC1 events in ERBB2 signaling 17 3.95e-01 0.119000 6.07e-01
Estrogen-dependent nuclear events downstream of ESR-membrane signaling 22 3.34e-01 0.119000 5.52e-01
Metabolism of carbohydrates 241 1.48e-03 -0.119000 1.04e-02
Synthesis of IP2, IP, and Ins in the cytosol 13 4.58e-01 0.119000 6.64e-01
Regulation of CDH11 gene transcription 5 6.46e-01 0.119000 7.90e-01
SMAD2/3 Phosphorylation Motif Mutants in Cancer 6 6.16e-01 0.118000 7.71e-01
TGFBR1 KD Mutants in Cancer 6 6.16e-01 0.118000 7.71e-01
Antiviral mechanism by IFN-stimulated genes 140 1.59e-02 -0.118000 7.24e-02
Disease 1633 1.99e-15 -0.118000 8.53e-14
Miscellaneous transport and binding events 20 3.62e-01 -0.118000 5.78e-01
Cardiogenesis 16 4.16e-01 -0.117000 6.25e-01
WNT mediated activation of DVL 8 5.69e-01 -0.116000 7.42e-01
Programmed Cell Death 187 6.15e-03 -0.116000 3.37e-02
PKR-mediated signaling 67 1.00e-01 -0.116000 2.62e-01
FGFRL1 modulation of FGFR1 signaling 7 5.95e-01 0.116000 7.56e-01
Sodium/Proton exchangers 7 5.95e-01 0.116000 7.56e-01
Activation of PPARGC1A (PGC-1alpha) by phosphorylation 8 5.70e-01 0.116000 7.43e-01
Sialic acid metabolism 28 2.88e-01 -0.116000 4.99e-01
Regulation of cytoskeletal remodeling and cell spreading by IPP complex components 8 5.72e-01 -0.115000 7.45e-01
TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain 20 3.73e-01 0.115000 5.88e-01
Autophagy 142 1.81e-02 -0.115000 8.01e-02
Toll Like Receptor 4 (TLR4) Cascade 138 1.98e-02 0.115000 8.60e-02
CaM pathway 28 2.93e-01 0.115000 5.04e-01
Calmodulin induced events 28 2.93e-01 0.115000 5.04e-01
TRAF6 mediated NF-kB activation 23 3.41e-01 0.115000 5.59e-01
SUMOylation of SUMOylation proteins 35 2.40e-01 -0.115000 4.49e-01
Platelet Aggregation (Plug Formation) 30 2.78e-01 -0.115000 4.85e-01
Processing of Intronless Pre-mRNAs 20 3.78e-01 -0.114000 5.91e-01
IRS-mediated signalling 35 2.45e-01 0.114000 4.53e-01
Cell-cell junction organization 60 1.30e-01 0.113000 3.13e-01
IGF1R signaling cascade 38 2.29e-01 0.113000 4.33e-01
NCAM signaling for neurite out-growth 48 1.76e-01 0.113000 3.72e-01
Amine ligand-binding receptors 10 5.37e-01 0.113000 7.19e-01
Response to metal ions 6 6.33e-01 0.112000 7.82e-01
Nectin/Necl trans heterodimerization 5 6.64e-01 0.112000 8.03e-01
NOD1/2 Signaling Pathway 36 2.44e-01 0.112000 4.53e-01
Homologous DNA Pairing and Strand Exchange 43 2.05e-01 0.112000 4.05e-01
Thyroxine biosynthesis 5 6.65e-01 -0.112000 8.05e-01
Ion homeostasis 42 2.12e-01 0.111000 4.13e-01
Sema4D in semaphorin signaling 22 3.66e-01 -0.111000 5.83e-01
FGFR2 ligand binding and activation 9 5.64e-01 -0.111000 7.39e-01
HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) 104 5.02e-02 -0.111000 1.66e-01
Interleukin-1 signaling 99 5.68e-02 -0.111000 1.78e-01
Negative regulators of DDX58/IFIH1 signaling 34 2.64e-01 0.111000 4.74e-01
Post-translational modification: synthesis of GPI-anchored proteins 59 1.43e-01 -0.110000 3.30e-01
Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA 7 6.14e-01 0.110000 7.71e-01
Pyruvate metabolism 44 2.07e-01 -0.110000 4.09e-01
Vpr-mediated nuclear import of PICs 34 2.70e-01 -0.109000 4.77e-01
Endosomal Sorting Complex Required For Transport (ESCRT) 29 3.09e-01 -0.109000 5.22e-01
Signaling by LTK 10 5.50e-01 0.109000 7.28e-01
Regulation of commissural axon pathfinding by SLIT and ROBO 7 6.17e-01 0.109000 7.72e-01
SHC-mediated cascade:FGFR2 13 4.96e-01 0.109000 6.91e-01
Glucuronidation 9 5.73e-01 -0.108000 7.45e-01
mRNA decay by 5’ to 3’ exoribonuclease 15 4.68e-01 -0.108000 6.72e-01
Nuclear signaling by ERBB4 24 3.59e-01 0.108000 5.75e-01
Regulation of glycolysis by fructose 2,6-bisphosphate metabolism 11 5.35e-01 0.108000 7.18e-01
Extra-nuclear estrogen signaling 67 1.26e-01 0.108000 3.08e-01
Maturation of nucleoprotein 9683610 11 5.36e-01 0.108000 7.19e-01
RUNX3 regulates CDKN1A transcription 7 6.22e-01 -0.108000 7.77e-01
Beta-oxidation of very long chain fatty acids 11 5.37e-01 -0.108000 7.19e-01
Mucopolysaccharidoses 11 5.37e-01 -0.107000 7.19e-01
Neurotransmitter clearance 6 6.49e-01 0.107000 7.93e-01
Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) 39 2.47e-01 0.107000 4.55e-01
TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) 16 4.58e-01 -0.107000 6.64e-01
Defective factor IX causes hemophilia B 6 6.50e-01 -0.107000 7.95e-01
Maturation of hRSV A proteins 13 5.05e-01 -0.107000 6.99e-01
Estrogen-stimulated signaling through PRKCZ 6 6.51e-01 0.107000 7.95e-01
Maturation of protein 3a 9683673 9 5.81e-01 -0.106000 7.47e-01
Maturation of protein 3a 9694719 9 5.81e-01 -0.106000 7.47e-01
Phospholipid metabolism 183 1.33e-02 0.106000 6.40e-02
Loss of Function of TGFBR1 in Cancer 7 6.27e-01 0.106000 7.80e-01
Activation of NOXA and translocation to mitochondria 5 6.82e-01 -0.106000 8.17e-01
Vitamin C (ascorbate) metabolism 8 6.04e-01 0.106000 7.64e-01
DDX58/IFIH1-mediated induction of interferon-alpha/beta 66 1.37e-01 0.106000 3.21e-01
Repression of WNT target genes 14 4.93e-01 0.106000 6.88e-01
Interleukin-4 and Interleukin-13 signaling 93 7.81e-02 0.106000 2.23e-01
Translesion synthesis by POLK 17 4.52e-01 -0.105000 6.59e-01
Platelet sensitization by LDL 16 4.66e-01 0.105000 6.71e-01
Nucleotide-like (purinergic) receptors 13 5.12e-01 0.105000 7.03e-01
Crosslinking of collagen fibrils 15 4.81e-01 -0.105000 6.80e-01
Heparan sulfate/heparin (HS-GAG) metabolism 40 2.50e-01 -0.105000 4.60e-01
Smooth Muscle Contraction 34 2.90e-01 -0.105000 5.01e-01
Sperm Motility And Taxes 6 6.58e-01 -0.104000 7.99e-01
Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways 56 1.77e-01 0.104000 3.72e-01
CD28 dependent PI3K/Akt signaling 22 3.97e-01 -0.104000 6.10e-01
CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde 7 6.34e-01 0.104000 7.82e-01
Mitotic Prophase 96 7.92e-02 -0.104000 2.24e-01
Creatine metabolism 6 6.61e-01 0.103000 8.00e-01
Metal ion SLC transporters 19 4.36e-01 -0.103000 6.43e-01
Glucagon-type ligand receptors 20 4.26e-01 0.103000 6.32e-01
Export of Viral Ribonucleoproteins from Nucleus 33 3.06e-01 -0.103000 5.19e-01
Nephron development 5 6.90e-01 -0.103000 8.23e-01
activated TAK1 mediates p38 MAPK activation 23 3.94e-01 -0.103000 6.06e-01
Signaling by FGFR 73 1.30e-01 -0.103000 3.13e-01
GP1b-IX-V activation signalling 12 5.39e-01 -0.102000 7.21e-01
TCR signaling 110 6.40e-02 -0.102000 1.92e-01
Neuronal System 276 3.47e-03 0.102000 2.15e-02
Beta-catenin independent WNT signaling 126 4.79e-02 -0.102000 1.61e-01
HDACs deacetylate histones 45 2.38e-01 -0.102000 4.45e-01
Role of ABL in ROBO-SLIT signaling 6 6.69e-01 0.101000 8.06e-01
Cyclin D associated events in G1 47 2.32e-01 -0.101000 4.37e-01
G1 Phase 47 2.32e-01 -0.101000 4.37e-01
Leishmania infection 211 1.16e-02 -0.101000 5.75e-02
Parasitic Infection Pathways 211 1.16e-02 -0.101000 5.75e-02
CDH11 homotypic and heterotypic interactions 6 6.70e-01 0.101000 8.07e-01
RUNX2 regulates bone development 26 3.77e-01 -0.100000 5.91e-01
Signal regulatory protein family interactions 13 5.32e-01 0.100000 7.16e-01
COPII-mediated vesicle transport 67 1.57e-01 -0.099900 3.52e-01
Vitamin D (calciferol) metabolism 11 5.66e-01 -0.099800 7.41e-01
SARS-CoV-1 targets host intracellular signalling and regulatory pathways 16 4.90e-01 -0.099700 6.85e-01
Thromboxane signalling through TP receptor 20 4.40e-01 0.099700 6.48e-01
Defective LFNG causes SCDO3 5 7.00e-01 -0.099600 8.30e-01
alpha-linolenic (omega3) and linoleic (omega6) acid metabolism 12 5.51e-01 -0.099500 7.28e-01
alpha-linolenic acid (ALA) metabolism 12 5.51e-01 -0.099500 7.28e-01
Sema3A PAK dependent Axon repulsion 15 5.08e-01 0.098800 7.00e-01
Signaling by NOTCH2 33 3.27e-01 0.098600 5.45e-01
RUNX3 regulates p14-ARF 10 5.90e-01 0.098500 7.52e-01
Oxidative Stress Induced Senescence 77 1.35e-01 -0.098500 3.19e-01
Reduction of cytosolic Ca++ levels 9 6.10e-01 -0.098300 7.69e-01
Detoxification of Reactive Oxygen Species 30 3.52e-01 -0.098100 5.70e-01
Signaling by NOTCH 175 2.53e-02 -0.098000 1.02e-01
Keratan sulfate/keratin metabolism 28 3.69e-01 -0.098000 5.86e-01
Eicosanoid ligand-binding receptors 13 5.41e-01 -0.098000 7.21e-01
Cytoprotection by HMOX1 53 2.17e-01 -0.097900 4.20e-01
Adenylate cyclase activating pathway 8 6.31e-01 0.097900 7.82e-01
Toll-like Receptor Cascades 162 3.17e-02 0.097800 1.21e-01
Formation of the cornified envelope 36 3.10e-01 0.097700 5.24e-01
Transmission across Chemical Synapses 188 2.11e-02 0.097500 8.95e-02
OAS antiviral response 8 6.33e-01 -0.097400 7.82e-01
CDC42 GTPase cycle 141 4.60e-02 0.097300 1.56e-01
Condensation of Prometaphase Chromosomes 11 5.77e-01 0.097200 7.46e-01
Downregulation of ERBB2 signaling 24 4.11e-01 -0.097000 6.20e-01
Anchoring of the basal body to the plasma membrane 97 9.96e-02 0.096800 2.61e-01
Insulin receptor recycling 24 4.12e-01 -0.096700 6.21e-01
Digestion and absorption 7 6.58e-01 0.096600 7.99e-01
Cell Cycle, Mitotic 488 2.65e-04 -0.096400 2.37e-03
Retinoid metabolism and transport 25 4.09e-01 -0.095400 6.19e-01
G0 and Early G1 27 3.91e-01 -0.095400 6.03e-01
Post-translational protein modification 1243 1.62e-08 -0.095200 4.36e-07
RHOU GTPase cycle 40 3.03e-01 0.094200 5.15e-01
MyD88-independent TLR4 cascade 108 9.09e-02 0.094200 2.46e-01
TRIF (TICAM1)-mediated TLR4 signaling 108 9.09e-02 0.094200 2.46e-01
Synthesis of PI 5 7.16e-01 0.093800 8.40e-01
CLEC7A (Dectin-1) signaling 86 1.34e-01 -0.093600 3.19e-01
Antigen processing: Ubiquitination & Proteasome degradation 275 7.71e-03 -0.093400 4.10e-02
Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase 20 4.72e-01 -0.092800 6.73e-01
Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation 36 3.36e-01 -0.092700 5.53e-01
EGR2 and SOX10-mediated initiation of Schwann cell myelination 22 4.52e-01 -0.092600 6.59e-01
Protein-protein interactions at synapses 61 2.11e-01 0.092600 4.13e-01
G alpha (z) signalling events 36 3.37e-01 0.092400 5.55e-01
Activated point mutants of FGFR2 7 6.73e-01 0.092200 8.09e-01
Meiosis 67 1.92e-01 -0.092200 3.87e-01
Response of Mtb to phagocytosis 22 4.55e-01 -0.092100 6.61e-01
Interleukin-9 signaling 8 6.52e-01 0.092000 7.95e-01
RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function 50 2.62e-01 -0.091700 4.70e-01
Cell Cycle 611 1.08e-04 -0.091700 1.09e-03
TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain 14 5.53e-01 -0.091700 7.30e-01
Regulation of TP53 Degradation 35 3.48e-01 -0.091600 5.67e-01
Glucagon signaling in metabolic regulation 26 4.19e-01 0.091500 6.28e-01
Regulation of MITF-M-dependent genes involved in pigmentation 37 3.35e-01 0.091500 5.52e-01
Serotonin Neurotransmitter Release Cycle 15 5.39e-01 0.091500 7.21e-01
Carboxyterminal post-translational modifications of tubulin 34 3.56e-01 -0.091500 5.73e-01
Downregulation of ERBB2:ERBB3 signaling 12 5.84e-01 -0.091200 7.49e-01
Iron uptake and transport 52 2.57e-01 -0.090900 4.65e-01
M Phase 346 3.71e-03 -0.090800 2.22e-02
NGF-stimulated transcription 32 3.76e-01 0.090500 5.89e-01
Integration of energy metabolism 88 1.44e-01 0.090100 3.32e-01
Early Phase of HIV Life Cycle 14 5.60e-01 -0.090000 7.35e-01
Signaling by CSF3 (G-CSF) 29 4.02e-01 0.089800 6.14e-01
PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling 86 1.53e-01 0.089200 3.45e-01
NOTCH4 Intracellular Domain Regulates Transcription 19 5.02e-01 0.088900 6.96e-01
TP53 Regulates Transcription of Caspase Activators and Caspases 12 5.94e-01 0.088900 7.56e-01
Synthesis of very long-chain fatty acyl-CoAs 22 4.72e-01 0.088600 6.73e-01
MyD88:MAL(TIRAP) cascade initiated on plasma membrane 108 1.12e-01 0.088500 2.85e-01
Toll Like Receptor TLR6:TLR2 Cascade 108 1.12e-01 0.088500 2.85e-01
G alpha (q) signalling events 139 7.28e-02 0.088100 2.14e-01
Sensory perception of sweet, bitter, and umami (glutamate) taste 19 5.07e-01 0.088000 7.00e-01
TRP channels 22 4.76e-01 0.087900 6.74e-01
SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription 36 3.63e-01 0.087500 5.80e-01
MAP2K and MAPK activation 36 3.64e-01 -0.087500 5.80e-01
Regulation of signaling by NODAL 6 7.11e-01 -0.087500 8.37e-01
Toll Like Receptor 2 (TLR2) Cascade 109 1.15e-01 0.087400 2.88e-01
Toll Like Receptor TLR1:TLR2 Cascade 109 1.15e-01 0.087400 2.88e-01
Termination of translesion DNA synthesis 32 3.95e-01 -0.087000 6.07e-01
RHOBTB1 GTPase cycle 23 4.71e-01 0.086900 6.73e-01
COPI-independent Golgi-to-ER retrograde traffic 45 3.13e-01 -0.086900 5.27e-01
PI3K Cascade 31 4.03e-01 0.086700 6.14e-01
Signaling by SCF-KIT 40 3.44e-01 0.086500 5.61e-01
Transcriptional regulation by RUNX1 170 5.18e-02 -0.086500 1.68e-01
Protein lipoylation 10 6.36e-01 -0.086400 7.82e-01
Synthesis of bile acids and bile salts via 24-hydroxycholesterol 10 6.37e-01 -0.086200 7.83e-01
Transcriptional Regulation by TP53 346 5.96e-03 -0.086000 3.28e-02
RHOT2 GTPase cycle 7 6.94e-01 -0.085800 8.26e-01
Signaling by RNF43 mutants 7 6.95e-01 0.085700 8.26e-01
Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template 38 3.62e-01 -0.085500 5.78e-01
Phosphorylation of CD3 and TCR zeta chains 27 4.42e-01 -0.085500 6.49e-01
Metalloprotease DUBs 20 5.09e-01 0.085400 7.00e-01
Nephrin family interactions 20 5.09e-01 0.085300 7.00e-01
Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation 11 6.26e-01 0.084900 7.80e-01
Phase I - Functionalization of compounds 70 2.20e-01 0.084800 4.20e-01
Attachment and Entry 9694614 14 5.84e-01 0.084600 7.49e-01
NS1 Mediated Effects on Host Pathways 40 3.56e-01 -0.084400 5.73e-01
Constitutive Signaling by AKT1 E17K in Cancer 25 4.65e-01 -0.084400 6.71e-01
MET activates PTK2 signaling 23 4.84e-01 -0.084300 6.80e-01
Toll Like Receptor 9 (TLR9) Cascade 108 1.31e-01 0.084200 3.14e-01
Glycosphingolipid metabolism 46 3.24e-01 -0.084100 5.41e-01
JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 22 4.95e-01 -0.084000 6.90e-01
G2 Phase 5 7.46e-01 -0.083500 8.61e-01
VEGFR2 mediated cell proliferation 18 5.40e-01 0.083400 7.21e-01
PI3K/AKT Signaling in Cancer 85 1.84e-01 0.083300 3.79e-01
Initiation of Nuclear Envelope (NE) Reformation 19 5.31e-01 -0.083100 7.16e-01
MECP2 regulates transcription of neuronal ligands 5 7.48e-01 -0.083100 8.62e-01
Keratinization 37 3.83e-01 0.082900 5.96e-01
RHO GTPases activate IQGAPs 25 4.74e-01 -0.082700 6.73e-01
Triglyceride metabolism 26 4.66e-01 0.082700 6.71e-01
Regulation of TNFR1 signaling 47 3.28e-01 0.082500 5.46e-01
Elastic fibre formation 33 4.13e-01 -0.082300 6.22e-01
Hemostasis 562 8.48e-04 -0.082300 6.55e-03
Aberrant regulation of mitotic exit in cancer due to RB1 defects 20 5.29e-01 -0.081300 7.15e-01
Class I MHC mediated antigen processing & presentation 344 9.61e-03 -0.081200 4.89e-02
p38MAPK events 13 6.13e-01 -0.081000 7.71e-01
PECAM1 interactions 12 6.28e-01 0.080900 7.80e-01
SHC-mediated cascade:FGFR1 13 6.14e-01 0.080900 7.71e-01
RSK activation 7 7.11e-01 0.080800 8.37e-01
Cell junction organization 82 2.07e-01 0.080700 4.09e-01
VEGFR2 mediated vascular permeability 26 4.77e-01 -0.080600 6.74e-01
FBXW7 Mutants and NOTCH1 in Cancer 5 7.55e-01 -0.080600 8.66e-01
Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling 5 7.55e-01 -0.080600 8.66e-01
Cell-Cell communication 114 1.38e-01 0.080500 3.21e-01
TNFR1-induced NF-kappa-B signaling pathway 32 4.31e-01 0.080500 6.38e-01
Integrin signaling 22 5.14e-01 -0.080400 7.05e-01
RUNX3 regulates WNT signaling 8 6.95e-01 0.080000 8.26e-01
Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) 32 4.35e-01 -0.079800 6.42e-01
Regulation of Glucokinase by Glucokinase Regulatory Protein 32 4.35e-01 -0.079800 6.42e-01
Transport of small molecules 558 1.26e-03 -0.079800 9.15e-03
SUMOylation of chromatin organization proteins 57 3.00e-01 -0.079400 5.13e-01
Deadenylation of mRNA 22 5.19e-01 0.079300 7.09e-01
SLC-mediated transmembrane transport 175 7.06e-02 -0.079200 2.08e-01
TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation 100 1.72e-01 0.079000 3.69e-01
MITF-M-dependent gene expression 83 2.14e-01 0.079000 4.15e-01
Carnitine shuttle 12 6.36e-01 -0.078900 7.82e-01
Kidney development 17 5.75e-01 -0.078600 7.45e-01
Death Receptor Signaling 145 1.03e-01 0.078500 2.67e-01
Alpha-protein kinase 1 signaling pathway 11 6.52e-01 0.078500 7.95e-01
Generation of second messenger molecules 38 4.05e-01 -0.078000 6.15e-01
Cargo recognition for clathrin-mediated endocytosis 89 2.05e-01 -0.077800 4.05e-01
Methylation 13 6.27e-01 -0.077800 7.80e-01
Vesicle-mediated transport 669 6.14e-04 -0.077600 4.98e-03
Interleukin-1 family signaling 127 1.31e-01 -0.077600 3.14e-01
IRAK2 mediated activation of TAK1 complex 10 6.73e-01 -0.077100 8.09e-01
Inactivation of CDC42 and RAC1 7 7.24e-01 -0.077100 8.47e-01
Transport of Ribonucleoproteins into the Host Nucleus 32 4.50e-01 -0.077100 6.58e-01
TNF signaling 56 3.19e-01 0.077000 5.35e-01
Trafficking and processing of endosomal TLR 13 6.31e-01 -0.076900 7.82e-01
IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation 15 6.06e-01 0.076900 7.66e-01
SARS-CoV-2 modulates autophagy 11 6.59e-01 -0.076800 7.99e-01
MyD88 dependent cascade initiated on endosome 101 1.83e-01 0.076600 3.77e-01
Interleukin-23 signaling 7 7.26e-01 0.076500 8.47e-01
Molecules associated with elastic fibres 26 5.03e-01 -0.076000 6.96e-01
Formation of the ureteric bud 5 7.69e-01 -0.075700 8.77e-01
Synthesis of PIPs at the Golgi membrane 16 6.00e-01 -0.075700 7.60e-01
Disassembly of the destruction complex and recruitment of AXIN to the membrane 29 4.82e-01 -0.075400 6.80e-01
Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells 29 4.83e-01 -0.075300 6.80e-01
RA biosynthesis pathway 13 6.39e-01 -0.075200 7.84e-01
ISG15 antiviral mechanism 72 2.71e-01 -0.075000 4.77e-01
O-linked glycosylation of mucins 47 3.73e-01 -0.075000 5.88e-01
Nuclear Receptor transcription pathway 40 4.12e-01 0.075000 6.21e-01
Activation of NMDA receptors and postsynaptic events 74 2.65e-01 0.074900 4.75e-01
Signaling by EGFR 48 3.70e-01 0.074800 5.86e-01
Glycogen synthesis 11 6.68e-01 -0.074700 8.06e-01
Synthesis of IP3 and IP4 in the cytosol 22 5.44e-01 0.074700 7.22e-01
Regulation of TP53 Expression and Degradation 36 4.39e-01 -0.074600 6.46e-01
Toll Like Receptor 7/8 (TLR7/8) Cascade 105 1.88e-01 0.074400 3.81e-01
HDR through MMEJ (alt-NHEJ) 12 6.57e-01 0.074100 7.99e-01
Chondroitin sulfate/dermatan sulfate metabolism 38 4.30e-01 -0.074000 6.38e-01
Transcriptional regulation of testis differentiation 5 7.76e-01 -0.073400 8.81e-01
Effects of PIP2 hydrolysis 24 5.35e-01 -0.073200 7.18e-01
Sphingolipid de novo biosynthesis 34 4.61e-01 -0.073000 6.67e-01
Signaling by high-kinase activity BRAF mutants 33 4.68e-01 -0.072900 6.72e-01
Sensory perception of taste 22 5.56e-01 0.072600 7.32e-01
RHO GTPase cycle 412 1.19e-02 0.072300 5.81e-02
Ub-specific processing proteases 153 1.24e-01 -0.072000 3.06e-01
Collagen chain trimerization 29 5.02e-01 0.072000 6.96e-01
Toll Like Receptor 3 (TLR3) Cascade 104 2.04e-01 0.072000 4.05e-01
Keratan sulfate degradation 9 7.08e-01 -0.072000 8.35e-01
Negative regulation of the PI3K/AKT network 93 2.32e-01 0.071800 4.37e-01
Signaling by FGFR4 32 4.84e-01 0.071500 6.80e-01
RHO GTPases Activate Formins 128 1.63e-01 -0.071500 3.58e-01
Extracellular matrix organization 222 6.68e-02 -0.071400 1.99e-01
Biosynthesis of EPA-derived SPMs 6 7.62e-01 -0.071400 8.71e-01
Diseases of DNA repair 51 3.81e-01 0.071000 5.93e-01
Signaling by NODAL 15 6.35e-01 0.070700 7.82e-01
RAB GEFs exchange GTP for GDP on RABs 89 2.50e-01 0.070600 4.59e-01
Activation of RAC1 11 6.85e-01 0.070600 8.20e-01
Nuclear Pore Complex (NPC) Disassembly 36 4.66e-01 -0.070200 6.71e-01
Beta-catenin phosphorylation cascade 17 6.16e-01 0.070200 7.71e-01
Glycosaminoglycan metabolism 98 2.32e-01 -0.069900 4.37e-01
Loss of MECP2 binding ability to the NCoR/SMRT complex 7 7.49e-01 0.069800 8.63e-01
RND3 GTPase cycle 36 4.70e-01 0.069600 6.73e-01
Collagen degradation 44 4.25e-01 0.069500 6.32e-01
Neurexins and neuroligins 40 4.48e-01 0.069400 6.55e-01
Dissolution of Fibrin Clot 12 6.78e-01 0.069100 8.15e-01
RUNX2 regulates osteoblast differentiation 21 5.85e-01 -0.068800 7.49e-01
Vitamin B5 (pantothenate) metabolism 20 5.96e-01 -0.068500 7.56e-01
Glycogen metabolism 21 5.90e-01 0.067900 7.52e-01
MyD88 cascade initiated on plasma membrane 95 2.54e-01 0.067700 4.62e-01
Toll Like Receptor 10 (TLR10) Cascade 95 2.54e-01 0.067700 4.62e-01
Toll Like Receptor 5 (TLR5) Cascade 95 2.54e-01 0.067700 4.62e-01
Diseases associated with O-glycosylation of proteins 50 4.08e-01 -0.067700 6.18e-01
Synthesis of PC 23 5.75e-01 0.067500 7.45e-01
Deactivation of the beta-catenin transactivating complex 36 4.86e-01 -0.067100 6.82e-01
RUNX1 regulates expression of components of tight junctions 5 7.96e-01 0.066900 8.92e-01
Interleukin-12 family signaling 53 4.03e-01 -0.066300 6.14e-01
RET signaling 32 5.17e-01 0.066200 7.07e-01
FGFR1 ligand binding and activation 10 7.18e-01 0.066000 8.41e-01
RND2 GTPase cycle 37 4.88e-01 -0.065900 6.83e-01
The canonical retinoid cycle in rods (twilight vision) 9 7.32e-01 -0.065900 8.50e-01
Antimicrobial peptides 34 5.07e-01 -0.065700 7.00e-01
CD28 dependent Vav1 pathway 12 6.94e-01 0.065600 8.26e-01
NR1H2 and NR1H3-mediated signaling 39 4.79e-01 0.065500 6.77e-01
Sphingolipid metabolism 91 2.82e-01 -0.065300 4.91e-01
Post NMDA receptor activation events 64 3.68e-01 0.065100 5.84e-01
RHO GTPases Activate NADPH Oxidases 21 6.07e-01 0.064900 7.66e-01
Ion channel transport 141 1.83e-01 0.064900 3.77e-01
CS/DS degradation 9 7.37e-01 -0.064700 8.53e-01
Syndecan interactions 26 5.69e-01 -0.064600 7.42e-01
Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants 18 6.36e-01 0.064500 7.82e-01
Signaling by Ligand-Responsive EGFR Variants in Cancer 18 6.36e-01 0.064500 7.82e-01
HATs acetylate histones 92 2.85e-01 -0.064500 4.95e-01
TICAM1,TRAF6-dependent induction of TAK1 complex 11 7.12e-01 -0.064400 8.37e-01
Noncanonical activation of NOTCH3 8 7.53e-01 -0.064200 8.65e-01
Aquaporin-mediated transport 38 4.96e-01 0.063800 6.90e-01
Cellular Senescence 143 1.90e-01 -0.063500 3.83e-01
Beta oxidation of butanoyl-CoA to acetyl-CoA 5 8.06e-01 0.063300 8.99e-01
NOTCH3 Intracellular Domain Regulates Transcription 22 6.09e-01 0.062900 7.69e-01
PPARA activates gene expression 105 2.66e-01 0.062800 4.76e-01
Negative regulation of TCF-dependent signaling by WNT ligand antagonists 6 7.91e-01 -0.062600 8.89e-01
Metabolism of steroid hormones 22 6.12e-01 -0.062500 7.71e-01
MHC class II antigen presentation 113 2.53e-01 -0.062200 4.61e-01
Signaling by NTRK1 (TRKA) 102 2.79e-01 0.062000 4.87e-01
Signaling by FGFR1 42 4.87e-01 0.062000 6.83e-01
Apoptotic execution phase 46 4.68e-01 0.061800 6.72e-01
Regulation of lipid metabolism by PPARalpha 107 2.71e-01 0.061600 4.77e-01
Negative regulation of FLT3 15 6.80e-01 -0.061500 8.16e-01
MTOR signalling 39 5.08e-01 -0.061300 7.00e-01
MAP3K8 (TPL2)-dependent MAPK1/3 activation 16 6.72e-01 0.061200 8.09e-01
Keratan sulfate biosynthesis 20 6.37e-01 -0.060900 7.83e-01
AMPK inhibits chREBP transcriptional activation activity 6 7.97e-01 0.060700 8.93e-01
NCAM1 interactions 27 5.86e-01 0.060600 7.49e-01
Assembly and cell surface presentation of NMDA receptors 34 5.41e-01 0.060500 7.21e-01
Signaling by BMP 23 6.16e-01 0.060500 7.71e-01
Insulin receptor signalling cascade 40 5.08e-01 0.060500 7.00e-01
TGF-beta receptor signaling activates SMADs 45 4.86e-01 -0.060100 6.82e-01
Biological oxidations 146 2.13e-01 -0.059700 4.15e-01
MAPK targets/ Nuclear events mediated by MAP kinases 31 5.66e-01 0.059600 7.40e-01
Uptake and actions of bacterial toxins 28 5.86e-01 0.059400 7.49e-01
Phase 4 - resting membrane potential 9 7.58e-01 0.059300 8.69e-01
L1CAM interactions 100 3.06e-01 0.059300 5.18e-01
Intra-Golgi and retrograde Golgi-to-ER traffic 191 1.60e-01 -0.059000 3.55e-01
Signaling by NTRKs 117 2.71e-01 0.058900 4.77e-01
Class B/2 (Secretin family receptors) 55 4.52e-01 0.058700 6.59e-01
Glycerophospholipid biosynthesis 105 3.00e-01 0.058600 5.13e-01
Signaling by TGFB family members 139 2.33e-01 0.058500 4.39e-01
WNT ligand biogenesis and trafficking 19 6.59e-01 0.058500 7.99e-01
Recycling pathway of L1 40 5.23e-01 -0.058400 7.12e-01
Clathrin-mediated endocytosis 128 2.59e-01 -0.057800 4.68e-01
PKA activation 15 7.00e-01 0.057500 8.30e-01
Signaling by WNT 241 1.24e-01 -0.057500 3.06e-01
A tetrasaccharide linker sequence is required for GAG synthesis 17 6.84e-01 -0.056900 8.19e-01
ER Quality Control Compartment (ERQC) 21 6.53e-01 -0.056700 7.96e-01
Defensins 8 7.83e-01 -0.056300 8.85e-01
Regulation of pyruvate dehydrogenase (PDH) complex 14 7.16e-01 -0.056200 8.40e-01
Pre-NOTCH Processing in Golgi 18 6.81e-01 -0.056100 8.16e-01
VEGFA-VEGFR2 Pathway 93 3.51e-01 0.056000 5.69e-01
Netrin-1 signaling 35 5.67e-01 0.055900 7.41e-01
Developmental Biology 929 4.02e-03 -0.055700 2.36e-02
Vasopressin regulates renal water homeostasis via Aquaporins 34 5.75e-01 0.055500 7.45e-01
Ethanol oxidation 8 7.87e-01 -0.055300 8.88e-01
Neurotransmitter release cycle 38 5.56e-01 0.055200 7.32e-01
Recruitment of NuMA to mitotic centrosomes 88 3.70e-01 -0.055200 5.86e-01
Formation of Fibrin Clot (Clotting Cascade) 26 6.27e-01 -0.055000 7.80e-01
Hyaluronan metabolism 16 7.04e-01 -0.055000 8.32e-01
Diseases associated with glycosaminoglycan metabolism 25 6.35e-01 -0.054900 7.82e-01
Telomere C-strand (Lagging Strand) Synthesis 34 5.80e-01 -0.054900 7.47e-01
Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol 19 6.79e-01 0.054900 8.15e-01
Transcriptional regulation of granulopoiesis 44 5.31e-01 -0.054600 7.16e-01
GPCR downstream signalling 398 6.18e-02 0.054500 1.90e-01
Nuclear Events (kinase and transcription factor activation) 54 4.90e-01 0.054300 6.85e-01
Coenzyme A biosynthesis 7 8.05e-01 -0.054000 8.98e-01
Platelet activation, signaling and aggregation 223 1.67e-01 -0.053700 3.64e-01
Cytosolic sensors of pathogen-associated DNA 63 4.61e-01 -0.053700 6.67e-01
DNA Damage Bypass 47 5.26e-01 -0.053500 7.14e-01
Adaptive Immune System 768 1.17e-02 -0.053500 5.75e-02
HDR through Homologous Recombination (HRR) 68 4.46e-01 -0.053400 6.54e-01
Sensory processing of sound by outer hair cells of the cochlea 41 5.54e-01 -0.053400 7.31e-01
Inositol phosphate metabolism 42 5.50e-01 0.053400 7.28e-01
RNA polymerase II transcribes snRNA genes 71 4.39e-01 -0.053200 6.46e-01
TICAM1, RIP1-mediated IKK complex recruitment 19 6.90e-01 0.052900 8.23e-01
RHOBTB GTPase Cycle 35 5.90e-01 0.052600 7.52e-01
Activation of SMO 13 7.43e-01 0.052500 8.59e-01
Formation of WDR5-containing histone-modifying complexes 42 5.56e-01 -0.052500 7.32e-01
SUMOylation of intracellular receptors 26 6.44e-01 0.052300 7.89e-01
Regulation of KIT signaling 15 7.26e-01 0.052300 8.47e-01
RHOG GTPase cycle 71 4.46e-01 0.052300 6.54e-01
Transport of inorganic cations/anions and amino acids/oligopeptides 81 4.18e-01 -0.052100 6.27e-01
Transport of bile salts and organic acids, metal ions and amine compounds 52 5.17e-01 0.052000 7.07e-01
HS-GAG biosynthesis 20 6.87e-01 -0.052000 8.21e-01
Signaling by NOTCH3 44 5.52e-01 -0.051800 7.30e-01
STING mediated induction of host immune responses 15 7.30e-01 0.051500 8.49e-01
Prostacyclin signalling through prostacyclin receptor 16 7.22e-01 0.051300 8.46e-01
Sema4D induced cell migration and growth-cone collapse 19 7.00e-01 -0.051000 8.30e-01
InlB-mediated entry of Listeria monocytogenes into host cell 12 7.60e-01 0.050900 8.69e-01
Signaling by TGF-beta Receptor Complex 91 4.04e-01 0.050700 6.14e-01
Signaling by FGFR in disease 52 5.28e-01 0.050500 7.15e-01
Nonhomologous End-Joining (NHEJ) 40 5.81e-01 -0.050400 7.47e-01
Transcriptional activation of mitochondrial biogenesis 52 5.30e-01 0.050300 7.16e-01
Cell death signalling via NRAGE, NRIF and NADE 69 4.76e-01 0.049600 6.74e-01
Synthesis of UDP-N-acetyl-glucosamine 8 8.08e-01 -0.049500 8.99e-01
Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) 79 4.47e-01 -0.049500 6.55e-01
Fertilization 12 7.67e-01 0.049400 8.76e-01
Formation of the beta-catenin:TCF transactivating complex 44 5.71e-01 -0.049400 7.44e-01
FasL/ CD95L signaling 5 8.49e-01 0.049300 9.24e-01
Signaling by Non-Receptor Tyrosine Kinases 47 5.60e-01 0.049100 7.35e-01
Signaling by PTK6 47 5.60e-01 0.049100 7.35e-01
MITF-M-regulated melanocyte development 113 3.67e-01 0.049100 5.84e-01
Regulation of TP53 Activity 153 2.95e-01 -0.049000 5.07e-01
RHO GTPases activate PAKs 20 7.06e-01 -0.048700 8.35e-01
Nef mediated downregulation of MHC class I complex cell surface expression 10 7.90e-01 0.048700 8.89e-01
PIP3 activates AKT signaling 235 1.99e-01 -0.048600 3.97e-01
Mitochondrial unfolded protein response (UPRmt) 17 7.29e-01 -0.048500 8.49e-01
Nuclear Envelope Breakdown 53 5.43e-01 -0.048200 7.22e-01
CD163 mediating an anti-inflammatory response 9 8.03e-01 0.048100 8.97e-01
Signaling by FGFR2 in disease 33 6.34e-01 -0.047900 7.82e-01
Netrin mediated repulsion signals 5 8.53e-01 0.047900 9.24e-01
Biosynthesis of specialized proresolving mediators (SPMs) 17 7.33e-01 0.047900 8.51e-01
Downstream signal transduction 27 6.68e-01 0.047700 8.06e-01
Phospholipase C-mediated cascade; FGFR2 8 8.16e-01 0.047600 9.03e-01
Cyclin A/B1/B2 associated events during G2/M transition 25 6.81e-01 -0.047500 8.16e-01
PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases 13 7.68e-01 0.047300 8.76e-01
Synaptic adhesion-like molecules 17 7.36e-01 0.047200 8.53e-01
Costimulation by the CD28 family 74 4.83e-01 -0.047200 6.80e-01
Sensory Perception 197 2.54e-01 0.047100 4.62e-01
Semaphorin interactions 56 5.42e-01 0.047100 7.22e-01
TRAF6-mediated induction of TAK1 complex within TLR4 complex 16 7.45e-01 0.047000 8.60e-01
Chondroitin sulfate biosynthesis 12 7.78e-01 0.046900 8.82e-01
Sodium/Calcium exchangers 9 8.08e-01 -0.046900 8.99e-01
Branched-chain ketoacid dehydrogenase kinase deficiency 5 8.56e-01 0.046800 9.27e-01
Dectin-2 family 19 7.24e-01 -0.046700 8.47e-01
FOXO-mediated transcription 58 5.38e-01 0.046700 7.20e-01
Cilium Assembly 186 2.75e-01 0.046400 4.81e-01
STAT5 Activation 7 8.32e-01 0.046400 9.15e-01
Anchoring fibril formation 10 8.00e-01 -0.046400 8.94e-01
RHOQ GTPase cycle 55 5.53e-01 -0.046300 7.30e-01
Intraflagellar transport 47 5.84e-01 0.046200 7.49e-01
Activation of Matrix Metalloproteinases 22 7.09e-01 -0.046000 8.35e-01
Signaling by NOTCH1 68 5.13e-01 0.045900 7.04e-01
Passive transport by Aquaporins 6 8.46e-01 0.045900 9.23e-01
Epigenetic regulation by WDR5-containing histone modifying complexes 117 3.93e-01 -0.045700 6.06e-01
G2/M DNA damage checkpoint 66 5.23e-01 -0.045400 7.12e-01
Trafficking of GluR2-containing AMPA receptors 11 7.94e-01 -0.045400 8.92e-01
TNFs bind their physiological receptors 25 6.96e-01 0.045100 8.27e-01
Interleukin-37 signaling 19 7.36e-01 -0.044700 8.53e-01
Interleukin-17 signaling 68 5.26e-01 0.044500 7.14e-01
Class C/3 (Metabotropic glutamate/pheromone receptors) 11 7.98e-01 -0.044500 8.94e-01
Synthesis of PE 12 7.90e-01 -0.044500 8.89e-01
Resolution of D-loop Structures through Holliday Junction Intermediates 34 6.54e-01 0.044400 7.96e-01
Tight junction interactions 17 7.52e-01 -0.044300 8.65e-01
Regulation of TP53 Activity through Association with Co-factors 13 7.83e-01 -0.044200 8.85e-01
SUMO is proteolytically processed 6 8.52e-01 -0.044000 9.24e-01
Peptide ligand-binding receptors 101 4.45e-01 0.044000 6.52e-01
Signaling by GPCR 442 1.14e-01 0.043900 2.87e-01
Fatty acyl-CoA biosynthesis 35 6.54e-01 -0.043800 7.96e-01
RHOD GTPase cycle 50 5.96e-01 -0.043300 7.56e-01
Signaling by VEGF 100 4.57e-01 0.043100 6.63e-01
Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants 55 5.81e-01 -0.043000 7.47e-01
Constitutive Signaling by NOTCH1 PEST Domain Mutants 55 5.81e-01 -0.043000 7.47e-01
Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer 55 5.81e-01 -0.043000 7.47e-01
Signaling by NOTCH1 PEST Domain Mutants in Cancer 55 5.81e-01 -0.043000 7.47e-01
Signaling by NOTCH1 in Cancer 55 5.81e-01 -0.043000 7.47e-01
Factors involved in megakaryocyte development and platelet production 129 3.99e-01 0.043000 6.11e-01
Inhibition of replication initiation of damaged DNA by RB1/E2F1 13 7.89e-01 -0.042900 8.89e-01
RAF/MAP kinase cascade 226 2.68e-01 -0.042700 4.77e-01
Signaling by MET 68 5.43e-01 0.042700 7.22e-01
MAP kinase activation 63 5.60e-01 0.042500 7.35e-01
Maternal to zygotic transition (MZT) 72 5.34e-01 0.042400 7.18e-01
RHOA GTPase cycle 139 3.88e-01 0.042400 6.01e-01
Negative regulation of FGFR2 signaling 24 7.21e-01 -0.042100 8.45e-01
RHO GTPase Effectors 258 2.45e-01 -0.042100 4.53e-01
Platelet calcium homeostasis 22 7.34e-01 -0.041800 8.51e-01
TICAM1-dependent activation of IRF3/IRF7 13 7.95e-01 0.041600 8.92e-01
Signalling to RAS 19 7.54e-01 -0.041600 8.65e-01
IRAK1 recruits IKK complex 14 7.88e-01 -0.041500 8.89e-01
IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation 14 7.88e-01 -0.041500 8.89e-01
Inactivation of CSF3 (G-CSF) signaling 24 7.25e-01 0.041400 8.47e-01
Metabolism of steroids 125 4.25e-01 -0.041300 6.32e-01
Induction of Cell-Cell Fusion 8 8.40e-01 -0.041200 9.21e-01
Notch-HLH transcription pathway 28 7.07e-01 0.041100 8.35e-01
cGMP effects 12 8.07e-01 0.040800 8.99e-01
Signaling by BRAF and RAF1 fusions 60 5.85e-01 0.040800 7.49e-01
Triglyceride catabolism 16 7.81e-01 -0.040200 8.84e-01
FOXO-mediated transcription of cell death genes 16 7.81e-01 -0.040200 8.84e-01
Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes 85 5.27e-01 -0.039700 7.14e-01
Epigenetic regulation of gene expression by MLL3 and MLL4 complexes 85 5.27e-01 -0.039700 7.14e-01
MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis 85 5.27e-01 -0.039700 7.14e-01
Kinesins 51 6.24e-01 -0.039700 7.78e-01
Advanced glycosylation endproduct receptor signaling 12 8.12e-01 0.039600 9.01e-01
ESR-mediated signaling 160 3.89e-01 0.039400 6.02e-01
Processing of DNA double-strand break ends 69 5.71e-01 -0.039400 7.44e-01
Downregulation of TGF-beta receptor signaling 26 7.31e-01 -0.039000 8.49e-01
Pre-NOTCH Processing in the Endoplasmic Reticulum 6 8.69e-01 -0.038700 9.35e-01
Energy dependent regulation of mTOR by LKB1-AMPK 27 7.28e-01 0.038600 8.49e-01
Sphingolipid catabolism 11 8.25e-01 0.038500 9.12e-01
RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) 9 8.42e-01 0.038300 9.21e-01
Regulation of endogenous retroelements 92 5.26e-01 -0.038200 7.14e-01
O-linked glycosylation 85 5.44e-01 -0.038100 7.22e-01
Polymerase switching on the C-strand of the telomere 26 7.38e-01 -0.037900 8.53e-01
Other interleukin signaling 19 7.75e-01 0.037900 8.81e-01
Transcriptional regulation of white adipocyte differentiation 77 5.66e-01 0.037900 7.40e-01
Activation of AMPK downstream of NMDARs 20 7.69e-01 -0.037900 8.77e-01
mRNA Editing 8 8.54e-01 0.037600 9.25e-01
G alpha (s) signalling events 97 5.22e-01 0.037600 7.12e-01
trans-Golgi Network Vesicle Budding 69 5.90e-01 -0.037500 7.52e-01
Synthesis of bile acids and bile salts via 27-hydroxycholesterol 10 8.39e-01 0.037100 9.21e-01
MAPK1/MAPK3 signaling 232 3.31e-01 -0.037100 5.49e-01
Gene expression (Transcription) 1413 2.00e-02 -0.036900 8.63e-02
The activation of arylsulfatases 10 8.40e-01 -0.036800 9.21e-01
Early SARS-CoV-2 Infection Events 31 7.24e-01 0.036700 8.47e-01
Mitotic Spindle Checkpoint 108 5.12e-01 -0.036500 7.03e-01
C-type lectin receptors (CLRs) 118 4.94e-01 -0.036500 6.88e-01
HDL remodeling 6 8.78e-01 0.036300 9.40e-01
Signaling by PDGF 50 6.58e-01 0.036200 7.99e-01
Calcineurin activates NFAT 9 8.51e-01 -0.036100 9.24e-01
Visual phototransduction 60 6.29e-01 -0.036000 7.81e-01
RHOF GTPase cycle 39 7.00e-01 0.035600 8.30e-01
Regulation of endogenous retroelements by KRAB-ZFP proteins 61 6.31e-01 -0.035600 7.82e-01
Cargo trafficking to the periciliary membrane 47 6.73e-01 -0.035500 8.09e-01
Defective RIPK1-mediated regulated necrosis 7 8.71e-01 -0.035400 9.36e-01
Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 16 8.07e-01 -0.035300 8.99e-01
Assembly of collagen fibrils and other multimeric structures 44 6.87e-01 -0.035100 8.21e-01
Regulation of CDH19 Expression and Function 6 8.83e-01 0.034800 9.43e-01
Regulation of pyruvate metabolism 32 7.34e-01 -0.034700 8.51e-01
Interferon Signaling 240 3.54e-01 -0.034700 5.72e-01
HS-GAG degradation 19 7.94e-01 -0.034600 8.92e-01
Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autophagy 16 8.12e-01 0.034400 9.01e-01
Telomere C-strand synthesis initiation 13 8.30e-01 -0.034300 9.15e-01
PKMTs methylate histone lysines 44 6.94e-01 -0.034200 8.26e-01
Rab regulation of trafficking 122 5.18e-01 0.033800 7.08e-01
TGFBR3 PTM regulation 10 8.53e-01 -0.033800 9.24e-01
Chemokine receptors bind chemokines 39 7.15e-01 0.033700 8.40e-01
HDL assembly 6 8.86e-01 0.033700 9.45e-01
RHOC GTPase cycle 72 6.22e-01 0.033600 7.77e-01
Suppression of phagosomal maturation 12 8.41e-01 -0.033400 9.21e-01
Oncogenic MAPK signaling 76 6.16e-01 0.033300 7.71e-01
Stimuli-sensing channels 81 6.06e-01 0.033200 7.66e-01
Retrograde transport at the Trans-Golgi-Network 49 6.88e-01 0.033100 8.22e-01
Metabolic disorders of biological oxidation enzymes 26 7.70e-01 -0.033100 8.77e-01
Negative regulation of FGFR1 signaling 25 7.78e-01 -0.032600 8.82e-01
Interleukin-12 signaling 44 7.09e-01 -0.032600 8.35e-01
Loss of Nlp from mitotic centrosomes 69 6.41e-01 0.032500 7.86e-01
Loss of proteins required for interphase microtubule organization from the centrosome 69 6.41e-01 0.032500 7.86e-01
Arachidonate metabolism 45 7.06e-01 -0.032500 8.35e-01
Depolymerization of the Nuclear Lamina 15 8.28e-01 0.032500 9.14e-01
Post-translational protein phosphorylation 70 6.44e-01 -0.032000 7.89e-01
Organelle biogenesis and maintenance 277 3.62e-01 -0.031800 5.78e-01
NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 12 8.49e-01 0.031700 9.24e-01
CD28 co-stimulation 33 7.53e-01 -0.031700 8.65e-01
Phosphate bond hydrolysis by NTPDase proteins 5 9.03e-01 0.031400 9.59e-01
AKT phosphorylates targets in the nucleus 9 8.72e-01 -0.031000 9.36e-01
Pyrimidine salvage 10 8.66e-01 -0.030800 9.32e-01
RNA Polymerase II Transcription 1206 7.48e-02 -0.030500 2.16e-01
SUMOylation of transcription cofactors 44 7.31e-01 0.030000 8.49e-01
Listeria monocytogenes entry into host cells 17 8.31e-01 0.029900 9.15e-01
FLT3 Signaling 38 7.50e-01 0.029800 8.64e-01
Generic Transcription Pathway 1088 9.87e-02 -0.029600 2.60e-01
Transcriptional and post-translational regulation of MITF-M expression and activity 38 7.52e-01 -0.029600 8.65e-01
TP53 Regulates Transcription of Cell Cycle Genes 48 7.25e-01 -0.029300 8.47e-01
Caspase-mediated cleavage of cytoskeletal proteins 12 8.60e-01 -0.029300 9.29e-01
RHOBTB2 GTPase cycle 23 8.09e-01 0.029200 8.99e-01
Miro GTPase Cycle 8 8.87e-01 -0.029000 9.45e-01
Negative regulation of FGFR4 signaling 22 8.15e-01 -0.028800 9.03e-01
Intracellular signaling by second messengers 268 4.17e-01 -0.028800 6.26e-01
RHO GTPases activate CIT 18 8.33e-01 -0.028700 9.16e-01
Pre-NOTCH Expression and Processing 63 6.97e-01 -0.028400 8.27e-01
SUMOylation of DNA damage response and repair proteins 77 6.68e-01 -0.028300 8.06e-01
Reproduction 85 6.57e-01 -0.027900 7.99e-01
Interferon alpha/beta signaling 64 7.03e-01 0.027500 8.32e-01
Signaling by ALK 24 8.16e-01 0.027400 9.04e-01
Defective B3GAT3 causes JDSSDHD 11 8.75e-01 0.027300 9.38e-01
EML4 and NUDC in mitotic spindle formation 107 6.28e-01 -0.027100 7.80e-01
Presynaptic depolarization and calcium channel opening 8 8.95e-01 0.026900 9.53e-01
Aspirin ADME 16 8.53e-01 -0.026800 9.24e-01
Chromatin modifying enzymes 215 4.99e-01 0.026700 6.94e-01
Chromatin organization 215 4.99e-01 0.026700 6.94e-01
Regulation of PLK1 Activity at G2/M Transition 87 6.67e-01 0.026700 8.06e-01
Tandem pore domain potassium channels 5 9.18e-01 0.026700 9.67e-01
Epigenetic regulation of gene expression 263 4.59e-01 -0.026500 6.65e-01
Interleukin-2 signaling 11 8.82e-01 -0.025800 9.43e-01
Acetylcholine Neurotransmitter Release Cycle 11 8.83e-01 0.025700 9.43e-01
Ca2+ activated K+ channels 6 9.14e-01 -0.025600 9.64e-01
Evasion by RSV of host interferon responses 20 8.46e-01 0.025100 9.23e-01
Wax and plasmalogen biosynthesis 5 9.23e-01 -0.024900 9.69e-01
PKA activation in glucagon signalling 14 8.73e-01 0.024700 9.37e-01
TYSND1 cleaves peroxisomal proteins 7 9.10e-01 -0.024600 9.61e-01
NOTCH1 Intracellular Domain Regulates Transcription 46 7.75e-01 0.024300 8.81e-01
SUMOylation of immune response proteins 12 8.85e-01 0.024000 9.45e-01
CREB3 factors activate genes 6 9.19e-01 0.023900 9.67e-01
The role of Nef in HIV-1 replication and disease pathogenesis 28 8.27e-01 -0.023900 9.13e-01
Resolution of D-Loop Structures 35 8.10e-01 0.023500 9.00e-01
Signaling by Rho GTPases 608 3.26e-01 0.023300 5.45e-01
E2F mediated regulation of DNA replication 22 8.50e-01 -0.023300 9.24e-01
The phototransduction cascade 26 8.37e-01 0.023200 9.20e-01
NOTCH4 Activation and Transmission of Signal to the Nucleus 10 9.00e-01 0.022800 9.57e-01
p75 NTR receptor-mediated signalling 89 7.12e-01 0.022600 8.37e-01
SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion 13 8.89e-01 0.022400 9.47e-01
ECM proteoglycans 48 7.89e-01 -0.022400 8.89e-01
Oncogene Induced Senescence 33 8.24e-01 0.022300 9.12e-01
Acetylcholine regulates insulin secretion 9 9.08e-01 -0.022300 9.60e-01
EPH-ephrin mediated repulsion of cells 43 8.01e-01 -0.022200 8.95e-01
Biosynthesis of Lipoxins (LX) 6 9.25e-01 -0.022100 9.69e-01
Toxicity of botulinum toxin type D (botD) 5 9.33e-01 -0.021700 9.74e-01
Toxicity of botulinum toxin type F (botF) 5 9.33e-01 -0.021700 9.74e-01
Metabolism of lipids 642 3.49e-01 -0.021600 5.68e-01
RHOT1 GTPase cycle 5 9.34e-01 -0.021500 9.75e-01
Transcriptional Regulation by E2F6 34 8.31e-01 -0.021100 9.15e-01
Signal attenuation 9 9.14e-01 -0.020900 9.64e-01
SARS-CoV-2 activates/modulates innate and adaptive immune responses 108 7.10e-01 -0.020700 8.36e-01
RHOB GTPase cycle 65 7.73e-01 0.020700 8.79e-01
CDC6 association with the ORC:origin complex 8 9.19e-01 -0.020700 9.67e-01
Signaling by ERBB2 44 8.16e-01 0.020300 9.03e-01
G alpha (i) signalling events 194 6.34e-01 0.019800 7.82e-01
RHOH GTPase cycle 34 8.42e-01 -0.019800 9.21e-01
Synthesis, secretion, and deacylation of Ghrelin 11 9.10e-01 -0.019700 9.61e-01
NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis 7 9.28e-01 0.019600 9.72e-01
GPCR ligand binding 241 6.01e-01 0.019500 7.61e-01
Membrane Trafficking 577 4.23e-01 -0.019500 6.31e-01
Amino acid transport across the plasma membrane 26 8.65e-01 -0.019300 9.31e-01
LGI-ADAM interactions 9 9.21e-01 0.019200 9.68e-01
Signaling by Interleukins 391 5.20e-01 0.019000 7.09e-01
Nuclear events stimulated by ALK signaling in cancer 33 8.51e-01 0.018900 9.24e-01
Aryl hydrocarbon receptor signalling 6 9.36e-01 0.018800 9.76e-01
Translation of Replicase and Assembly of the Replication Transcription Complex 9694676 13 9.07e-01 -0.018800 9.59e-01
Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal 91 7.60e-01 -0.018500 8.69e-01
Amplification of signal from the kinetochores 91 7.60e-01 -0.018500 8.69e-01
TBC/RABGAPs 45 8.30e-01 -0.018500 9.15e-01
Leading Strand Synthesis 14 9.06e-01 -0.018200 9.59e-01
Polymerase switching 14 9.06e-01 -0.018200 9.59e-01
Resolution of Sister Chromatid Cohesion 116 7.37e-01 -0.018100 8.53e-01
SLC15A4:TASL-dependent IRF5 activation 6 9.40e-01 -0.017800 9.78e-01
Plasma lipoprotein assembly 10 9.24e-01 -0.017400 9.69e-01
Platelet Adhesion to exposed collagen 16 9.05e-01 -0.017300 9.59e-01
Regulation of TP53 Activity through Phosphorylation 88 7.80e-01 -0.017200 8.84e-01
Paradoxical activation of RAF signaling by kinase inactive BRAF 41 8.49e-01 -0.017200 9.24e-01
Signaling by RAS mutants 41 8.49e-01 -0.017200 9.24e-01
Signaling by moderate kinase activity BRAF mutants 41 8.49e-01 -0.017200 9.24e-01
Signaling downstream of RAS mutants 41 8.49e-01 -0.017200 9.24e-01
ROS and RNS production in phagocytes 30 8.71e-01 0.017100 9.36e-01
Estrogen-dependent gene expression 97 7.74e-01 0.016900 8.80e-01
RSV-host interactions 78 7.97e-01 0.016900 8.93e-01
Signaling by Rho GTPases, Miro GTPases and RHOBTB3 624 4.73e-01 0.016800 6.73e-01
Regulation of cholesterol biosynthesis by SREBP (SREBF) 55 8.31e-01 -0.016600 9.15e-01
TLR3-mediated TICAM1-dependent programmed cell death 6 9.45e-01 0.016200 9.80e-01
Non-integrin membrane-ECM interactions 51 8.43e-01 0.016100 9.21e-01
Innate Immune System 971 4.01e-01 -0.015900 6.13e-01
Neurofascin interactions 5 9.52e-01 -0.015700 9.80e-01
EPH-Ephrin signaling 81 8.08e-01 0.015600 8.99e-01
Constitutive Signaling by Overexpressed ERBB2 11 9.29e-01 -0.015500 9.72e-01
High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells 59 8.39e-01 -0.015300 9.21e-01
Degradation of the extracellular matrix 99 7.94e-01 0.015200 8.92e-01
Endosomal/Vacuolar pathway 12 9.30e-01 -0.014700 9.72e-01
Transport of fatty acids 5 9.55e-01 -0.014600 9.81e-01
MET promotes cell motility 33 8.87e-01 0.014300 9.45e-01
Signaling by Insulin receptor 63 8.45e-01 0.014200 9.23e-01
Cell-extracellular matrix interactions 16 9.23e-01 -0.014000 9.69e-01
Transcriptional Regulation by VENTX 39 8.80e-01 -0.014000 9.42e-01
Regulated Necrosis 56 8.62e-01 -0.013400 9.29e-01
EPHA-mediated growth cone collapse 21 9.17e-01 -0.013100 9.67e-01
Translocation of SLC2A4 (GLUT4) to the plasma membrane 62 8.59e-01 0.013100 9.28e-01
Glycine degradation 7 9.54e-01 -0.012700 9.81e-01
DCC mediated attractive signaling 13 9.37e-01 -0.012600 9.76e-01
Regulated proteolysis of p75NTR 11 9.42e-01 -0.012600 9.79e-01
Mitotic Prometaphase 193 7.64e-01 0.012500 8.72e-01
Interleukin-27 signaling 11 9.43e-01 0.012400 9.79e-01
SUMOylation 167 7.83e-01 -0.012400 8.85e-01
Integration of provirus 9 9.49e-01 -0.012300 9.80e-01
Signaling by RAF1 mutants 37 8.98e-01 0.012100 9.56e-01
RAS signaling downstream of NF1 loss-of-function variants 7 9.56e-01 0.012100 9.81e-01
IRF3-mediated induction of type I IFN 12 9.45e-01 0.011600 9.80e-01
Centrosome maturation 81 8.58e-01 -0.011500 9.27e-01
Recruitment of mitotic centrosome proteins and complexes 81 8.58e-01 -0.011500 9.27e-01
Class A/1 (Rhodopsin-like receptors) 175 8.00e-01 0.011100 8.94e-01
Caspase activation via Dependence Receptors in the absence of ligand 9 9.54e-01 -0.011100 9.81e-01
Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580 K2555) Translocation Mutant 6 9.63e-01 0.010900 9.83e-01
Signaling by NOTCH1 t(7;9)(NOTCH1:M1580 K2555) Translocation Mutant 6 9.63e-01 0.010900 9.83e-01
Transferrin endocytosis and recycling 26 9.24e-01 0.010900 9.69e-01
Signaling by ALK fusions and activated point mutants 89 8.61e-01 0.010700 9.29e-01
Signaling by ALK in cancer 89 8.61e-01 0.010700 9.29e-01
Activation of NIMA Kinases NEK9, NEK6, NEK7 7 9.62e-01 -0.010400 9.83e-01
Signal Transduction 2058 4.36e-01 0.010400 6.43e-01
The NLRP3 inflammasome 16 9.43e-01 0.010400 9.79e-01
SARS-CoV-1 activates/modulates innate immune responses 40 9.10e-01 0.010300 9.61e-01
Disorders of Developmental Biology 12 9.51e-01 0.010200 9.80e-01
Disorders of Nervous System Development 12 9.51e-01 0.010200 9.80e-01
Loss of function of MECP2 in Rett syndrome 12 9.51e-01 0.010200 9.80e-01
Pervasive developmental disorders 12 9.51e-01 0.010200 9.80e-01
Receptor Mediated Mitophagy 11 9.55e-01 -0.009910 9.81e-01
RHOJ GTPase cycle 50 9.05e-01 0.009790 9.59e-01
Scavenging by Class A Receptors 14 9.50e-01 0.009610 9.80e-01
Defective EXT1 causes exostoses 1, TRPS2 and CHDS 10 9.61e-01 -0.009000 9.83e-01
Defective EXT2 causes exostoses 2 10 9.61e-01 -0.009000 9.83e-01
Negative regulation of MAPK pathway 42 9.20e-01 -0.008950 9.68e-01
Neutrophil degranulation 458 7.44e-01 0.008890 8.60e-01
EGFR downregulation 27 9.38e-01 -0.008700 9.76e-01
Integrin cell surface interactions 68 9.02e-01 -0.008630 9.59e-01
Cargo concentration in the ER 31 9.35e-01 -0.008530 9.75e-01
Adipogenesis 96 8.85e-01 0.008510 9.45e-01
Activation of gene expression by SREBF (SREBP) 42 9.25e-01 -0.008370 9.69e-01
AURKA Activation by TPX2 72 9.03e-01 0.008280 9.59e-01
MAPK family signaling cascades 264 8.18e-01 -0.008230 9.05e-01
ERK/MAPK targets 22 9.48e-01 -0.007970 9.80e-01
NOTCH2 Activation and Transmission of Signal to the Nucleus 23 9.47e-01 0.007960 9.80e-01
Biosynthesis of DHA-derived SPMs 15 9.58e-01 0.007830 9.83e-01
Nitric oxide stimulates guanylate cyclase 15 9.61e-01 -0.007330 9.83e-01
Prolactin receptor signaling 12 9.65e-01 -0.007260 9.83e-01
Type I hemidesmosome assembly 8 9.72e-01 -0.007150 9.87e-01
Transcriptional regulation of brown and beige adipocyte differentiation 24 9.52e-01 -0.007150 9.80e-01
Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 24 9.52e-01 -0.007150 9.80e-01
Respiratory Syncytial Virus Infection Pathway 99 9.04e-01 -0.007040 9.59e-01
Lipophagy 7 9.74e-01 -0.007030 9.88e-01
Pyrimidine catabolism 9 9.71e-01 -0.006890 9.87e-01
Glutamate Neurotransmitter Release Cycle 20 9.58e-01 0.006830 9.83e-01
SUMO E3 ligases SUMOylate target proteins 161 8.81e-01 -0.006810 9.43e-01
Bacterial Infection Pathways 66 9.27e-01 0.006560 9.70e-01
Deubiquitination 225 8.68e-01 -0.006420 9.34e-01
Golgi Associated Vesicle Biogenesis 55 9.36e-01 0.006280 9.76e-01
Regulation of FZD by ubiquitination 16 9.66e-01 -0.006240 9.83e-01
Diseases of signal transduction by growth factor receptors and second messengers 404 8.36e-01 0.006010 9.19e-01
Vitamin B2 (riboflavin) metabolism 6 9.80e-01 0.005900 9.92e-01
TP53 Regulates Transcription of Cell Death Genes 43 9.48e-01 0.005760 9.80e-01
Signal transduction by L1 20 9.65e-01 -0.005680 9.83e-01
CTLA4 inhibitory signaling 21 9.64e-01 -0.005680 9.83e-01
TAK1-dependent IKK and NF-kappa-B activation 43 9.52e-01 -0.005330 9.80e-01
Translation of Replicase and Assembly of the Replication Transcription Complex 9679504 12 9.75e-01 0.005310 9.88e-01
Cell recruitment (pro-inflammatory response) 25 9.64e-01 -0.005190 9.83e-01
Purinergic signaling in leishmaniasis infection 25 9.64e-01 -0.005190 9.83e-01
Sensory processing of sound 58 9.46e-01 0.005140 9.80e-01
E2F-enabled inhibition of pre-replication complex formation 9 9.79e-01 0.005050 9.91e-01
Activated NOTCH1 Transmits Signal to the Nucleus 27 9.66e-01 0.004720 9.83e-01
HuR (ELAVL1) binds and stabilizes mRNA 10 9.80e-01 0.004510 9.92e-01
Ephrin signaling 18 9.75e-01 0.004270 9.88e-01
Immune System 1841 7.62e-01 -0.004260 8.71e-01
GPER1 signaling 38 9.64e-01 0.004250 9.83e-01
Cytokine Signaling in Immune system 670 8.64e-01 0.003890 9.31e-01
Defective B3GALT6 causes EDSP2 and SEMDJL1 11 9.83e-01 -0.003800 9.92e-01
RHOV GTPase cycle 36 9.70e-01 0.003660 9.86e-01
Inactivation, recovery and regulation of the phototransduction cascade 25 9.76e-01 0.003510 9.89e-01
Glycerophospholipid catabolism 6 9.88e-01 0.003410 9.96e-01
RND1 GTPase cycle 37 9.74e-01 0.003070 9.88e-01
Synthesis of PIPs at the ER membrane 5 9.91e-01 -0.003000 9.96e-01
RAB geranylgeranylation 61 9.68e-01 -0.002990 9.85e-01
Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion 7 9.89e-01 -0.002950 9.96e-01
Elevation of cytosolic Ca2+ levels 13 9.86e-01 -0.002730 9.96e-01
Common Pathway of Fibrin Clot Formation 13 9.88e-01 -0.002430 9.96e-01
2-LTR circle formation 7 9.92e-01 0.002290 9.96e-01
Attachment of GPI anchor to uPAR 7 9.92e-01 -0.002270 9.96e-01
Signaling by Receptor Tyrosine Kinases 449 9.41e-01 -0.002040 9.78e-01
Phospholipase C-mediated cascade: FGFR1 8 9.92e-01 0.002010 9.96e-01
STAT5 activation downstream of FLT3 ITD mutants 9 9.94e-01 -0.001540 9.96e-01
Cellular responses to mechanical stimuli 82 9.83e-01 -0.001380 9.92e-01
Response of endothelial cells to shear stress 82 9.83e-01 -0.001380 9.92e-01
Platelet homeostasis 69 9.88e-01 -0.001020 9.96e-01
DARPP-32 events 22 9.94e-01 0.000989 9.96e-01
Formation of the Editosome 6 9.97e-01 0.000970 9.98e-01
mRNA Editing: C to U Conversion 6 9.97e-01 0.000970 9.98e-01
Signaling by MAPK mutants 6 9.97e-01 -0.000803 9.98e-01
Sensory processing of sound by inner hair cells of the cochlea 54 9.93e-01 -0.000739 9.96e-01
Pre-NOTCH Transcription and Translation 47 9.93e-01 -0.000709 9.96e-01
Signaling by Nuclear Receptors 214 9.89e-01 -0.000540 9.96e-01
Negative regulation of FGFR3 signaling 21 9.98e-01 -0.000338 9.98e-01
Defective B4GALT7 causes EDS, progeroid type 11 9.99e-01 -0.000190 9.99e-01



Detailed Gene set reports



Arachidonate production from DAG
set Arachidonate production from DAG
setSize 5
pANOVA 0.00155
s.dist -0.817
p.adjustANOVA 0.0108


Top enriched genes
Top 20 genes
GeneID Gene Rank
ABHD12 -9727
MGLL -9542
DAGLA -8876
ABHD6 -8836
DAGLB -7231

Click HERE to show all gene set members

All member genes
GeneID Gene Rank
ABHD12 -9727
MGLL -9542
DAGLA -8876
ABHD6 -8836
DAGLB -7231



Formation of ATP by chemiosmotic coupling
set Formation of ATP by chemiosmotic coupling
setSize 20
pANOVA 2.93e-10
s.dist -0.814
p.adjustANOVA 8.83e-09


Top enriched genes
Top 20 genes
GeneID Gene Rank
ATP5PF -10746
ATP5MK -10711
ATP5MC1 -10679
ATP5MC3 -10305
ATP5F1B -10186
ATP5MC2 -10022
ATP5MF -9980
MT-ATP8 -9565
ATP5F1E -9301
ATP5PO -8788
ATP5F1A -8780
DMAC2L -8508
ATP5PD -8425
ATP5ME -8411
ATP5MG -8402
ATP5F1D -7509
ATP5F1C -7214
ATP5PB -7108
MT-ATP6 -6047
ATP5MJ -5260

Click HERE to show all gene set members

All member genes
GeneID Gene Rank
ATP5PF -10746
ATP5MK -10711
ATP5MC1 -10679
ATP5MC3 -10305
ATP5F1B -10186
ATP5MC2 -10022
ATP5MF -9980
MT-ATP8 -9565
ATP5F1E -9301
ATP5PO -8788
ATP5F1A -8780
DMAC2L -8508
ATP5PD -8425
ATP5ME -8411
ATP5MG -8402
ATP5F1D -7509
ATP5F1C -7214
ATP5PB -7108
MT-ATP6 -6047
ATP5MJ -5260



MET activates PI3K/AKT signaling
set MET activates PI3K/AKT signaling
setSize 5
pANOVA 0.00263
s.dist 0.777
p.adjustANOVA 0.0169


Top enriched genes
Top 20 genes
GeneID Gene Rank
GAB1 11052
HGF 10962
PIK3R1 10906
PIK3CA 9393
GRB2 1127

Click HERE to show all gene set members

All member genes
GeneID Gene Rank
GAB1 11052
HGF 10962
PIK3R1 10906
PIK3CA 9393
GRB2 1127



PI3K events in ERBB4 signaling
set PI3K events in ERBB4 signaling
setSize 6
pANOVA 0.00153
s.dist 0.747
p.adjustANOVA 0.0107


Top enriched genes
Top 20 genes
GeneID Gene Rank
PIK3R1 10906
HBEGF 9553
PIK3CA 9393
NRG1 8788
EREG 7006
NRG4 4500

Click HERE to show all gene set members

All member genes
GeneID Gene Rank
PIK3R1 10906
HBEGF 9553
PIK3CA 9393
NRG1 8788
EREG 7006
NRG4 4500



Malate-aspartate shuttle
set Malate-aspartate shuttle
setSize 8
pANOVA 0.000435
s.dist -0.718
p.adjustANOVA 0.00368


Top enriched genes
Top 20 genes
GeneID Gene Rank
GOT2 -9776
SLC25A11 -9456
GOT1 -9285
SLC25A22 -8753
SLC25A12 -7968
MDH2 -7876
MDH1 -6891
SLC25A13 -2010

Click HERE to show all gene set members

All member genes
GeneID Gene Rank
GOT2 -9776
SLC25A11 -9456
GOT1 -9285
SLC25A22 -8753
SLC25A12 -7968
MDH2 -7876
MDH1 -6891
SLC25A13 -2010



Negative regulation of activity of TFAP2 (AP-2) family transcription factors
set Negative regulation of activity of TFAP2 (AP-2) family transcription factors
setSize 6
pANOVA 0.00236
s.dist -0.717
p.adjustANOVA 0.0154


Top enriched genes
Top 20 genes
GeneID Gene Rank
TFAP2E -10825
KCTD1 -10533
KCTD15 -9839
UBE2I -9435
WWOX -8811
SUMO1 3015

Click HERE to show all gene set members

All member genes
GeneID Gene Rank
TFAP2E -10825
KCTD1 -10533
KCTD15 -9839
UBE2I -9435
WWOX -8811
SUMO1 3015



Synthesis of Ketone Bodies
set Synthesis of Ketone Bodies
setSize 6
pANOVA 0.00277
s.dist -0.705
p.adjustANOVA 0.0176


Top enriched genes
Top 20 genes
GeneID Gene Rank
BDH1 -10326
AACS -9411
BDH2 -8668
ACAT1 -8568
HMGCL -5508
ACSS3 -3180

Click HERE to show all gene set members

All member genes
GeneID Gene Rank
BDH1 -10326
AACS -9411
BDH2 -8668
ACAT1 -8568
HMGCL -5508
ACSS3 -3180



Purine ribonucleoside monophosphate biosynthesis
set Purine ribonucleoside monophosphate biosynthesis
setSize 9
pANOVA 0.000305
s.dist -0.695
p.adjustANOVA 0.00267


Top enriched genes
Top 20 genes
GeneID Gene Rank
PAICS -10738
ATIC -10499
ADSL -9903
PFAS -9865
GART -8706
GMPS -7046
IMPDH2 -6249
PPAT -2473
IMPDH1 -1998

Click HERE to show all gene set members

All member genes
GeneID Gene Rank
PAICS -10738
ATIC -10499
ADSL -9903
PFAS -9865
GART -8706
GMPS -7046
IMPDH2 -6249
PPAT -2473
IMPDH1 -1998



Maturation of spike protein_9683686
set Maturation of spike protein_9683686
setSize 5
pANOVA 0.00716
s.dist -0.694
p.adjustANOVA 0.0385


Top enriched genes
Top 20 genes
GeneID Gene Rank
MOGS -9800
MGAT1 -9734
GANAB -7941
CANX -7344
PRKCSH -2638

Click HERE to show all gene set members

All member genes
GeneID Gene Rank
MOGS -9800
MGAT1 -9734
GANAB -7941
CANX -7344
PRKCSH -2638



Ketone body metabolism
set Ketone body metabolism
setSize 8
pANOVA 0.000727
s.dist -0.69
p.adjustANOVA 0.00578


Top enriched genes
Top 20 genes
GeneID Gene Rank
BDH1 -10326
AACS -9411
OXCT2 -9356
BDH2 -8668
ACAT1 -8568
HMGCL -5508
OXCT1 -4504
ACSS3 -3180

Click HERE to show all gene set members

All member genes
GeneID Gene Rank
BDH1 -10326
AACS -9411
OXCT2 -9356
BDH2 -8668
ACAT1 -8568
HMGCL -5508
OXCT1 -4504
ACSS3 -3180



Mitochondrial translation elongation
set Mitochondrial translation elongation
setSize 90
pANOVA 1.03e-29
s.dist -0.689
p.adjustANOVA 1.53e-27


Top enriched genes
Top 20 genes
GeneID Gene Rank
MT-RNR2 -10737
MRPL12 -10724
MRPL57 -10718
MRPL17 -10715
MRPL34 -10677
MRPS7 -10627
MRPL16 -10565
MT-RNR1 -10561
TSFM -10558
MRPL37 -10545
MRPS21 -10500
GADD45GIP1 -10465
MRPS16 -10342
MRPL20 -10240
MRPL49 -10231
MRPS15 -10213
MRPS28 -10199
MRPS25 -10192
MRPL4 -10113
MRPS18C -10058

Click HERE to show all gene set members

All member genes
GeneID Gene Rank
MT-RNR2 -10737
MRPL12 -10724
MRPL57 -10718
MRPL17 -10715
MRPL34 -10677
MRPS7 -10627
MRPL16 -10565
MT-RNR1 -10561
TSFM -10558
MRPL37 -10545
MRPS21 -10500
GADD45GIP1 -10465
MRPS16 -10342
MRPL20 -10240
MRPL49 -10231
MRPS15 -10213
MRPS28 -10199
MRPS25 -10192
MRPL4 -10113
MRPS18C -10058
MRPL3 -10050
MRPL51 -10029
MRPL9 -9996
MRPL54 -9947
MRPL40 -9883
MRPL18 -9837
MRPL21 -9781
MRPL14 -9729
MRPL43 -9664
MRPS18B -9476
MRPL15 -9421
MRPL48 -9379
MRPL27 -9214
MRPS23 -9170
MRPS33 -9139
TUFM -9030
MRPS26 -9013
MRPL11 -8996
MRPL2 -8922
MRPS30 -8824
MRPS27 -8817
MRPL36 -8812
MRPL24 -8789
MRPL46 -8624
AURKAIP1 -8616
MRPS14 -8605
MRPS11 -8389
MRPS34 -8343
CHCHD1 -8235
MRPS18A -8206
MRPL41 -8198
MRPS24 -8160
MRPS17 -8141
MRPS35 -8096
MRPL23 -8083
MRPL38 -8015
MRPS10 -7994
ERAL1 -7603
MRPL32 -7456
MRPL52 -7286
MRPS36 -7283
MRPL13 -6858
MRPS5 -6803
DAP3 -6643
MRPL47 -6516
RPS12 -6437
MRPS22 -6346
MRPS9 -6109
MRPL22 -6039
MRPL28 -5910
MRPS2 -5543
MRPL39 -5494
MRPL33 -5424
MRPL30 -5402
MRPL53 -5046
OXA1L -5023
MRPL55 -4696
MRPL10 -4693
MRPL45 -4519
MRPL19 -4442
MRPL44 -3863
MRPL58 -3372
PTCD3 -3265
MRPS6 -1409
MRPL35 2184
MRPS31 2353
GFM1 2700
MRPL42 3107
MRPL50 4502
MRPL1 8557



Peptide chain elongation
set Peptide chain elongation
setSize 88
pANOVA 1.76e-28
s.dist -0.682
p.adjustANOVA 1.7e-26


Top enriched genes
Top 20 genes
GeneID Gene Rank
RPL35A -10314
RPS7 -10107
RPS4X -10083
RPL35 -10064
RPS25 -9974
RPL39 -9902
RPL10A -9900
RPS15 -9843
RPL37A -9724
RPS27 -9692
RPL12 -9678
RPS29 -9493
RPL27 -9376
RPS23 -9366
RPS19 -9249
RPL32 -9210
RPL8 -9182
RPL18A -9140
RPS13 -9069
RPS9 -8898

Click HERE to show all gene set members

All member genes
GeneID Gene Rank
RPL35A -10314
RPS7 -10107
RPS4X -10083
RPL35 -10064
RPS25 -9974
RPL39 -9902
RPL10A -9900
RPS15 -9843
RPL37A -9724
RPS27 -9692
RPL12 -9678
RPS29 -9493
RPL27 -9376
RPS23 -9366
RPS19 -9249
RPL32 -9210
RPL8 -9182
RPL18A -9140
RPS13 -9069
RPS9 -8898
RPS20 -8867
RPL7 -8818
RPL36 -8752
RPL38 -8730
RPL29 -8721
RPL30 -8707
RPL31 -8696
RPL11 -8598
RPL41 -8584
RPS11 -8581
RPL39L -8567
RPL10 -8533
RPL13A -8502
RPL24 -8450
UBA52 -8361
RPL15 -8344
RPS3 -8338
RPL9 -8330
RPL4 -8294
RPL36A -8292
EEF2 -8291
RPL22L1 -8268
RPL34 -8174
RPL19 -8095
RPL5 -8051
RPS14 -8044
RPLP0 -8042
FAU -7970
RPS27L -7769
RPS28 -7746
RPL37 -7713
RPSA -7582
RPL18 -7362
RPS6 -7352
RPS17 -7300
RPS8 -7263
RPL6 -7218
EEF1A1 -7133
RPL23 -7070
RPL7A -7016
RPS16 -6912
RPS21 -6724
RPL3 -6594
RPS10 -6588
RPL17 -6568
RPL13 -6547
RPL28 -6445
RPS12 -6437
RPL22 -6398
RPL21 -6245
RPLP1 -6177
RPS27A -5923
RPS15A -5860
RPL36AL -5694
RPS5 -5467
RPS18 -5196
RPS24 -5184
RPLP2 -5083
RPL23A -4710
RPL14 -4505
RPS3A -4498
RPS2 -4449
RPL27A -3830
RPL26 -3436
RPL26L1 -2674
RPL3L 1485
RPS4Y1 2742
RPS26 6214



Mitochondrial translation initiation
set Mitochondrial translation initiation
setSize 90
pANOVA 9.6e-29
s.dist -0.677
p.adjustANOVA 1.03e-26


Top enriched genes
Top 20 genes
GeneID Gene Rank
MT-RNR2 -10737
MRPL12 -10724
MRPL57 -10718
MRPL17 -10715
MRPL34 -10677
MRPS7 -10627
MRPL16 -10565
MT-RNR1 -10561
MRPL37 -10545
MRPS21 -10500
GADD45GIP1 -10465
MRPS16 -10342
MRPL20 -10240
MRPL49 -10231
MRPS15 -10213
MRPS28 -10199
MRPS25 -10192
MRPL4 -10113
MRPS18C -10058
MRPL3 -10050

Click HERE to show all gene set members

All member genes
GeneID Gene Rank
MT-RNR2 -10737
MRPL12 -10724
MRPL57 -10718
MRPL17 -10715
MRPL34 -10677
MRPS7 -10627
MRPL16 -10565
MT-RNR1 -10561
MRPL37 -10545
MRPS21 -10500
GADD45GIP1 -10465
MRPS16 -10342
MRPL20 -10240
MRPL49 -10231
MRPS15 -10213
MRPS28 -10199
MRPS25 -10192
MRPL4 -10113
MRPS18C -10058
MRPL3 -10050
MRPL51 -10029
MRPL9 -9996
MRPL54 -9947
MRPL40 -9883
MRPL18 -9837
MRPL21 -9781
MRPL14 -9729
MRPL43 -9664
MRPS18B -9476
MRPL15 -9421
MRPL48 -9379
MRPL27 -9214
MRPS23 -9170
MRPS33 -9139
MRPS26 -9013
MRPL11 -8996
MRPL2 -8922
MRPS30 -8824
MRPS27 -8817
MRPL36 -8812
MRPL24 -8789
MRPL46 -8624
AURKAIP1 -8616
MRPS14 -8605
MRPS11 -8389
MRPS34 -8343
CHCHD1 -8235
MRPS18A -8206
MRPL41 -8198
MRPS24 -8160
MRPS17 -8141
MRPS35 -8096
MRPL23 -8083
MRPL38 -8015
MRPS10 -7994
ERAL1 -7603
MRPL32 -7456
MRPL52 -7286
MRPS36 -7283
MRPL13 -6858
MRPS5 -6803
DAP3 -6643
MRPL47 -6516
RPS12 -6437
MRPS22 -6346
MRPS9 -6109
MRPL22 -6039
MRPL28 -5910
MTFMT -5700
MRPS2 -5543
MRPL39 -5494
MRPL33 -5424
MRPL30 -5402
MRPL53 -5046
OXA1L -5023
MRPL55 -4696
MRPL10 -4693
MRPL45 -4519
MRPL19 -4442
MRPL44 -3863
MRPL58 -3372
PTCD3 -3265
MTIF2 -3055
MRPS6 -1409
MRPL35 2184
MRPS31 2353
MRPL42 3107
MTIF3 3693
MRPL50 4502
MRPL1 8557



Viral mRNA Translation
set Viral mRNA Translation
setSize 88
pANOVA 1.72e-27
s.dist -0.669
p.adjustANOVA 1.45e-25


Top enriched genes
Top 20 genes
GeneID Gene Rank
RPL35A -10314
RPS7 -10107
RPS4X -10083
RPL35 -10064
RPS25 -9974
RPL39 -9902
RPL10A -9900
RPS15 -9843
RPL37A -9724
RPS27 -9692
RPL12 -9678
RPS29 -9493
RPL27 -9376
RPS23 -9366
RPS19 -9249
RPL32 -9210
RPL8 -9182
RPL18A -9140
RPS13 -9069
RPS9 -8898

Click HERE to show all gene set members

All member genes
GeneID Gene Rank
RPL35A -10314
RPS7 -10107
RPS4X -10083
RPL35 -10064
RPS25 -9974
RPL39 -9902
RPL10A -9900
RPS15 -9843
RPL37A -9724
RPS27 -9692
RPL12 -9678
RPS29 -9493
RPL27 -9376
RPS23 -9366
RPS19 -9249
RPL32 -9210
RPL8 -9182
RPL18A -9140
RPS13 -9069
RPS9 -8898
RPS20 -8867
RPL7 -8818
RPL36 -8752
RPL38 -8730
RPL29 -8721
RPL30 -8707
RPL31 -8696
RPL11 -8598
RPL41 -8584
RPS11 -8581
RPL39L -8567
RPL10 -8533
RPL13A -8502
RPL24 -8450
UBA52 -8361
RPL15 -8344
RPS3 -8338
RPL9 -8330
RPL4 -8294
RPL36A -8292
RPL22L1 -8268
RPL34 -8174
RPL19 -8095
RPL5 -8051
RPS14 -8044
RPLP0 -8042
FAU -7970
RPS27L -7769
RPS28 -7746
RPL37 -7713
RPSA -7582
GRSF1 -7524
RPL18 -7362
RPS6 -7352
RPS17 -7300
RPS8 -7263
RPL6 -7218
RPL23 -7070
RPL7A -7016
RPS16 -6912
RPS21 -6724
RPL3 -6594
RPS10 -6588
RPL17 -6568
RPL13 -6547
RPL28 -6445
RPS12 -6437
RPL22 -6398
RPL21 -6245
RPLP1 -6177
RPS27A -5923
RPS15A -5860
RPL36AL -5694
RPS5 -5467
RPS18 -5196
RPS24 -5184
RPLP2 -5083
RPL23A -4710
RPL14 -4505
RPS3A -4498
RPS2 -4449
RPL27A -3830
RPL26 -3436
RPL26L1 -2674
RPL3L 1485
RPS4Y1 2742
DNAJC3 4300
RPS26 6214



Cristae formation
set Cristae formation
setSize 33
pANOVA 3.62e-11
s.dist -0.665
p.adjustANOVA 1.13e-09


Top enriched genes
Top 20 genes
GeneID Gene Rank
ATP5PF -10746
ATP5MK -10711
ATP5MC1 -10679
ATP5MC3 -10305
ATP5F1B -10186
ATP5MC2 -10022
ATP5MF -9980
MICOS10 -9860
MICOS13 -9758
MT-ATP8 -9565
ATP5F1E -9301
HSPA9 -9167
ATP5PO -8788
ATP5F1A -8780
DMAC2L -8508
ATP5PD -8425
ATP5ME -8411
ATP5MG -8402
TMEM11 -7592
CHCHD3 -7572

Click HERE to show all gene set members

All member genes
GeneID Gene Rank
ATP5PF -10746
ATP5MK -10711
ATP5MC1 -10679
ATP5MC3 -10305
ATP5F1B -10186
ATP5MC2 -10022
ATP5MF -9980
MICOS10 -9860
MICOS13 -9758
MT-ATP8 -9565
ATP5F1E -9301
HSPA9 -9167
ATP5PO -8788
ATP5F1A -8780
DMAC2L -8508
ATP5PD -8425
ATP5ME -8411
ATP5MG -8402
TMEM11 -7592
CHCHD3 -7572
ATP5F1D -7509
ATP5F1C -7214
ATP5PB -7108
MTX2 -7036
DNAJC11 -6127
MT-ATP6 -6047
ATP5MJ -5260
SAMM50 -4915
IMMT -3991
APOOL -484
MTX1 -219
APOO 1924
CHCHD6 4351



Eukaryotic Translation Elongation
set Eukaryotic Translation Elongation
setSize 93
pANOVA 1.4e-28
s.dist -0.664
p.adjustANOVA 1.42e-26


Top enriched genes
Top 20 genes
GeneID Gene Rank
RPL35A -10314
RPS7 -10107
RPS4X -10083
RPL35 -10064
RPS25 -9974
RPL39 -9902
RPL10A -9900
RPS15 -9843
RPL37A -9724
RPS27 -9692
RPL12 -9678
RPS29 -9493
RPL27 -9376
RPS23 -9366
RPS19 -9249
RPL32 -9210
RPL8 -9182
RPL18A -9140
RPS13 -9069
RPS9 -8898

Click HERE to show all gene set members

All member genes
GeneID Gene Rank
RPL35A -10314
RPS7 -10107
RPS4X -10083
RPL35 -10064
RPS25 -9974
RPL39 -9902
RPL10A -9900
RPS15 -9843
RPL37A -9724
RPS27 -9692
RPL12 -9678
RPS29 -9493
RPL27 -9376
RPS23 -9366
RPS19 -9249
RPL32 -9210
RPL8 -9182
RPL18A -9140
RPS13 -9069
RPS9 -8898
RPS20 -8867
RPL7 -8818
RPL36 -8752
RPL38 -8730
RPL29 -8721
RPL30 -8707
RPL31 -8696
RPL11 -8598
RPL41 -8584
RPS11 -8581
RPL39L -8567
RPL10 -8533
RPL13A -8502
RPL24 -8450
UBA52 -8361
RPL15 -8344
RPS3 -8338
RPL9 -8330
RPL4 -8294
RPL36A -8292
EEF2 -8291
RPL22L1 -8268
RPL34 -8174
RPL19 -8095
RPL5 -8051
RPS14 -8044
RPLP0 -8042
FAU -7970
EEF1A1P5 -7861
RPS27L -7769
RPS28 -7746
RPL37 -7713
RPSA -7582
RPL18 -7362
RPS6 -7352
RPS17 -7300
EEF1B2 -7268
RPS8 -7263
RPL6 -7218
EEF1A1 -7133
RPL23 -7070
RPL7A -7016
RPS16 -6912
RPS21 -6724
RPL3 -6594
RPS10 -6588
RPL17 -6568
RPL13 -6547
RPL28 -6445
RPS12 -6437
RPL22 -6398
RPL21 -6245
RPLP1 -6177
EEF1G -6066
RPS27A -5923
RPS15A -5860
RPL36AL -5694
RPS5 -5467
RPS18 -5196
RPS24 -5184
RPLP2 -5083
EEF1D -4889
RPL23A -4710
RPL14 -4505
RPS3A -4498
RPS2 -4449
RPL27A -3830
RPL26 -3436
RPL26L1 -2674
RPL3L 1485
RPS4Y1 2742
RPS26 6214
EEF1A2 7215



Complex III assembly
set Complex III assembly
setSize 23
pANOVA 3.92e-08
s.dist -0.662
p.adjustANOVA 9.46e-07


Top enriched genes
Top 20 genes
GeneID Gene Rank
UQCRH -10810
FXN -10753
CYC1 -10536
UQCR11 -10154
UQCRQ -10011
UQCC2 -9933
LETM1 -9324
HSPA9 -9167
UQCC1 -8460
HSCB -8415
UQCRC2 -8046
NFS1 -8035
UQCR10 -8028
UQCRC1 -7483
BCS1L -7442
UQCC3 -7199
UQCRB -6659
LYRM4 -6396
UQCRFS1 -5026
ISCU -3239

Click HERE to show all gene set members

All member genes
GeneID Gene Rank
UQCRH -10810
FXN -10753
CYC1 -10536
UQCR11 -10154
UQCRQ -10011
UQCC2 -9933
LETM1 -9324
HSPA9 -9167
UQCC1 -8460
HSCB -8415
UQCRC2 -8046
NFS1 -8035
UQCR10 -8028
UQCRC1 -7483
BCS1L -7442
UQCC3 -7199
UQCRB -6659
LYRM4 -6396
UQCRFS1 -5026
ISCU -3239
TTC19 -1797
MT-CYB -1782
LYRM7 4825



Mitochondrial translation termination
set Mitochondrial translation termination
setSize 90
pANOVA 2.15e-27
s.dist -0.66
p.adjustANOVA 1.73e-25


Top enriched genes
Top 20 genes
GeneID Gene Rank
MT-RNR2 -10737
MRPL12 -10724
MRPL57 -10718
MRPL17 -10715
MRPL34 -10677
MRPS7 -10627
MRPL16 -10565
MT-RNR1 -10561
MRPL37 -10545
MRPS21 -10500
GADD45GIP1 -10465
MRPS16 -10342
MRPL20 -10240
MRPL49 -10231
MRPS15 -10213
MRPS28 -10199
MRPS25 -10192
MRPL4 -10113
MRPS18C -10058
MRPL3 -10050

Click HERE to show all gene set members

All member genes
GeneID Gene Rank
MT-RNR2 -10737
MRPL12 -10724
MRPL57 -10718
MRPL17 -10715
MRPL34 -10677
MRPS7 -10627
MRPL16 -10565
MT-RNR1 -10561
MRPL37 -10545
MRPS21 -10500
GADD45GIP1 -10465
MRPS16 -10342
MRPL20 -10240
MRPL49 -10231
MRPS15 -10213
MRPS28 -10199
MRPS25 -10192
MRPL4 -10113
MRPS18C -10058
MRPL3 -10050
MRPL51 -10029
MRPL9 -9996
MRPL54 -9947
MRPL40 -9883
MRPL18 -9837
MRPL21 -9781
MRPL14 -9729
MRPL43 -9664
MRPS18B -9476
MRPL15 -9421
MRPL48 -9379
MRPL27 -9214
MRPS23 -9170
MRPS33 -9139
MRPS26 -9013
MRPL11 -8996
MRPL2 -8922
MRPS30 -8824
MRPS27 -8817
MRPL36 -8812
MRPL24 -8789
MRPL46 -8624
AURKAIP1 -8616
MRPS14 -8605
MRPS11 -8389
MRPS34 -8343
CHCHD1 -8235
MRPS18A -8206
MRPL41 -8198
MRPS24 -8160
MRPS17 -8141
MRPS35 -8096
MRPL23 -8083
MRPL38 -8015
MRPS10 -7994
ERAL1 -7603
MRPL32 -7456
MRPL52 -7286
MRPS36 -7283
MRPL13 -6858
MRPS5 -6803
DAP3 -6643
MRPL47 -6516
RPS12 -6437
MRPS22 -6346
MRPS9 -6109
MRPL22 -6039
MRPL28 -5910
MRPS2 -5543
MRPL39 -5494
MRPL33 -5424
MRPL30 -5402
MRRF -5314
MRPL53 -5046
OXA1L -5023
MRPL55 -4696
MRPL10 -4693
MRPL45 -4519
MRPL19 -4442
MRPL44 -3863
MRPL58 -3372
PTCD3 -3265
MRPS6 -1409
MRPL35 2184
MRPS31 2353
MRPL42 3107
MRPL50 4502
GFM2 6932
MRPL1 8557
MTRF1L 10143



Eukaryotic Translation Termination
set Eukaryotic Translation Termination
setSize 92
pANOVA 1.09e-27
s.dist -0.657
p.adjustANOVA 1e-25


Top enriched genes
Top 20 genes
GeneID Gene Rank
RPL35A -10314
RPS7 -10107
RPS4X -10083
RPL35 -10064
RPS25 -9974
RPL39 -9902
RPL10A -9900
RPS15 -9843
RPL37A -9724
RPS27 -9692
RPL12 -9678
RPS29 -9493
RPL27 -9376
RPS23 -9366
RPS19 -9249
RPL32 -9210
RPL8 -9182
RPL18A -9140
TRMT112 -9102
RPS13 -9069

Click HERE to show all gene set members

All member genes
GeneID Gene Rank
RPL35A -10314
RPS7 -10107
RPS4X -10083
RPL35 -10064
RPS25 -9974
RPL39 -9902
RPL10A -9900
RPS15 -9843
RPL37A -9724
RPS27 -9692
RPL12 -9678
RPS29 -9493
RPL27 -9376
RPS23 -9366
RPS19 -9249
RPL32 -9210
RPL8 -9182
RPL18A -9140
TRMT112 -9102
RPS13 -9069
RPS9 -8898
RPS20 -8867
RPL7 -8818
RPL36 -8752
RPL38 -8730
RPL29 -8721
RPL30 -8707
RPL31 -8696
RPL11 -8598
RPL41 -8584
RPS11 -8581
RPL39L -8567
RPL10 -8533
RPL13A -8502
RPL24 -8450
UBA52 -8361
RPL15 -8344
RPS3 -8338
RPL9 -8330
RPL4 -8294
RPL36A -8292
RPL22L1 -8268
APEH -8252
RPL34 -8174
RPL19 -8095
RPL5 -8051
RPS14 -8044
RPLP0 -8042
FAU -7970
RPS27L -7769
RPS28 -7746
RPL37 -7713
RPSA -7582
RPL18 -7362
RPS6 -7352
RPS17 -7300
RPS8 -7263
RPL6 -7218
RPL23 -7070
RPL7A -7016
RPS16 -6912
RPS21 -6724
RPL3 -6594
RPS10 -6588
RPL17 -6568
RPL13 -6547
RPL28 -6445
RPS12 -6437
RPL22 -6398
RPL21 -6245
RPLP1 -6177
RPS27A -5923
RPS15A -5860
RPL36AL -5694
RPS5 -5467
RPS18 -5196
RPS24 -5184
RPLP2 -5083
RPL23A -4710
RPL14 -4505
RPS3A -4498
RPS2 -4449
RPL27A -3830
RPL26 -3436
RPL26L1 -2674
N6AMT1 -1581
GSPT2 -748
GSPT1 -168
ETF1 253
RPL3L 1485
RPS4Y1 2742
RPS26 6214



SRP-dependent cotranslational protein targeting to membrane
set SRP-dependent cotranslational protein targeting to membrane
setSize 111
pANOVA 7.62e-33
s.dist -0.655
p.adjustANOVA 1.64e-30


Top enriched genes
Top 20 genes
GeneID Gene Rank
SRPRB -10828
SEC61A1 -10547
RPL35A -10314
SSR4 -10215
SEC61G -10208
SEC61B -10118
RPS7 -10107
DDOST -10098
RPS4X -10083
RPL35 -10064
RPS25 -9974
RPL39 -9902
RPL10A -9900
RPS15 -9843
SEC11C -9765
RPL37A -9724
RPS27 -9692
RPL12 -9678
RPS29 -9493
RPL27 -9376

Click HERE to show all gene set members

All member genes
GeneID Gene Rank
SRPRB -10828
SEC61A1 -10547
RPL35A -10314
SSR4 -10215
SEC61G -10208
SEC61B -10118
RPS7 -10107
DDOST -10098
RPS4X -10083
RPL35 -10064
RPS25 -9974
RPL39 -9902
RPL10A -9900
RPS15 -9843
SEC11C -9765
RPL37A -9724
RPS27 -9692
RPL12 -9678
RPS29 -9493
RPL27 -9376
RPS23 -9366
SEC11A -9348
RPS19 -9249
RPL32 -9210
RPL8 -9182
RPL18A -9140
RPS13 -9069
RPN1 -8901
RPS9 -8898
RPN2 -8897
RPS20 -8867
RPL7 -8818
RPL36 -8752
RPL38 -8730
RPL29 -8721
RPL30 -8707
RPL31 -8696
RPL11 -8598
RPL41 -8584
RPS11 -8581
RPL39L -8567
RPL10 -8533
RPL13A -8502
SSR3 -8498
RPL24 -8450
UBA52 -8361
RPL15 -8344
RPS3 -8338
RPL9 -8330
RPL4 -8294
RPL36A -8292
RPL22L1 -8268
RPL34 -8174
RPL19 -8095
RPL5 -8051
RPS14 -8044
RPLP0 -8042
FAU -7970
SRP68 -7844
RPS27L -7769
RPS28 -7746
RPL37 -7713
RPSA -7582
RPL18 -7362
RPS6 -7352
RPS17 -7300
RPS8 -7263
RPL6 -7218
SSR2 -7083
RPL23 -7070
RPL7A -7016
RPS16 -6912
RPS21 -6724
SPCS1 -6626
RPL3 -6594
RPS10 -6588
RPL17 -6568
RPL13 -6547
RPL28 -6445
RPS12 -6437
RPL22 -6398
RPL21 -6245
RPLP1 -6177
SRP14 -6103
RPS27A -5923
RPS15A -5860
RPL36AL -5694
SPCS2 -5637
RPS5 -5467
RPS18 -5196
RPS24 -5184
RPLP2 -5083
SRP72 -4844
RPL23A -4710
RPL14 -4505
RPS3A -4498
RPS2 -4449
SRPRA -4136
RPL27A -3830
RPL26 -3436
RPL26L1 -2674
SEC61A2 -2080
SRP54 -1981
SRP19 -1452
SRP9 -838
TRAM1 -32
SPCS3 940
RPL3L 1485
RPS4Y1 2742
SSR1 4910
RPS26 6214



Formation of a pool of free 40S subunits
set Formation of a pool of free 40S subunits
setSize 100
pANOVA 1.88e-29
s.dist -0.651
p.adjustANOVA 2.14e-27


Top enriched genes
Top 20 genes
GeneID Gene Rank
RPL35A -10314
EIF3B -10153
RPS7 -10107
RPS4X -10083
RPL35 -10064
RPS25 -9974
RPL39 -9902
RPL10A -9900
RPS15 -9843
RPL37A -9724
RPS27 -9692
RPL12 -9678
EIF3I -9532
RPS29 -9493
RPL27 -9376
RPS23 -9366
RPS19 -9249
RPL32 -9210
RPL8 -9182
RPL18A -9140

Click HERE to show all gene set members

All member genes
GeneID Gene Rank
RPL35A -10314
EIF3B -10153
RPS7 -10107
RPS4X -10083
RPL35 -10064
RPS25 -9974
RPL39 -9902
RPL10A -9900
RPS15 -9843
RPL37A -9724
RPS27 -9692
RPL12 -9678
EIF3I -9532
RPS29 -9493
RPL27 -9376
RPS23 -9366
RPS19 -9249
RPL32 -9210
RPL8 -9182
RPL18A -9140
RPS13 -9069
RPS9 -8898
RPS20 -8867
RPL7 -8818
RPL36 -8752
RPL38 -8730
RPL29 -8721
RPL30 -8707
RPL31 -8696
RPL11 -8598
RPL41 -8584
RPS11 -8581
RPL39L -8567
RPL10 -8533
RPL13A -8502
RPL24 -8450
UBA52 -8361
RPL15 -8344
RPS3 -8338
RPL9 -8330
RPL4 -8294
RPL36A -8292
RPL22L1 -8268
EIF3G -8229
RPL34 -8174
RPL19 -8095
RPL5 -8051
RPS14 -8044
RPLP0 -8042
FAU -7970
RPS27L -7769
RPS28 -7746
RPL37 -7713
RPSA -7582
RPL18 -7362
RPS6 -7352
RPS17 -7300
RPS8 -7263
RPL6 -7218
RPL23 -7070
RPL7A -7016
RPS16 -6912
RPS21 -6724
EIF3K -6700
RPL3 -6594
RPS10 -6588
RPL17 -6568
RPL13 -6547
RPL28 -6445
RPS12 -6437
EIF3H -6411
RPL22 -6398
RPL21 -6245
EIF3L -6237
RPLP1 -6177
EIF3D -6167
EIF3M -6070
RPS27A -5923
RPS15A -5860
RPL36AL -5694
RPS5 -5467
EIF3C -5239
RPS18 -5196
RPS24 -5184
RPLP2 -5083
RPL23A -4710
RPL14 -4505
RPS3A -4498
RPS2 -4449
EIF3E -3969
RPL27A -3830
RPL26 -3436
EIF3A -2993
EIF3F -2893
RPL26L1 -2674
EIF3J -1222
RPL3L 1485
RPS4Y1 2742
RPS26 6214
EIF1AX 6407



Selenocysteine synthesis
set Selenocysteine synthesis
setSize 92
pANOVA 4.54e-27
s.dist -0.649
p.adjustANOVA 3.37e-25


Top enriched genes
Top 20 genes
GeneID Gene Rank
RPL35A -10314
EEFSEC -10115
RPS7 -10107
RPS4X -10083
RPL35 -10064
RPS25 -9974
RPL39 -9902
RPL10A -9900
RPS15 -9843
RPL37A -9724
RPS27 -9692
RPL12 -9678
RPS29 -9493
RPL27 -9376
RPS23 -9366
RPS19 -9249
RPL32 -9210
RPL8 -9182
RPL18A -9140
RPS13 -9069

Click HERE to show all gene set members

All member genes
GeneID Gene Rank
RPL35A -10314
EEFSEC -10115
RPS7 -10107
RPS4X -10083
RPL35 -10064
RPS25 -9974
RPL39 -9902
RPL10A -9900
RPS15 -9843
RPL37A -9724
RPS27 -9692
RPL12 -9678
RPS29 -9493
RPL27 -9376
RPS23 -9366
RPS19 -9249
RPL32 -9210
RPL8 -9182
RPL18A -9140
RPS13 -9069
RPS9 -8898
RPS20 -8867
RPL7 -8818
RPL36 -8752
RPL38 -8730
RPL29 -8721
RPL30 -8707
RPL31 -8696
RPL11 -8598
RPL41 -8584
RPS11 -8581
RPL39L -8567
RPL10 -8533
RPL13A -8502
RPL24 -8450
UBA52 -8361
RPL15 -8344
RPS3 -8338
RPL9 -8330
RPL4 -8294
RPL36A -8292
RPL22L1 -8268
RPL34 -8174
RPL19 -8095
RPL5 -8051
RPS14 -8044
RPLP0 -8042
FAU -7970
RPS27L -7769
RPS28 -7746
RPL37 -7713
RPSA -7582
RPL18 -7362
RPS6 -7352
RPS17 -7300
RPS8 -7263
RPL6 -7218
RPL23 -7070
RPL7A -7016
RPS16 -6912
RPS21 -6724
RPL3 -6594
RPS10 -6588
RPL17 -6568
RPL13 -6547
RPL28 -6445
RPS12 -6437
RPL22 -6398
RPL21 -6245
RPLP1 -6177
RPS27A -5923
RPS15A -5860
RPL36AL -5694
RPS5 -5467
RPS18 -5196
RPS24 -5184
RPLP2 -5083
RPL23A -4710
SARS1 -4601
RPL14 -4505
RPS3A -4498
RPS2 -4449
RPL27A -3830
SEPHS2 -3520
RPL26 -3436
RPL26L1 -2674
SEPSECS 1390
RPL3L 1485
PSTK 1551
RPS4Y1 2742
SECISBP2 3596
RPS26 6214



SARS-CoV-1 modulates host translation machinery
set SARS-CoV-1 modulates host translation machinery
setSize 36
pANOVA 1.7e-11
s.dist -0.648
p.adjustANOVA 5.46e-10


Top enriched genes
Top 20 genes
GeneID Gene Rank
RPS7 -10107
RPS4X -10083
RPS25 -9974
RPS15 -9843
RPS27 -9692
RPS29 -9493
RPS23 -9366
RPS19 -9249
RPS13 -9069
RPS9 -8898
RPS20 -8867
RPS11 -8581
RPS3 -8338
RPS14 -8044
FAU -7970
RPS27L -7769
RPS28 -7746
RPSA -7582
RPS6 -7352
RPS17 -7300

Click HERE to show all gene set members

All member genes
GeneID Gene Rank
RPS7 -10107
RPS4X -10083
RPS25 -9974
RPS15 -9843
RPS27 -9692
RPS29 -9493
RPS23 -9366
RPS19 -9249
RPS13 -9069
RPS9 -8898
RPS20 -8867
RPS11 -8581
RPS3 -8338
RPS14 -8044
FAU -7970
RPS27L -7769
RPS28 -7746
RPSA -7582
RPS6 -7352
RPS17 -7300
RPS8 -7263
EEF1A1 -7133
RPS16 -6912
HNRNPA1 -6887
RPS21 -6724
RPS10 -6588
RPS12 -6437
RPS27A -5923
RPS15A -5860
RPS5 -5467
RPS18 -5196
RPS24 -5184
RPS3A -4498
RPS2 -4449
RPS4Y1 2742
RPS26 6214



Synthesis of GDP-mannose
set Synthesis of GDP-mannose
setSize 6
pANOVA 0.00602
s.dist -0.648
p.adjustANOVA 0.033


Top enriched genes
Top 20 genes
GeneID Gene Rank
GMPPB -10624
PMM2 -9983
PMM1 -8496
HK1 -5801
GMPPA -4330
MPI -2618

Click HERE to show all gene set members

All member genes
GeneID Gene Rank
GMPPB -10624
PMM2 -9983
PMM1 -8496
HK1 -5801
GMPPA -4330
MPI -2618



Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)
set Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)
setSize 94
pANOVA 3.18e-27
s.dist -0.644
p.adjustANOVA 2.45e-25


Top enriched genes
Top 20 genes
GeneID Gene Rank
RPL35A -10314
RPS7 -10107
RPS4X -10083
RPL35 -10064
RPS25 -9974
RPL39 -9902
RPL10A -9900
RPS15 -9843
RPL37A -9724
RPS27 -9692
RPL12 -9678
RPS29 -9493
RPL27 -9376
RPS23 -9366
RPS19 -9249
RPL32 -9210
RPL8 -9182
RPL18A -9140
RPS13 -9069
RPS9 -8898

Click HERE to show all gene set members

All member genes
GeneID Gene Rank
RPL35A -10314
RPS7 -10107
RPS4X -10083
RPL35 -10064
RPS25 -9974
RPL39 -9902
RPL10A -9900
RPS15 -9843
RPL37A -9724
RPS27 -9692
RPL12 -9678
RPS29 -9493
RPL27 -9376
RPS23 -9366
RPS19 -9249
RPL32 -9210
RPL8 -9182
RPL18A -9140
RPS13 -9069
RPS9 -8898
RPS20 -8867
RPL7 -8818
RPL36 -8752
RPL38 -8730
RPL29 -8721
RPL30 -8707
RPL31 -8696
RPL11 -8598
RPL41 -8584
RPS11 -8581
RPL39L -8567
RPL10 -8533
RPL13A -8502
RPL24 -8450
UBA52 -8361
RPL15 -8344
RPS3 -8338
RPL9 -8330
RPL4 -8294
RPL36A -8292
RPL22L1 -8268
RPL34 -8174
RPL19 -8095
RPL5 -8051
RPS14 -8044
RPLP0 -8042
FAU -7970
NCBP2 -7851
RPS27L -7769
RPS28 -7746
RPL37 -7713
RPSA -7582
EIF4G1 -7513
RPL18 -7362
RPS6 -7352
RPS17 -7300
RPS8 -7263
RPL6 -7218
RPL23 -7070
RPL7A -7016
RPS16 -6912
RPS21 -6724
RPL3 -6594
RPS10 -6588
RPL17 -6568
RPL13 -6547
RPL28 -6445
RPS12 -6437
RPL22 -6398
RPL21 -6245
RPLP1 -6177
RPS27A -5923
UPF1 -5913
RPS15A -5860
RPL36AL -5694
RPS5 -5467
RPS18 -5196
RPS24 -5184
RPLP2 -5083
RPL23A -4710
RPL14 -4505
RPS3A -4498
RPS2 -4449
RPL27A -3830
RPL26 -3436
RPL26L1 -2674
GSPT2 -748
PABPC1 -591
GSPT1 -168
ETF1 253
RPL3L 1485
NCBP1 2072
RPS4Y1 2742
RPS26 6214



Mitochondrial translation
set Mitochondrial translation
setSize 96
pANOVA 1.63e-27
s.dist -0.641
p.adjustANOVA 1.44e-25


Top enriched genes
Top 20 genes
GeneID Gene Rank
MT-RNR2 -10737
MRPL12 -10724
MRPL57 -10718
MRPL17 -10715
MRPL34 -10677
MRPS7 -10627
MRPL16 -10565
MT-RNR1 -10561
TSFM -10558
MRPL37 -10545
MRPS21 -10500
GADD45GIP1 -10465
MRPS16 -10342
MRPL20 -10240
MRPL49 -10231
MRPS15 -10213
MRPS28 -10199
MRPS25 -10192
MRPL4 -10113
MRPS18C -10058

Click HERE to show all gene set members

All member genes
GeneID Gene Rank
MT-RNR2 -10737
MRPL12 -10724
MRPL57 -10718
MRPL17 -10715
MRPL34 -10677
MRPS7 -10627
MRPL16 -10565
MT-RNR1 -10561
TSFM -10558
MRPL37 -10545
MRPS21 -10500
GADD45GIP1 -10465
MRPS16 -10342
MRPL20 -10240
MRPL49 -10231
MRPS15 -10213
MRPS28 -10199
MRPS25 -10192
MRPL4 -10113
MRPS18C -10058
MRPL3 -10050
MRPL51 -10029
MRPL9 -9996
MRPL54 -9947
MRPL40 -9883
MRPL18 -9837
MRPL21 -9781
MRPL14 -9729
MRPL43 -9664
MRPS18B -9476
MRPL15 -9421
MRPL48 -9379
MRPL27 -9214
MRPS23 -9170
MRPS33 -9139
TUFM -9030
MRPS26 -9013
MRPL11 -8996
MRPL2 -8922
MRPS30 -8824
MRPS27 -8817
MRPL36 -8812
MRPL24 -8789
MRPL46 -8624
AURKAIP1 -8616
MRPS14 -8605
MRPS11 -8389
MRPS34 -8343
CHCHD1 -8235
MRPS18A -8206
MRPL41 -8198
MRPS24 -8160
MRPS17 -8141
MRPS35 -8096
MRPL23 -8083
MRPL38 -8015
MRPS10 -7994
ERAL1 -7603
MRPL32 -7456
MRPL52 -7286
MRPS36 -7283
MRPL13 -6858
MRPS5 -6803
DAP3 -6643
MRPL47 -6516
RPS12 -6437
MRPS22 -6346
MRPS9 -6109
MRPL22 -6039
MRPL28 -5910
MTFMT -5700
MRPS2 -5543
MRPL39 -5494
MRPL33 -5424
MRPL30 -5402
MRRF -5314
MRPL53 -5046
OXA1L -5023
MRPL55 -4696
MRPL10 -4693
MRPL45 -4519
MRPL19 -4442
MRPL44 -3863
MRPL58 -3372
PTCD3 -3265
MTIF2 -3055
MRPS6 -1409
MRPL35 2184
MRPS31 2353
GFM1 2700
MRPL42 3107
MTIF3 3693
MRPL50 4502
GFM2 6932
MRPL1 8557
MTRF1L 10143



Mitochondrial protein import
set Mitochondrial protein import
setSize 63
pANOVA 1.71e-18
s.dist -0.639
p.adjustANOVA 8.24e-17


Top enriched genes
Top 20 genes
GeneID Gene Rank
COA6 -10815
FXN -10753
TIMM44 -10695
ATP5MC1 -10679
TIMM22 -10616
CYC1 -10536
TOMM5 -10516
TOMM22 -10381
CHCHD4 -10295
ATP5F1B -10186
TOMM6 -10163
TIMM8A -9973
TIMM8B -9925
GFER -9639
TIMM23 -9624
TOMM40 -9328
TIMM17A -9310
VDAC1 -9241
HSPA9 -9167
COX17 -9009

Click HERE to show all gene set members

All member genes
GeneID Gene Rank
COA6 -10815
FXN -10753
TIMM44 -10695
ATP5MC1 -10679
TIMM22 -10616
CYC1 -10536
TOMM5 -10516
TOMM22 -10381
CHCHD4 -10295
ATP5F1B -10186
TOMM6 -10163
TIMM8A -9973
TIMM8B -9925
GFER -9639
TIMM23 -9624
TOMM40 -9328
TIMM17A -9310
VDAC1 -9241
HSPA9 -9167
COX17 -9009
ATP5F1A -8780
TIMM10 -8608
SLC25A6 -8441
HSCB -8415
COA4 -8383
TIMM13 -8247
NDUFB8 -8124
SLC25A12 -7968
CHCHD2 -7908
TOMM20 -7871
CHCHD3 -7572
CS -7474
BCS1L -7442
TIMM50 -7384
PITRM1 -7266
HSPD1 -7042
MTX2 -7036
PAM16 -6680
PMPCA -6095
GRPEL2 -6018
CHCHD10 -5867
TIMM9 -5815
DNAJC19 -5805
COX19 -5531
SLC25A4 -5222
CHCHD5 -5103
TOMM70 -5097
TIMM21 -5088
SAMM50 -4915
GRPEL1 -4827
TOMM7 -4720
TIMM17B -4692
ACO2 -4669
TIMM10B -4629
CMC2 -4506
CMC4 -3761
PMPCB -3587
IDH3G -3364
SLC25A13 -2010
CHCHD7 -908
MTX1 -219
DLD 4942
COQ2 6802



Nucleotide biosynthesis
set Nucleotide biosynthesis
setSize 12
pANOVA 0.000158
s.dist -0.63
p.adjustANOVA 0.00149


Top enriched genes
Top 20 genes
GeneID Gene Rank
PAICS -10738
ATIC -10499
ADSL -9903
PFAS -9865
CAD -8737
GART -8706
GMPS -7046
IMPDH2 -6249
DHODH -6113
PPAT -2473
IMPDH1 -1998
UMPS 977

Click HERE to show all gene set members

All member genes
GeneID Gene Rank
PAICS -10738
ATIC -10499
ADSL -9903
PFAS -9865
CAD -8737
GART -8706
GMPS -7046
IMPDH2 -6249
DHODH -6113
PPAT -2473
IMPDH1 -1998
UMPS 977



L13a-mediated translational silencing of Ceruloplasmin expression
set L13a-mediated translational silencing of Ceruloplasmin expression
setSize 110
pANOVA 1.15e-29
s.dist -0.623
p.adjustANOVA 1.59e-27


Top enriched genes
Top 20 genes
GeneID Gene Rank
RPL35A -10314
EIF3B -10153
RPS7 -10107
RPS4X -10083
RPL35 -10064
RPS25 -9974
RPL39 -9902
RPL10A -9900
RPS15 -9843
RPL37A -9724
RPS27 -9692
RPL12 -9678
EIF3I -9532
RPS29 -9493
RPL27 -9376
RPS23 -9366
RPS19 -9249
RPL32 -9210
RPL8 -9182
RPL18A -9140

Click HERE to show all gene set members

All member genes
GeneID Gene Rank
RPL35A -10314
EIF3B -10153
RPS7 -10107
RPS4X -10083
RPL35 -10064
RPS25 -9974
RPL39 -9902
RPL10A -9900
RPS15 -9843
RPL37A -9724
RPS27 -9692
RPL12 -9678
EIF3I -9532
RPS29 -9493
RPL27 -9376
RPS23 -9366
RPS19 -9249
RPL32 -9210
RPL8 -9182
RPL18A -9140
RPS13 -9069
RPS9 -8898
RPS20 -8867
RPL7 -8818
RPL36 -8752
RPL38 -8730
RPL29 -8721
RPL30 -8707
RPL31 -8696
RPL11 -8598
EIF4H -8586
RPL41 -8584
RPS11 -8581
RPL39L -8567
RPL10 -8533
RPL13A -8502
RPL24 -8450
UBA52 -8361
RPL15 -8344
RPS3 -8338
RPL9 -8330
RPL4 -8294
RPL36A -8292
RPL22L1 -8268
EIF3G -8229
RPL34 -8174
RPL19 -8095
RPL5 -8051
RPS14 -8044
RPLP0 -8042
FAU -7970
RPS27L -7769
RPS28 -7746
RPL37 -7713
RPSA -7582
EIF4G1 -7513
RPL18 -7362
RPS6 -7352
RPS17 -7300
RPS8 -7263
RPL6 -7218
RPL23 -7070
RPL7A -7016
RPS16 -6912
RPS21 -6724
EIF3K -6700
RPL3 -6594
RPS10 -6588
RPL17 -6568
RPL13 -6547
RPL28 -6445
RPS12 -6437
EIF3H -6411
RPL22 -6398
EIF4A1 -6254
RPL21 -6245
EIF3L -6237
RPLP1 -6177
EIF3D -6167
EIF3M -6070
RPS27A -5923
RPS15A -5860
EIF4B -5727
RPL36AL -5694
RPS5 -5467
EIF3C -5239
RPS18 -5196
RPS24 -5184
RPLP2 -5083
RPL23A -4710
RPL14 -4505
RPS3A -4498
RPS2 -4449
EIF3E -3969
RPL27A -3830
EIF2S3 -3687
RPL26 -3436
EIF3A -2993
EIF3F -2893
EIF2S1 -2885
RPL26L1 -2674
EIF2S2 -1965
EIF4E -1527
EIF3J -1222
PABPC1 -591
RPL3L 1485
EIF4A2 2695
RPS4Y1 2742
RPS26 6214
EIF1AX 6407



Release of apoptotic factors from the mitochondria
set Release of apoptotic factors from the mitochondria
setSize 6
pANOVA 0.00848
s.dist -0.621
p.adjustANOVA 0.0442


Top enriched genes
Top 20 genes
GeneID Gene Rank
BAK1 -10221
BAX -8118
DIABLO -7954
CYCS -6499
GSDMD -5060
GSDME -2222

Click HERE to show all gene set members

All member genes
GeneID Gene Rank
BAK1 -10221
BAX -8118
DIABLO -7954
CYCS -6499
GSDMD -5060
GSDME -2222



GTP hydrolysis and joining of the 60S ribosomal subunit
set GTP hydrolysis and joining of the 60S ribosomal subunit
setSize 111
pANOVA 1.25e-29
s.dist -0.62
p.adjustANOVA 1.59e-27


Top enriched genes
Top 20 genes
GeneID Gene Rank
RPL35A -10314
EIF3B -10153
RPS7 -10107
RPS4X -10083
RPL35 -10064
RPS25 -9974
RPL39 -9902
RPL10A -9900
RPS15 -9843
RPL37A -9724
RPS27 -9692
RPL12 -9678
EIF3I -9532
RPS29 -9493
RPL27 -9376
RPS23 -9366
RPS19 -9249
RPL32 -9210
RPL8 -9182
RPL18A -9140

Click HERE to show all gene set members

All member genes
GeneID Gene Rank
RPL35A -10314
EIF3B -10153
RPS7 -10107
RPS4X -10083
RPL35 -10064
RPS25 -9974
RPL39 -9902
RPL10A -9900
RPS15 -9843
RPL37A -9724
RPS27 -9692
RPL12 -9678
EIF3I -9532
RPS29 -9493
RPL27 -9376
RPS23 -9366
RPS19 -9249
RPL32 -9210
RPL8 -9182
RPL18A -9140
RPS13 -9069
RPS9 -8898
RPS20 -8867
RPL7 -8818
RPL36 -8752
RPL38 -8730
RPL29 -8721
RPL30 -8707
RPL31 -8696
RPL11 -8598
EIF4H -8586
RPL41 -8584
RPS11 -8581
RPL39L -8567
RPL10 -8533
RPL13A -8502
RPL24 -8450
UBA52 -8361
RPL15 -8344
RPS3 -8338
RPL9 -8330
RPL4 -8294
RPL36A -8292
RPL22L1 -8268
EIF3G -8229
RPL34 -8174
RPL19 -8095
RPL5 -8051
RPS14 -8044
RPLP0 -8042
FAU -7970
RPS27L -7769
RPS28 -7746
RPL37 -7713
RPSA -7582
EIF4G1 -7513
RPL18 -7362
RPS6 -7352
RPS17 -7300
RPS8 -7263
RPL6 -7218
RPL23 -7070
RPL7A -7016
RPS16 -6912
RPS21 -6724
EIF3K -6700
RPL3 -6594
RPS10 -6588
RPL17 -6568
RPL13 -6547
EIF5 -6459
RPL28 -6445
RPS12 -6437
EIF3H -6411
RPL22 -6398
EIF4A1 -6254
RPL21 -6245
EIF3L -6237
RPLP1 -6177
EIF3D -6167
EIF3M -6070
RPS27A -5923
RPS15A -5860
EIF4B -5727
RPL36AL -5694
RPS5 -5467
EIF3C -5239
RPS18 -5196
RPS24 -5184
RPLP2 -5083
RPL23A -4710
RPL14 -4505
RPS3A -4498
RPS2 -4449
EIF3E -3969
RPL27A -3830
EIF2S3 -3687
RPL26 -3436
EIF3A -2993
EIF3F -2893
EIF2S1 -2885
RPL26L1 -2674
EIF2S2 -1965
EIF4E -1527
EIF3J -1222
RPL3L 1485
EIF4A2 2695
RPS4Y1 2742
EIF5B 3096
RPS26 6214
EIF1AX 6407



Response of EIF2AK4 (GCN2) to amino acid deficiency
set Response of EIF2AK4 (GCN2) to amino acid deficiency
setSize 100
pANOVA 7.88e-27
s.dist -0.62
p.adjustANOVA 5.64e-25


Top enriched genes
Top 20 genes
GeneID Gene Rank
RPL35A -10314
RPS7 -10107
RPS4X -10083
RPL35 -10064
RPS25 -9974
DDIT3 -9949
RPL39 -9902
RPL10A -9900
RPS15 -9843
RPL37A -9724
RPS27 -9692
RPL12 -9678
RPS29 -9493
RPL27 -9376
RPS23 -9366
RPS19 -9249
RPL32 -9210
RPL8 -9182
RPL18A -9140
RPS13 -9069

Click HERE to show all gene set members

All member genes
GeneID Gene Rank
RPL35A -10314
RPS7 -10107
RPS4X -10083
RPL35 -10064
RPS25 -9974
DDIT3 -9949
RPL39 -9902
RPL10A -9900
RPS15 -9843
RPL37A -9724
RPS27 -9692
RPL12 -9678
RPS29 -9493
RPL27 -9376
RPS23 -9366
RPS19 -9249
RPL32 -9210
RPL8 -9182
RPL18A -9140
RPS13 -9069
RPS9 -8898
RPS20 -8867
RPL7 -8818
RPL36 -8752
RPL38 -8730
RPL29 -8721
RPL30 -8707
RPL31 -8696
RPL11 -8598
RPL41 -8584
RPS11 -8581
RPL39L -8567
RPL10 -8533
RPL13A -8502
RPL24 -8450
UBA52 -8361
RPL15 -8344
RPS3 -8338
RPL9 -8330
RPL4 -8294
RPL36A -8292
RPL22L1 -8268
RPL34 -8174
RPL19 -8095
RPL5 -8051
RPS14 -8044
RPLP0 -8042
FAU -7970
CEBPG -7924
RPS27L -7769
RPS28 -7746
RPL37 -7713
RPSA -7582
TRIB3 -7568
RPL18 -7362
RPS6 -7352
RPS17 -7300
RPS8 -7263
RPL6 -7218
RPL23 -7070
RPL7A -7016
RPS16 -6912
RPS21 -6724
RPL3 -6594
RPS10 -6588
RPL17 -6568
RPL13 -6547
RPL28 -6445
RPS12 -6437
RPL22 -6398
GCN1 -6329
RPL21 -6245
RPLP1 -6177
RPS27A -5923
RPS15A -5860
EIF2AK4 -5766
RPL36AL -5694
RPS5 -5467
RPS18 -5196
RPS24 -5184
RPLP2 -5083
RPL23A -4710
RPL14 -4505
RPS3A -4498
RPS2 -4449
RPL27A -3830
EIF2S3 -3687
ATF4 -3673
ATF3 -3663
RPL26 -3436
EIF2S1 -2885
RPL26L1 -2674
EIF2S2 -1965
IMPACT -951
RPL3L 1485
RPS4Y1 2742
ASNS 5520
CEBPB 5599
RPS26 6214
ATF2 8191



Cohesin Loading onto Chromatin
set Cohesin Loading onto Chromatin
setSize 10
pANOVA 0.000731
s.dist 0.617
p.adjustANOVA 0.00579


Top enriched genes
Top 20 genes
GeneID Gene Rank
NIPBL 10646
STAG2 10561
PDS5B 9808
SMC3 9649
RAD21 9282
MAU2 8423
PDS5A 4222
WAPL 4212
STAG1 2170
SMC1A 288

Click HERE to show all gene set members

All member genes
GeneID Gene Rank
NIPBL 10646
STAG2 10561
PDS5B 9808
SMC3 9649
RAD21 9282
MAU2 8423
PDS5A 4222
WAPL 4212
STAG1 2170
SMC1A 288



Cap-dependent Translation Initiation
set Cap-dependent Translation Initiation
setSize 118
pANOVA 8.08e-31
s.dist -0.614
p.adjustANOVA 1.42e-28


Top enriched genes
Top 20 genes
GeneID Gene Rank
RPL35A -10314
EIF3B -10153
RPS7 -10107
RPS4X -10083
RPL35 -10064
RPS25 -9974
RPL39 -9902
RPL10A -9900
RPS15 -9843
RPL37A -9724
RPS27 -9692
RPL12 -9678
EIF3I -9532
RPS29 -9493
RPL27 -9376
RPS23 -9366
RPS19 -9249
RPL32 -9210
RPL8 -9182
RPL18A -9140

Click HERE to show all gene set members

All member genes
GeneID Gene Rank
RPL35A -10314
EIF3B -10153
RPS7 -10107
RPS4X -10083
RPL35 -10064
RPS25 -9974
RPL39 -9902
RPL10A -9900
RPS15 -9843
RPL37A -9724
RPS27 -9692
RPL12 -9678
EIF3I -9532
RPS29 -9493
RPL27 -9376
RPS23 -9366
RPS19 -9249
RPL32 -9210
RPL8 -9182
RPL18A -9140
RPS13 -9069
RPS9 -8898
RPS20 -8867
RPL7 -8818
RPL36 -8752
RPL38 -8730
RPL29 -8721
RPL30 -8707
RPL31 -8696
RPL11 -8598
EIF4H -8586
RPL41 -8584
RPS11 -8581
RPL39L -8567
RPL10 -8533
RPL13A -8502
RPL24 -8450
UBA52 -8361
RPL15 -8344
RPS3 -8338
RPL9 -8330
RPL4 -8294
RPL36A -8292
RPL22L1 -8268
EIF3G -8229
RPL34 -8174
RPL19 -8095
RPL5 -8051
RPS14 -8044
RPLP0 -8042
FAU -7970
EIF4EBP1 -7960
EIF2B3 -7914
RPS27L -7769
RPS28 -7746
RPL37 -7713
RPSA -7582
EIF4G1 -7513
RPL18 -7362
RPS6 -7352
RPS17 -7300
RPS8 -7263
RPL6 -7218
RPL23 -7070
RPL7A -7016
RPS16 -6912
RPS21 -6724
EIF3K -6700
RPL3 -6594
RPS10 -6588
RPL17 -6568
RPL13 -6547
EIF2B2 -6501
EIF5 -6459
RPL28 -6445
RPS12 -6437
EIF3H -6411
RPL22 -6398
EIF4A1 -6254
RPL21 -6245
EIF3L -6237
EIF2B5 -6215
RPLP1 -6177
EIF3D -6167
EIF3M -6070
RPS27A -5923
RPS15A -5860
EIF4B -5727
RPL36AL -5694
RPS5 -5467
EIF2B4 -5272
EIF3C -5239
RPS18 -5196
RPS24 -5184
RPLP2 -5083
RPL23A -4710
RPL14 -4505
RPS3A -4498
RPS2 -4449
EIF2B1 -4095
EIF3E -3969
RPL27A -3830
EIF2S3 -3687
RPL26 -3436
EIF3A -2993
EIF3F -2893
EIF2S1 -2885
RPL26L1 -2674
EIF2S2 -1965
EIF4E -1527
EIF3J -1222
PABPC1 -591
RPL3L 1485
EIF4A2 2695
RPS4Y1 2742
EIF5B 3096
RPS26 6214
EIF1AX 6407



Eukaryotic Translation Initiation
set Eukaryotic Translation Initiation
setSize 118
pANOVA 8.08e-31
s.dist -0.614
p.adjustANOVA 1.42e-28


Top enriched genes
Top 20 genes
GeneID Gene Rank
RPL35A -10314
EIF3B -10153
RPS7 -10107
RPS4X -10083
RPL35 -10064
RPS25 -9974
RPL39 -9902
RPL10A -9900
RPS15 -9843
RPL37A -9724
RPS27 -9692
RPL12 -9678
EIF3I -9532
RPS29 -9493
RPL27 -9376
RPS23 -9366
RPS19 -9249
RPL32 -9210
RPL8 -9182
RPL18A -9140

Click HERE to show all gene set members

All member genes
GeneID Gene Rank
RPL35A -10314
EIF3B -10153
RPS7 -10107
RPS4X -10083
RPL35 -10064
RPS25 -9974
RPL39 -9902
RPL10A -9900
RPS15 -9843
RPL37A -9724
RPS27 -9692
RPL12 -9678
EIF3I -9532
RPS29 -9493
RPL27 -9376
RPS23 -9366
RPS19 -9249
RPL32 -9210
RPL8 -9182
RPL18A -9140
RPS13 -9069
RPS9 -8898
RPS20 -8867
RPL7 -8818
RPL36 -8752
RPL38 -8730
RPL29 -8721
RPL30 -8707
RPL31 -8696
RPL11 -8598
EIF4H -8586
RPL41 -8584
RPS11 -8581
RPL39L -8567
RPL10 -8533
RPL13A -8502
RPL24 -8450
UBA52 -8361
RPL15 -8344
RPS3 -8338
RPL9 -8330
RPL4 -8294
RPL36A -8292
RPL22L1 -8268
EIF3G -8229
RPL34 -8174
RPL19 -8095
RPL5 -8051
RPS14 -8044
RPLP0 -8042
FAU -7970
EIF4EBP1 -7960
EIF2B3 -7914
RPS27L -7769
RPS28 -7746
RPL37 -7713
RPSA -7582
EIF4G1 -7513
RPL18 -7362
RPS6 -7352
RPS17 -7300
RPS8 -7263
RPL6 -7218
RPL23 -7070
RPL7A -7016
RPS16 -6912
RPS21 -6724
EIF3K -6700
RPL3 -6594
RPS10 -6588
RPL17 -6568
RPL13 -6547
EIF2B2 -6501
EIF5 -6459
RPL28 -6445
RPS12 -6437
EIF3H -6411
RPL22 -6398
EIF4A1 -6254
RPL21 -6245
EIF3L -6237
EIF2B5 -6215
RPLP1 -6177
EIF3D -6167
EIF3M -6070
RPS27A -5923
RPS15A -5860
EIF4B -5727
RPL36AL -5694
RPS5 -5467
EIF2B4 -5272
EIF3C -5239
RPS18 -5196
RPS24 -5184
RPLP2 -5083
RPL23A -4710
RPL14 -4505
RPS3A -4498
RPS2 -4449
EIF2B1 -4095
EIF3E -3969
RPL27A -3830
EIF2S3 -3687
RPL26 -3436
EIF3A -2993
EIF3F -2893
EIF2S1 -2885
RPL26L1 -2674
EIF2S2 -1965
EIF4E -1527
EIF3J -1222
PABPC1 -591
RPL3L 1485
EIF4A2 2695
RPS4Y1 2742
EIF5B 3096
RPS26 6214
EIF1AX 6407



Translation
set Translation
setSize 293
pANOVA 1.36e-70
s.dist -0.601
p.adjustANOVA 2.63e-67


Top enriched genes
Top 20 genes
GeneID Gene Rank
SRPRB -10828
MT-RNR2 -10737
MRPL12 -10724
MRPL57 -10718
MRPL17 -10715
MRPL34 -10677
MARS2 -10667
VARS2 -10632
MRPS7 -10627
MRPL16 -10565
MT-RNR1 -10561
TSFM -10558
SEC61A1 -10547
MRPL37 -10545
AIMP2 -10529
FARSA -10520
MRPS21 -10500
GADD45GIP1 -10465
MRPS16 -10342
NARS2 -10325

Click HERE to show all gene set members

All member genes
GeneID Gene Rank
SRPRB -10828
MT-RNR2 -10737
MRPL12 -10724
MRPL57 -10718
MRPL17 -10715
MRPL34 -10677
MARS2 -10667
VARS2 -10632
MRPS7 -10627
MRPL16 -10565
MT-RNR1 -10561
TSFM -10558
SEC61A1 -10547
MRPL37 -10545
AIMP2 -10529
FARSA -10520
MRPS21 -10500
GADD45GIP1 -10465
MRPS16 -10342
NARS2 -10325
RPL35A -10314
EARS2 -10256
MRPL20 -10240
MRPL49 -10231
SSR4 -10215
MRPS15 -10213
SEC61G -10208
MRPS28 -10199
MRPS25 -10192
EIF3B -10153
VARS1 -10119
SEC61B -10118
MRPL4 -10113
RPS7 -10107
DDOST -10098
RPS4X -10083
RPL35 -10064
MRPS18C -10058
MRPL3 -10050
MRPL51 -10029
MRPL9 -9996
RPS25 -9974
MRPL54 -9947
RPL39 -9902
RPL10A -9900
MRPL40 -9883
RPS15 -9843
MRPL18 -9837
MRPL21 -9781
SEC11C -9765
MRPL14 -9729
RPL37A -9724
RPS27 -9692
RPL12 -9678
MRPL43 -9664
EIF3I -9532
SARS2 -9512
RPS29 -9493
MRPS18B -9476
PPA1 -9461
MRPL15 -9421
MRPL48 -9379
RPL27 -9376
WARS2 -9372
RPS23 -9366
SEC11A -9348
RPS19 -9249
HARS1 -9230
MRPL27 -9214
RPL32 -9210
RPL8 -9182
MRPS23 -9170
YARS2 -9143
RPL18A -9140
MRPS33 -9139
TRMT112 -9102
RPS13 -9069
TUFM -9030
MRPS26 -9013
MRPL11 -8996
MRPL2 -8922
RPN1 -8901
RPS9 -8898
RPN2 -8897
RPS20 -8867
MRPS30 -8824
RPL7 -8818
MRPS27 -8817
MRPL36 -8812
MRPL24 -8789
RPL36 -8752
RPL38 -8730
RPL29 -8721
RPL30 -8707
RPL31 -8696
AARS1 -8632
DARS2 -8625
MRPL46 -8624
AURKAIP1 -8616
MRPS14 -8605
RPL11 -8598
EIF4H -8586
RPL41 -8584
RPS11 -8581
RPL39L -8567
RPL10 -8533
RPL13A -8502
SSR3 -8498
RPL24 -8450
KARS1 -8420
MRPS11 -8389
UBA52 -8361
RPL15 -8344
MRPS34 -8343
RPS3 -8338
RPL9 -8330
RPL4 -8294
RPL36A -8292
EEF2 -8291
RPL22L1 -8268
APEH -8252
CHCHD1 -8235
EIF3G -8229
AARS2 -8209
MRPS18A -8206
MRPL41 -8198
RPL34 -8174
FARSB -8172
MRPS24 -8160
MRPS17 -8141
MRPS35 -8096
RPL19 -8095
MRPL23 -8083
RPL5 -8051
RPS14 -8044
RPLP0 -8042
EEF1E1 -8040
MRPL38 -8015
MRPS10 -7994
FAU -7970
EIF4EBP1 -7960
EIF2B3 -7914
EEF1A1P5 -7861
SRP68 -7844
RPS27L -7769
RPS28 -7746
IARS1 -7737
RPL37 -7713
ERAL1 -7603
TARS2 -7595
RPSA -7582
EIF4G1 -7513
MRPL32 -7456
RPL18 -7362
RPS6 -7352
RPS17 -7300
MRPL52 -7286
MRPS36 -7283
EEF1B2 -7268
RPS8 -7263
RPL6 -7218
EEF1A1 -7133
SSR2 -7083
RPL23 -7070
RPL7A -7016
RPS16 -6912
MRPL13 -6858
YARS1 -6831
MRPS5 -6803
RPS21 -6724
EIF3K -6700
DAP3 -6643
SPCS1 -6626
RPL3 -6594
RPS10 -6588
RPL17 -6568
RPL13 -6547
MRPL47 -6516
EIF2B2 -6501
EIF5 -6459
RPL28 -6445
RPS12 -6437
EIF3H -6411
RPL22 -6398
MRPS22 -6346
EIF4A1 -6254
RPL21 -6245
EIF3L -6237
EIF2B5 -6215
RPLP1 -6177
EIF3D -6167
QARS1 -6124
MRPS9 -6109
SRP14 -6103
EIF3M -6070
EEF1G -6066
MRPL22 -6039
RPS27A -5923
MRPL28 -5910
RARS2 -5865
RPS15A -5860
EIF4B -5727
MTFMT -5700
RPL36AL -5694
SPCS2 -5637
MRPS2 -5543
MRPL39 -5494
RPS5 -5467
MRPL33 -5424
MRPL30 -5402
MRRF -5314
EIF2B4 -5272
EIF3C -5239
RPS18 -5196
RPS24 -5184
RPLP2 -5083
MRPL53 -5046
OXA1L -5023
EEF1D -4889
SRP72 -4844
GARS1 -4779
RPL23A -4710
FARS2 -4708
MRPL55 -4696
MRPL10 -4693
PARS2 -4625
SARS1 -4601
MRPL45 -4519
RPL14 -4505
RPS3A -4498
EPRS1 -4453
RPS2 -4449
MRPL19 -4442
SRPRA -4136
MARS1 -4123
EIF2B1 -4095
PPA2 -4018
EIF3E -3969
MRPL44 -3863
RPL27A -3830
HARS2 -3771
EIF2S3 -3687
LARS1 -3649
RPL26 -3436
MRPL58 -3372
TARS1 -3309
PTCD3 -3265
MTIF2 -3055
LARS2 -3026
EIF3A -2993
NARS1 -2936
EIF3F -2893
EIF2S1 -2885
IARS2 -2797
RPL26L1 -2674
CARS1 -2165
SEC61A2 -2080
SRP54 -1981
EIF2S2 -1965
N6AMT1 -1581
EIF4E -1527
SRP19 -1452
MRPS6 -1409
EIF3J -1222
SRP9 -838
GSPT2 -748
PABPC1 -591
RARS1 -516
AIMP1 -390
GSPT1 -168
TRAM1 -32
ETF1 253
SPCS3 940
RPL3L 1485
MRPL35 2184
MRPS31 2353
EIF4A2 2695
GFM1 2700
RPS4Y1 2742
EIF5B 3096
MRPL42 3107
MTIF3 3693
MRPL50 4502
DARS1 4906
SSR1 4910
RPS26 6214
EIF1AX 6407
GFM2 6932
EEF1A2 7215
MRPL1 8557
WARS1 8694
CARS2 8969
MTRF1L 10143



SARS-CoV-2 modulates host translation machinery
set SARS-CoV-2 modulates host translation machinery
setSize 49
pANOVA 5.28e-13
s.dist -0.596
p.adjustANOVA 1.93e-11


Top enriched genes
Top 20 genes
GeneID Gene Rank
SNRPG -10469
RPS7 -10107
RPS4X -10083
RPS25 -9974
RPS15 -9843
SNRPE -9833
RPS27 -9692
RPS29 -9493
RPS23 -9366
SNRPB -9362
RPS19 -9249
SNRPD2 -9093
RPS13 -9069
RPS9 -8898
RPS20 -8867
GEMIN4 -8763
GEMIN6 -8650
RPS11 -8581
RPS3 -8338
GEMIN5 -8188

Click HERE to show all gene set members

All member genes
GeneID Gene Rank
SNRPG -10469
RPS7 -10107
RPS4X -10083
RPS25 -9974
RPS15 -9843
SNRPE -9833
RPS27 -9692
RPS29 -9493
RPS23 -9366
SNRPB -9362
RPS19 -9249
SNRPD2 -9093
RPS13 -9069
RPS9 -8898
RPS20 -8867
GEMIN4 -8763
GEMIN6 -8650
RPS11 -8581
RPS3 -8338
GEMIN5 -8188
RPS14 -8044
FAU -7970
SNRPD1 -7854
RPS27L -7769
RPS28 -7746
RPSA -7582
RPS6 -7352
RPS17 -7300
RPS8 -7263
RPS16 -6912
SNRPF -6760
RPS21 -6724
RPS10 -6588
RPS12 -6437
RPS27A -5923
RPS15A -5860
DDX20 -5666
RPS5 -5467
RPS18 -5196
RPS24 -5184
RPS3A -4498
RPS2 -4449
GEMIN7 -2934
SMN1 -379
SNRPD3 -159
RPS4Y1 2742
GEMIN2 4066
RPS26 6214
GEMIN8 7687



rRNA processing in the nucleus and cytosol
set rRNA processing in the nucleus and cytosol
setSize 189
pANOVA 6.04e-45
s.dist -0.592
p.adjustANOVA 3.89e-42


Top enriched genes
Top 20 genes
GeneID Gene Rank
RPP25 -10842
EBNA1BP2 -10669
EXOSC2 -10635
EXOSC6 -10625
EXOSC1 -10587
NHP2 -10549
NAT10 -10542
UTP18 -10440
RRP36 -10427
WDR46 -10365
BOP1 -10336
UTP4 -10318
PNO1 -10316
RPL35A -10314
IMP3 -10308
PDCD11 -10296
RCL1 -10217
IMP4 -10116
RPS7 -10107
EXOSC5 -10092

Click HERE to show all gene set members

All member genes
GeneID Gene Rank
RPP25 -10842
EBNA1BP2 -10669
EXOSC2 -10635
EXOSC6 -10625
EXOSC1 -10587
NHP2 -10549
NAT10 -10542
UTP18 -10440
RRP36 -10427
WDR46 -10365
BOP1 -10336
UTP4 -10318
PNO1 -10316
RPL35A -10314
IMP3 -10308
PDCD11 -10296
RCL1 -10217
IMP4 -10116
RPS7 -10107
EXOSC5 -10092
RPS4X -10083
RPL35 -10064
UTP11 -10023
UTP25 -10001
RPS25 -9974
RPL39 -9902
RPL10A -9900
TSR1 -9893
NOL9 -9872
RPS15 -9843
NOP14 -9831
RPL37A -9724
NOL6 -9702
RPS27 -9692
EMG1 -9688
RPL12 -9678
DHX37 -9626
TSR3 -9533
RPS29 -9493
RPL27 -9376
RPS23 -9366
EXOSC8 -9355
GNL3 -9339
UTP14A -9279
RPS19 -9249
NIP7 -9248
EXOSC7 -9227
RPL32 -9210
RPP40 -9202
RPL8 -9182
RRP9 -9163
WDR12 -9147
RPL18A -9140
TRMT112 -9102
RPS13 -9069
RPS9 -8898
DKC1 -8895
RPS20 -8867
RPL7 -8818
WDR18 -8756
RPL36 -8752
RPL38 -8730
RPL29 -8721
RPL30 -8707
RPL31 -8696
RPL11 -8598
RPL41 -8584
RPS11 -8581
RPL39L -8567
RPL10 -8533
RPL13A -8502
RPL24 -8450
UBA52 -8361
RPL15 -8344
RPS3 -8338
RPL9 -8330
PES1 -8296
RPL4 -8294
RPL36A -8292
RPL22L1 -8268
NOC4L -8265
RRP1 -8263
NOP10 -8242
NOB1 -8223
RPL34 -8174
RPL19 -8095
RPL5 -8051
RPS14 -8044
RPLP0 -8042
FAU -7970
NOL12 -7862
RPS27L -7769
EXOSC3 -7748
RPS28 -7746
RPL37 -7713
FTSJ3 -7707
NOP2 -7643
RPSA -7582
LTV1 -7497
NOP56 -7383
RPL18 -7362
RPS6 -7352
RRP7A -7346
RIOK1 -7324
RPS17 -7300
RPS8 -7263
RPL6 -7218
RPP21 -7169
RPL23 -7070
RPL7A -7016
ISG20L2 -6958
RPS16 -6912
RPS21 -6724
FBL -6693
SNU13 -6621
RPL3 -6594
RPS10 -6588
RPL17 -6568
RPL13 -6547
RPL28 -6445
RPS12 -6437
RPL22 -6398
RPL21 -6245
BYSL -6210
RPLP1 -6177
DDX49 -6001
RPS27A -5923
RPS15A -5860
DDX47 -5752
RPL36AL -5694
RPS5 -5467
DIMT1 -5352
TBL3 -5309
RPS18 -5196
RPS24 -5184
RPLP2 -5083
DDX21 -5043
CSNK1E -5011
EXOSC4 -4974
DCAF13 -4966
UTP6 -4775
RPL23A -4710
WDR75 -4638
WDR3 -4606
UTP20 -4555
RPL14 -4505
RPS3A -4498
RPS2 -4449
BMS1 -4219
WDR43 -4193
SENP3 -4000
RPL27A -3830
RPP14 -3522
UTP3 -3466
RPL26 -3436
XRN2 -3409
EXOSC10 -3104
LAS1L -2788
RPL26L1 -2674
C1D -2646
NOP58 -2450
RBM28 -2400
PWP2 -2372
HEATR1 -2050
RPP38 -1540
MPHOSPH10 -1536
EXOSC9 -1534
NCL -1124
PELP1 -1092
GAR1 -548
UTP14C -518
UTP15 140
NOL11 391
TEX10 490
WDR36 1090
ERI1 1444
RPL3L 1485
RPP30 1604
RPS4Y1 2742
DIS3 3443
CSNK1D 3902
FCF1 4460
RIOK2 5348
THUMPD1 5418
KRR1 5609
RPS26 6214
RIOK3 6757
DDX52 7025
MPHOSPH6 10669



Mitochondrial tRNA aminoacylation
set Mitochondrial tRNA aminoacylation
setSize 21
pANOVA 2.66e-06
s.dist -0.592
p.adjustANOVA 3.99e-05


Top enriched genes
Top 20 genes
GeneID Gene Rank
MARS2 -10667
VARS2 -10632
NARS2 -10325
EARS2 -10256
SARS2 -9512
WARS2 -9372
YARS2 -9143
DARS2 -8625
KARS1 -8420
AARS2 -8209
TARS2 -7595
QARS1 -6124
RARS2 -5865
GARS1 -4779
FARS2 -4708
PARS2 -4625
PPA2 -4018
HARS2 -3771
LARS2 -3026
IARS2 -2797

Click HERE to show all gene set members

All member genes
GeneID Gene Rank
MARS2 -10667
VARS2 -10632
NARS2 -10325
EARS2 -10256
SARS2 -9512
WARS2 -9372
YARS2 -9143
DARS2 -8625
KARS1 -8420
AARS2 -8209
TARS2 -7595
QARS1 -6124
RARS2 -5865
GARS1 -4779
FARS2 -4708
PARS2 -4625
PPA2 -4018
HARS2 -3771
LARS2 -3026
IARS2 -2797
CARS2 8969



Major pathway of rRNA processing in the nucleolus and cytosol
set Major pathway of rRNA processing in the nucleolus and cytosol
setSize 179
pANOVA 1.69e-42
s.dist -0.591
p.adjustANOVA 8.17e-40


Top enriched genes
Top 20 genes
GeneID Gene Rank
RPP25 -10842
EBNA1BP2 -10669
EXOSC2 -10635
EXOSC6 -10625
EXOSC1 -10587
UTP18 -10440
RRP36 -10427
WDR46 -10365
BOP1 -10336
UTP4 -10318
PNO1 -10316
RPL35A -10314
IMP3 -10308
PDCD11 -10296
RCL1 -10217
IMP4 -10116
RPS7 -10107
EXOSC5 -10092
RPS4X -10083
RPL35 -10064

Click HERE to show all gene set members

All member genes
GeneID Gene Rank
RPP25 -10842
EBNA1BP2 -10669
EXOSC2 -10635
EXOSC6 -10625
EXOSC1 -10587
UTP18 -10440
RRP36 -10427
WDR46 -10365
BOP1 -10336
UTP4 -10318
PNO1 -10316
RPL35A -10314
IMP3 -10308
PDCD11 -10296
RCL1 -10217
IMP4 -10116
RPS7 -10107
EXOSC5 -10092
RPS4X -10083
RPL35 -10064
UTP11 -10023
UTP25 -10001
RPS25 -9974
RPL39 -9902
RPL10A -9900
TSR1 -9893
NOL9 -9872
RPS15 -9843
NOP14 -9831
RPL37A -9724
NOL6 -9702
RPS27 -9692
EMG1 -9688
RPL12 -9678
DHX37 -9626
RPS29 -9493
RPL27 -9376
RPS23 -9366
EXOSC8 -9355
GNL3 -9339
UTP14A -9279
RPS19 -9249
NIP7 -9248
EXOSC7 -9227
RPL32 -9210
RPP40 -9202
RPL8 -9182
RRP9 -9163
WDR12 -9147
RPL18A -9140
RPS13 -9069
RPS9 -8898
RPS20 -8867
RPL7 -8818
WDR18 -8756
RPL36 -8752
RPL38 -8730
RPL29 -8721
RPL30 -8707
RPL31 -8696
RPL11 -8598
RPL41 -8584
RPS11 -8581
RPL39L -8567
RPL10 -8533
RPL13A -8502
RPL24 -8450
UBA52 -8361
RPL15 -8344
RPS3 -8338
RPL9 -8330
PES1 -8296
RPL4 -8294
RPL36A -8292
RPL22L1 -8268
NOC4L -8265
RRP1 -8263
NOB1 -8223
RPL34 -8174
RPL19 -8095
RPL5 -8051
RPS14 -8044
RPLP0 -8042
FAU -7970
NOL12 -7862
RPS27L -7769
EXOSC3 -7748
RPS28 -7746
RPL37 -7713
FTSJ3 -7707
RPSA -7582
LTV1 -7497
NOP56 -7383
RPL18 -7362
RPS6 -7352
RRP7A -7346
RIOK1 -7324
RPS17 -7300
RPS8 -7263
RPL6 -7218
RPP21 -7169
RPL23 -7070
RPL7A -7016
ISG20L2 -6958
RPS16 -6912
RPS21 -6724
FBL -6693
SNU13 -6621
RPL3 -6594
RPS10 -6588
RPL17 -6568
RPL13 -6547
RPL28 -6445
RPS12 -6437
RPL22 -6398
RPL21 -6245
BYSL -6210
RPLP1 -6177
DDX49 -6001
RPS27A -5923
RPS15A -5860
DDX47 -5752
RPL36AL -5694
RPS5 -5467
TBL3 -5309
RPS18 -5196
RPS24 -5184
RPLP2 -5083
DDX21 -5043
CSNK1E -5011
EXOSC4 -4974
DCAF13 -4966
UTP6 -4775
RPL23A -4710
WDR75 -4638
WDR3 -4606
UTP20 -4555
RPL14 -4505
RPS3A -4498
RPS2 -4449
BMS1 -4219
WDR43 -4193
SENP3 -4000
RPL27A -3830
RPP14 -3522
UTP3 -3466
RPL26 -3436
XRN2 -3409
EXOSC10 -3104
LAS1L -2788
RPL26L1 -2674
C1D -2646
NOP58 -2450
RBM28 -2400
PWP2 -2372
HEATR1 -2050
RPP38 -1540
MPHOSPH10 -1536
EXOSC9 -1534
NCL -1124
PELP1 -1092
UTP14C -518
UTP15 140
NOL11 391
TEX10 490
WDR36 1090
ERI1 1444
RPL3L 1485
RPP30 1604
RPS4Y1 2742
DIS3 3443
CSNK1D 3902
FCF1 4460
RIOK2 5348
KRR1 5609
RPS26 6214
RIOK3 6757
DDX52 7025
MPHOSPH6 10669



rRNA processing
set rRNA processing
setSize 213
pANOVA 1.07e-49
s.dist -0.588
p.adjustANOVA 1.03e-46


Top enriched genes
Top 20 genes
GeneID Gene Rank
RPP25 -10842
MT-RNR2 -10737
EBNA1BP2 -10669
EXOSC2 -10635
EXOSC6 -10625
EXOSC1 -10587
MT-RNR1 -10561
NHP2 -10549
NAT10 -10542
UTP18 -10440
RRP36 -10427
WDR46 -10365
BOP1 -10336
UTP4 -10318
PNO1 -10316
RPL35A -10314
IMP3 -10308
PDCD11 -10296
RCL1 -10217
ELAC2 -10139

Click HERE to show all gene set members

All member genes
GeneID Gene Rank
RPP25 -10842
MT-RNR2 -10737
EBNA1BP2 -10669
EXOSC2 -10635
EXOSC6 -10625
EXOSC1 -10587
MT-RNR1 -10561
NHP2 -10549
NAT10 -10542
UTP18 -10440
RRP36 -10427
WDR46 -10365
BOP1 -10336
UTP4 -10318
PNO1 -10316
RPL35A -10314
IMP3 -10308
PDCD11 -10296
RCL1 -10217
ELAC2 -10139
IMP4 -10116
RPS7 -10107
EXOSC5 -10092
MRM2 -10086
RPS4X -10083
MT-ND3 -10068
RPL35 -10064
UTP11 -10023
UTP25 -10001
RPS25 -9974
RPL39 -9902
RPL10A -9900
TSR1 -9893
NOL9 -9872
RPS15 -9843
NOP14 -9831
RPL37A -9724
NOL6 -9702
RPS27 -9692
EMG1 -9688
RPL12 -9678
HSD17B10 -9671
DHX37 -9626
MT-ATP8 -9565
TSR3 -9533
RPS29 -9493
RPL27 -9376
RPS23 -9366
EXOSC8 -9355
GNL3 -9339
UTP14A -9279
RPS19 -9249
NIP7 -9248
EXOSC7 -9227
RPL32 -9210
RPP40 -9202
MRM3 -9187
RPL8 -9182
RRP9 -9163
WDR12 -9147
RPL18A -9140
TRMT112 -9102
RPS13 -9069
RPS9 -8898
DKC1 -8895
RPS20 -8867
RPL7 -8818
WDR18 -8756
RPL36 -8752
RPL38 -8730
RPL29 -8721
RPL30 -8707
RPL31 -8696
MT-ND4L -8652
RPL11 -8598
RPL41 -8584
RPS11 -8581
RPL39L -8567
RPL10 -8533
RPL13A -8502
RPL24 -8450
UBA52 -8361
RPL15 -8344
RPS3 -8338
RPL9 -8330
PES1 -8296
RPL4 -8294
RPL36A -8292
MRM1 -8282
RPL22L1 -8268
NOC4L -8265
RRP1 -8263
NOP10 -8242
NOB1 -8223
RPL34 -8174
RPL19 -8095
RPL5 -8051
RPS14 -8044
RPLP0 -8042
FAU -7970
NOL12 -7862
RPS27L -7769
EXOSC3 -7748
RPS28 -7746
RPL37 -7713
FTSJ3 -7707
NOP2 -7643
RPSA -7582
LTV1 -7497
NOP56 -7383
RPL18 -7362
RPS6 -7352
RRP7A -7346
RIOK1 -7324
RPS17 -7300
MT-ND2 -7271
RPS8 -7263
RPL6 -7218
MT-ND1 -7183
RPP21 -7169
RPL23 -7070
RPL7A -7016
ISG20L2 -6958
MT-CO2 -6916
RPS16 -6912
RPS21 -6724
FBL -6693
SNU13 -6621
RPL3 -6594
RPS10 -6588
RPL17 -6568
RPL13 -6547
RPL28 -6445
RPS12 -6437
RPL22 -6398
RPL21 -6245
BYSL -6210
RPLP1 -6177
MT-ATP6 -6047
DDX49 -6001
RPS27A -5923
RPS15A -5860
DDX47 -5752
RPL36AL -5694
RPS5 -5467
DIMT1 -5352
TBL3 -5309
MT-ND4 -5282
RPS18 -5196
RPS24 -5184
RPLP2 -5083
DDX21 -5043
CSNK1E -5011
EXOSC4 -4974
DCAF13 -4966
MT-CO3 -4964
UTP6 -4775
RPL23A -4710
WDR75 -4638
WDR3 -4606
UTP20 -4555
RPL14 -4505
RPS3A -4498
RPS2 -4449
BMS1 -4219
WDR43 -4193
SENP3 -4000
PRORP -3920
RPL27A -3830
RPP14 -3522
UTP3 -3466
RPL26 -3436
XRN2 -3409
EXOSC10 -3104
TFB1M -2974
LAS1L -2788
MTERF4 -2701
RPL26L1 -2674
C1D -2646
NOP58 -2450
RBM28 -2400
PWP2 -2372
HEATR1 -2050
MT-CYB -1782
MT-ND5 -1733
RPP38 -1540
MPHOSPH10 -1536
EXOSC9 -1534
NCL -1124
PELP1 -1092
TRMT10C -799
GAR1 -548
UTP14C -518
MT-CO1 49
UTP15 140
NOL11 391
TEX10 490
WDR36 1090
ERI1 1444
RPL3L 1485
RPP30 1604
RPS4Y1 2742
DIS3 3443
CSNK1D 3902
FCF1 4460
RIOK2 5348
THUMPD1 5418
KRR1 5609
RPS26 6214
RIOK3 6757
DDX52 7025
NSUN4 8464
MPHOSPH6 10669



Formation of xylulose-5-phosphate
set Formation of xylulose-5-phosphate
setSize 5
pANOVA 0.0254
s.dist -0.577
p.adjustANOVA 0.102


Top enriched genes
Top 20 genes
GeneID Gene Rank
XYLB -9998
DCXR -8257
CRYL1 -7709
AKR1A1 -7668
SORD 2625

Click HERE to show all gene set members

All member genes
GeneID Gene Rank
XYLB -9998
DCXR -8257
CRYL1 -7709
AKR1A1 -7668
SORD 2625



Classical antibody-mediated complement activation
set Classical antibody-mediated complement activation
setSize 69
pANOVA 1.19e-16
s.dist -0.576
p.adjustANOVA 5.47e-15


Top enriched genes
Top 20 genes
GeneID Gene Rank
C1QB -10817
C1QC -10809
IGKV2-28 -10807
IGKV1-33 -10805
IGLV6-57 -10802
IGKV4-1 -10770
IGLV1-36 -10734
IGLV3-27 -10723
IGLC2 -10702
C1QA -10645
IGHV4-34 -10617
IGLV7-43 -10594
IGKV3-20 -10513
IGLV2-11 -10488
IGKV3D-20 -10456
IGLV1-51 -10379
IGLV3-1 -10206
IGLV7-46 -10095
IGLC3 -10035
IGLV1-47 -9946

Click HERE to show all gene set members

All member genes
GeneID Gene Rank
C1QB -10817
C1QC -10809
IGKV2-28 -10807
IGKV1-33 -10805
IGLV6-57 -10802
IGKV4-1 -10770
IGLV1-36 -10734
IGLV3-27 -10723
IGLC2 -10702
C1QA -10645
IGHV4-34 -10617
IGLV7-43 -10594
IGKV3-20 -10513
IGLV2-11 -10488
IGKV3D-20 -10456
IGLV1-51 -10379
IGLV3-1 -10206
IGLV7-46 -10095
IGLC3 -10035
IGLV1-47 -9946
IGLV3-21 -9929
IGLV3-19 -9884
IGLV1-44 -9858
IGKV1D-39 -9779
IGLV3-25 -9665
IGHV1-2 -9628
IGHV2-70 -9589
IGHG4 -9495
IGHV3-33 -9479
IGLV2-8 -9219
IGLC1 -9026
IGLV2-18 -8832
IGKV1-16 -8690
IGHV3-7 -8400
IGKV3-15 -8367
IGLC7 -8214
IGLV2-23 -8115
IGKC -8001
IGLV1-40 -7292
IGHV1-46 -7248
IGHV3-48 -6908
IGHV4-39 -6727
IGHV2-5 -6647
IGKV1-5 -6206
IGHG3 -6202
IGHV4-59 -5710
IGKV1-12 -5595
IGHV3-11 -5440
IGHG1 -5252
IGHG2 -4240
C1S -3483
IGHV3-30 -3434
IGLV5-45 -3183
IGHV3-13 -2907
IGKV1-17 -2753
IGLV2-14 -2027
IGLV8-61 -1836
IGKV2D-28 -1493
IGKV2-29 -755
IGHV3-23 90
IGHV1-69 125
IGKV2-30 689
IGLV4-69 1961
IGLV10-54 2526
C1R 4842
IGKV3-11 7469
IGHV3-53 8185
IGLV4-60 8394
IGLV3-12 10166



Formation of the ternary complex, and subsequently, the 43S complex
set Formation of the ternary complex, and subsequently, the 43S complex
setSize 51
pANOVA 1.11e-12
s.dist -0.576
p.adjustANOVA 3.89e-11


Top enriched genes
Top 20 genes
GeneID Gene Rank
EIF3B -10153
RPS7 -10107
RPS4X -10083
RPS25 -9974
RPS15 -9843
RPS27 -9692
EIF3I -9532
RPS29 -9493
RPS23 -9366
RPS19 -9249
RPS13 -9069
RPS9 -8898
RPS20 -8867
RPS11 -8581
RPS3 -8338
EIF3G -8229
RPS14 -8044
FAU -7970
RPS27L -7769
RPS28 -7746

Click HERE to show all gene set members

All member genes
GeneID Gene Rank
EIF3B -10153
RPS7 -10107
RPS4X -10083
RPS25 -9974
RPS15 -9843
RPS27 -9692
EIF3I -9532
RPS29 -9493
RPS23 -9366
RPS19 -9249
RPS13 -9069
RPS9 -8898
RPS20 -8867
RPS11 -8581
RPS3 -8338
EIF3G -8229
RPS14 -8044
FAU -7970
RPS27L -7769
RPS28 -7746
RPSA -7582
RPS6 -7352
RPS17 -7300
RPS8 -7263
RPS16 -6912
RPS21 -6724
EIF3K -6700
RPS10 -6588
RPS12 -6437
EIF3H -6411
EIF3L -6237
EIF3D -6167
EIF3M -6070
RPS27A -5923
RPS15A -5860
RPS5 -5467
EIF3C -5239
RPS18 -5196
RPS24 -5184
RPS3A -4498
RPS2 -4449
EIF3E -3969
EIF2S3 -3687
EIF3A -2993
EIF3F -2893
EIF2S1 -2885
EIF2S2 -1965
EIF3J -1222
RPS4Y1 2742
RPS26 6214
EIF1AX 6407



SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs
set SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs
setSize 11
pANOVA 0.00103
s.dist -0.571
p.adjustANOVA 0.00787


Top enriched genes
Top 20 genes
GeneID Gene Rank
SNRPG -10469
SNRPE -9833
SLBP -9459
SNRPB -9362
NCBP2 -7851
LSM11 -7765
SNRPF -6760
LSM10 -4071
ZNF473 -3833
SNRPD3 -159
NCBP1 2072

Click HERE to show all gene set members

All member genes
GeneID Gene Rank
SNRPG -10469
SNRPE -9833
SLBP -9459
SNRPB -9362
NCBP2 -7851
LSM11 -7765
SNRPF -6760
LSM10 -4071
ZNF473 -3833
SNRPD3 -159
NCBP1 2072



Folding of actin by CCT/TriC
set Folding of actin by CCT/TriC
setSize 10
pANOVA 0.00203
s.dist -0.564
p.adjustANOVA 0.0137


Top enriched genes
Top 20 genes
GeneID Gene Rank
CCT4 -10388
CCT7 -9695
CCT3 -9539
CCT6A -8656
CCT8 -8599
CCT5 -8029
CCT2 -5546
TCP1 -4794
CCT6B -580
ACTB 5309

Click HERE to show all gene set members

All member genes
GeneID Gene Rank
CCT4 -10388
CCT7 -9695
CCT3 -9539
CCT6A -8656
CCT8 -8599
CCT5 -8029
CCT2 -5546
TCP1 -4794
CCT6B -580
ACTB 5309



Ribosomal scanning and start codon recognition
set Ribosomal scanning and start codon recognition
setSize 58
pANOVA 1.5e-13
s.dist -0.56
p.adjustANOVA 5.92e-12


Top enriched genes
Top 20 genes
GeneID Gene Rank
EIF3B -10153
RPS7 -10107
RPS4X -10083
RPS25 -9974
RPS15 -9843
RPS27 -9692
EIF3I -9532
RPS29 -9493
RPS23 -9366
RPS19 -9249
RPS13 -9069
RPS9 -8898
RPS20 -8867
EIF4H -8586
RPS11 -8581
RPS3 -8338
EIF3G -8229
RPS14 -8044
FAU -7970
RPS27L -7769

Click HERE to show all gene set members

All member genes
GeneID Gene Rank
EIF3B -10153
RPS7 -10107
RPS4X -10083
RPS25 -9974
RPS15 -9843
RPS27 -9692
EIF3I -9532
RPS29 -9493
RPS23 -9366
RPS19 -9249
RPS13 -9069
RPS9 -8898
RPS20 -8867
EIF4H -8586
RPS11 -8581
RPS3 -8338
EIF3G -8229
RPS14 -8044
FAU -7970
RPS27L -7769
RPS28 -7746
RPSA -7582
EIF4G1 -7513
RPS6 -7352
RPS17 -7300
RPS8 -7263
RPS16 -6912
RPS21 -6724
EIF3K -6700
RPS10 -6588
EIF5 -6459
RPS12 -6437
EIF3H -6411
EIF4A1 -6254
EIF3L -6237
EIF3D -6167
EIF3M -6070
RPS27A -5923
RPS15A -5860
EIF4B -5727
RPS5 -5467
EIF3C -5239
RPS18 -5196
RPS24 -5184
RPS3A -4498
RPS2 -4449
EIF3E -3969
EIF2S3 -3687
EIF3A -2993
EIF3F -2893
EIF2S1 -2885
EIF2S2 -1965
EIF4E -1527
EIF3J -1222
EIF4A2 2695
RPS4Y1 2742
RPS26 6214
EIF1AX 6407



Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus
set Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus
setSize 5
pANOVA 0.0301
s.dist -0.56
p.adjustANOVA 0.116


Top enriched genes
Top 20 genes
GeneID Gene Rank
GAS6 -10599
PROZ -6508
PROS1 -6348
PROC -4989
BGLAP -1634

Click HERE to show all gene set members

All member genes
GeneID Gene Rank
GAS6 -10599
PROZ -6508
PROS1 -6348
PROC -4989
BGLAP -1634



Cytosolic iron-sulfur cluster assembly
set Cytosolic iron-sulfur cluster assembly
setSize 13
pANOVA 0.000472
s.dist -0.56
p.adjustANOVA 0.00399


Top enriched genes
Top 20 genes
GeneID Gene Rank
CIAPIN1 -10384
CIAO1 -10052
NUBP2 -8835
NUBP1 -7969
RTEL1 -7410
ERCC2 -7317
POLD1 -7050
CIAO2B -6120
CIAO3 -5947
NDOR1 -5661
ABCB7 -4559
MMS19 -3707
BRIP1 6880

Click HERE to show all gene set members

All member genes
GeneID Gene Rank
CIAPIN1 -10384
CIAO1 -10052
NUBP2 -8835
NUBP1 -7969
RTEL1 -7410
ERCC2 -7317
POLD1 -7050
CIAO2B -6120
CIAO3 -5947
NDOR1 -5661
ABCB7 -4559
MMS19 -3707
BRIP1 6880



Selenoamino acid metabolism
set Selenoamino acid metabolism
setSize 115
pANOVA 3.38e-25
s.dist -0.559
p.adjustANOVA 2.25e-23


Top enriched genes
Top 20 genes
GeneID Gene Rank
AIMP2 -10529
RPL35A -10314
EEFSEC -10115
RPS7 -10107
RPS4X -10083
RPL35 -10064
RPS25 -9974
AHCY -9963
RPL39 -9902
RPL10A -9900
RPS15 -9843
RPL37A -9724
RPS27 -9692
RPL12 -9678
RPS29 -9493
RPL27 -9376
RPS23 -9366
RPS19 -9249
RPL32 -9210
RPL8 -9182

Click HERE to show all gene set members

All member genes
GeneID Gene Rank
AIMP2 -10529
RPL35A -10314
EEFSEC -10115
RPS7 -10107
RPS4X -10083
RPL35 -10064
RPS25 -9974
AHCY -9963
RPL39 -9902
RPL10A -9900
RPS15 -9843
RPL37A -9724
RPS27 -9692
RPL12 -9678
RPS29 -9493
RPL27 -9376
RPS23 -9366
RPS19 -9249
RPL32 -9210
RPL8 -9182
RPL18A -9140
RPS13 -9069
RPS9 -8898
RPS20 -8867
RPL7 -8818
RPL36 -8752
RPL38 -8730
RPL29 -8721
RPL30 -8707
RPL31 -8696
RPL11 -8598
RPL41 -8584
RPS11 -8581
RPL39L -8567
RPL10 -8533
RPL13A -8502
RPL24 -8450
KARS1 -8420
UBA52 -8361
RPL15 -8344
RPS3 -8338
RPL9 -8330
RPL4 -8294
RPL36A -8292
RPL22L1 -8268
RPL34 -8174
RPL19 -8095
RPL5 -8051
RPS14 -8044
RPLP0 -8042
EEF1E1 -8040
FAU -7970
RPS27L -7769
RPS28 -7746
IARS1 -7737
RPL37 -7713
RPSA -7582
PAPSS1 -7563
RPL18 -7362
RPS6 -7352
RPS17 -7300
RPS8 -7263
RPL6 -7218
RPL23 -7070
RPL7A -7016
RPS16 -6912
RPS21 -6724
RPL3 -6594
RPS10 -6588
RPL17 -6568
RPL13 -6547
RPL28 -6445
RPS12 -6437
RPL22 -6398
RPL21 -6245
RPLP1 -6177
QARS1 -6124
TXNRD1 -6032
RPS27A -5923
RPS15A -5860
RPL36AL -5694
RPS5 -5467
RPS18 -5196
RPS24 -5184
RPLP2 -5083
GSR -4796
RPL23A -4710
SARS1 -4601
RPL14 -4505
RPS3A -4498
EPRS1 -4453
RPS2 -4449
MARS1 -4123
RPL27A -3830
LARS1 -3649
SEPHS2 -3520
RPL26 -3436
RPL26L1 -2674
CBS -798
SCLY -754
RARS1 -516
AIMP1 -390
SEPSECS 1390
RPL3L 1485
PSTK 1551
INMT 1929
NNMT 2471
RPS4Y1 2742
SECISBP2 3596
DARS1 4906
GNMT 5059
RPS26 6214
PAPSS2 6217
HNMT 8428
CTH 8735



Here is the session info with all the versions of packages used.

sessionInfo()
## R version 4.4.1 (2024-06-14)
## Platform: x86_64-pc-linux-gnu
## Running under: Ubuntu 22.04.5 LTS
## 
## Matrix products: default
## BLAS:   /usr/lib/x86_64-linux-gnu/blas/libblas.so.3.10.0 
## LAPACK: /usr/lib/x86_64-linux-gnu/lapack/liblapack.so.3.10.0
## 
## locale:
##  [1] LC_CTYPE=en_US.UTF-8          LC_NUMERIC=C                 
##  [3] LC_TIME=en_US.UTF-8           LC_COLLATE=en_US.UTF-8       
##  [5] LC_MONETARY=en_US.UTF-8       LC_MESSAGES=en_US.UTF-8      
##  [7] LC_PAPER=en_US.UTF-8          LC_NAME=en_US.UTF-8          
##  [9] LC_ADDRESS=en_US.UTF-8        LC_TELEPHONE=en_US.UTF-8     
## [11] LC_MEASUREMENT=en_US.UTF-8    LC_IDENTIFICATION=en_US.UTF-8
## 
## time zone: Australia/Melbourne
## tzcode source: system (glibc)
## 
## attached base packages:
## [1] stats4    stats     graphics  grDevices utils     datasets  methods  
## [8] base     
## 
## other attached packages:
##  [1] pkgload_1.4.0               GGally_2.2.1               
##  [3] beeswarm_0.4.0              gtools_3.9.5               
##  [5] tibble_3.2.1                echarts4r_0.4.5            
##  [7] xlsx_0.6.5                  DT_0.33                    
##  [9] eulerr_7.0.2                ggplot2_3.5.1              
## [11] kableExtra_1.4.0            MASS_7.3-61                
## [13] mitch_1.17.4                DESeq2_1.44.0              
## [15] SummarizedExperiment_1.34.0 Biobase_2.64.0             
## [17] MatrixGenerics_1.16.0       matrixStats_1.4.1          
## [19] GenomicRanges_1.56.1        GenomeInfoDb_1.40.1        
## [21] IRanges_2.38.1              S4Vectors_0.42.1           
## [23] BiocGenerics_0.50.0         dplyr_1.1.4                
## [25] WGCNA_1.73                  fastcluster_1.2.6          
## [27] dynamicTreeCut_1.63-1       reshape2_1.4.4             
## [29] gplots_3.2.0               
## 
## loaded via a namespace (and not attached):
##   [1] RColorBrewer_1.1-3      rstudioapi_0.17.1       jsonlite_1.8.9         
##   [4] magrittr_2.0.3          farver_2.1.2            rmarkdown_2.28         
##   [7] zlibbioc_1.50.0         vctrs_0.6.5             memoise_2.0.1.9000     
##  [10] base64enc_0.1-3         progress_1.2.3          htmltools_0.5.8.1      
##  [13] S4Arrays_1.4.1          SparseArray_1.4.8       Formula_1.2-5          
##  [16] sass_0.4.9              KernSmooth_2.23-24      bslib_0.8.0            
##  [19] htmlwidgets_1.6.4       plyr_1.8.9              impute_1.78.0          
##  [22] cachem_1.1.0            mime_0.12               lifecycle_1.0.4        
##  [25] iterators_1.0.14        pkgconfig_2.0.3         Matrix_1.7-0           
##  [28] R6_2.5.1                fastmap_1.2.0           GenomeInfoDbData_1.2.12
##  [31] shiny_1.9.1             digest_0.6.37           colorspace_2.1-1       
##  [34] AnnotationDbi_1.66.0    Hmisc_5.1-3             RSQLite_2.3.7          
##  [37] labeling_0.4.3          fansi_1.0.6             httr_1.4.7             
##  [40] abind_1.4-8             compiler_4.4.1          bit64_4.5.2            
##  [43] withr_3.0.1             doParallel_1.0.17       htmlTable_2.4.3        
##  [46] backports_1.5.0         BiocParallel_1.38.0     DBI_1.2.3              
##  [49] ggstats_0.7.0           highr_0.11              DelayedArray_0.30.1    
##  [52] caTools_1.18.3          tools_4.4.1             foreign_0.8-87         
##  [55] httpuv_1.6.15           nnet_7.3-19             glue_1.8.0             
##  [58] promises_1.3.0          grid_4.4.1              checkmate_2.3.2        
##  [61] cluster_2.1.6           generics_0.1.3          gtable_0.3.5           
##  [64] preprocessCore_1.66.0   tidyr_1.3.1             hms_1.1.3              
##  [67] data.table_1.16.0       xml2_1.3.6              utf8_1.2.4             
##  [70] XVector_0.44.0          foreach_1.5.2           pillar_1.9.0           
##  [73] stringr_1.5.1           later_1.3.2             rJava_1.0-11           
##  [76] splines_4.4.1           lattice_0.22-6          survival_3.7-0         
##  [79] bit_4.5.0               tidyselect_1.2.1        GO.db_3.19.1           
##  [82] locfit_1.5-9.10         Biostrings_2.72.1       knitr_1.48             
##  [85] gridExtra_2.3           svglite_2.1.3           xfun_0.48              
##  [88] stringi_1.8.4           UCSC.utils_1.0.0        yaml_2.3.10            
##  [91] xlsxjars_0.6.1          evaluate_1.0.1          codetools_0.2-20       
##  [94] cli_3.6.3               rpart_4.1.23            xtable_1.8-4           
##  [97] systemfonts_1.1.0       munsell_0.5.1           jquerylib_0.1.4        
## [100] Rcpp_1.0.13             png_0.1-8               parallel_4.4.1         
## [103] blob_1.2.4              prettyunits_1.2.0       bitops_1.0-9           
## [106] viridisLite_0.4.2       scales_1.3.0            purrr_1.0.2            
## [109] crayon_1.5.3            rlang_1.1.4             KEGGREST_1.44.1

END of report